
<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="en">
	<id>https://proteopedia.org/api.php?action=feedcontributions&amp;feedformat=atom&amp;user=Mahalia+Serrano</id>
	<title>Proteopedia - User contributions [en]</title>
	<link rel="self" type="application/atom+xml" href="https://proteopedia.org/api.php?action=feedcontributions&amp;feedformat=atom&amp;user=Mahalia+Serrano"/>
	<link rel="alternate" type="text/html" href="https://proteopedia.org/Special:Contributions/Mahalia_Serrano"/>
	<updated>2026-09-18T08:31:38Z</updated>
	<subtitle>User contributions</subtitle>
	<generator>MediaWiki 1.43.8</generator>
	<entry>
		<id>https://proteopedia.org/index.php?title=Molecular_Playground/Human_Serum_Albumin&amp;diff=2079641</id>
		<title>Molecular Playground/Human Serum Albumin</title>
		<link rel="alternate" type="text/html" href="https://proteopedia.org/index.php?title=Molecular_Playground/Human_Serum_Albumin&amp;diff=2079641"/>
		<updated>2014-12-08T20:39:17Z</updated>

		<summary type="html">&lt;p&gt;Mahalia Serrano: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;==&#039;&#039;&#039;HUMAN SERUM ALBUMIN (HSA)&#039;&#039;&#039;==&lt;br /&gt;
&amp;lt;StructureSection load=&#039;4K2C_all_domains_v2.pdb&#039; size=&#039;500&#039; side=&#039;right&#039; caption=&#039;Human serum albumin (PDB code [[4iw1]])&#039; scene=&#039;&#039;&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Human serum albumin&#039;&#039;&#039; (HSA) is the most abundant protein in the blood plasma, amounting to about 35 to 50 grams per liter of serum.  With a molecular weight of about 66.5 kDa, it functions mainly to maintain the pH and osmotic pressure of the blood and to transport a wide variety of endogenous and exogenous substances.&lt;br /&gt;
&lt;br /&gt;
== Structure ==&lt;br /&gt;
&lt;br /&gt;
HSA exists as a monomer that is comprised mostly of alpha helices. Each of the &amp;lt;scene name=&#039;57/571397/Different_domains_v2/1&#039;&amp;gt;three homologous helical domains&amp;lt;/scene&amp;gt; &lt;br /&gt;
(&amp;lt;B&amp;gt;&amp;lt;font color=&amp;quot;purple&amp;quot;&amp;gt;domain I&amp;lt;/font&amp;gt;&amp;lt;/B&amp;gt;, &amp;lt;B&amp;gt;&amp;lt;font color=&amp;quot;orange&amp;quot;&amp;gt;domain II&amp;lt;/font&amp;gt;&amp;lt;/B&amp;gt;, &amp;lt;B&amp;gt;&amp;lt;font color=&amp;quot;cyan&amp;quot;&amp;gt;domain III&amp;lt;/font&amp;gt;&amp;lt;/B&amp;gt;)&lt;br /&gt;
is further divided into subdomains A and B (A=darker shade, B=lighter shade), which then form several hydrophobic pockets throughout the molecule. This multidomain structure of HSA allows it to bind many different classes of ligands at multiple sites.&lt;br /&gt;
&lt;br /&gt;
== Function ==&lt;br /&gt;
&lt;br /&gt;
Being the major protein in blood, HSA functions to maintain the osmotic pressure and the pH of the blood. Most importantly, it acts as a depot and carrier of various substances through the bloodstream.  HSA does not carry a specific cargo, although it does have preference for fat-soluble substances as it can bury the water-insoluble molecules into its hydrophobic core.  &amp;lt;scene name=&#039;57/571397/Hsa_with_myr_and_aspirin/5&#039;&amp;gt;Here&amp;lt;/scene&amp;gt;, we can see  HSA with both &amp;lt;B&amp;gt;&amp;lt;font color=&amp;quot;grey&amp;quot;&amp;gt;myristate&amp;lt;/font&amp;gt;&amp;lt;/B&amp;gt; (a fatty acid) and &amp;lt;B&amp;gt;&amp;lt;font color=&amp;quot;magenta&amp;quot;&amp;gt;aspirin&amp;lt;/font&amp;gt;&amp;lt;/B&amp;gt; (a common analgesic) bound to its hydrophobic pockets.  HSA transports a wide variety of substances through the bloodstream including carbohydrates (e.g &amp;lt;scene name=&#039;57/571397/Hsa_with_glucose/6&#039;&amp;gt;glucose&amp;lt;/scene&amp;gt;), fatty acids (e.g. &amp;lt;scene name=&#039;57/571397/Hsa_with_arachidonic_acid/3&#039;&amp;gt;arachidonic acid&amp;lt;/scene&amp;gt;), hormones (e.g. &amp;lt;scene name=&#039;57/571397/Hsa_with_thyroxine/6&#039;&amp;gt;thyroxine&amp;lt;/scene&amp;gt;, a thyroid hormone), and drugs (e.g. &amp;lt;scene name=&#039;57/571397/Hsa_with_ibp/3&#039;&amp;gt;ibuprofen&amp;lt;/scene&amp;gt;, an anti-inflammatory drug).&lt;br /&gt;
&lt;br /&gt;
       [[Image:Various HSA ligands small.png]]&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== Role in pharmacokinetics ==&lt;br /&gt;
&lt;br /&gt;
The affinity of HSA for various drugs affects their pharmacokinetics and efficacy. Although binding to HSA helps solubilize the drug in the plasma, too strong affinity to HSA limits the free/available forms of the drug, meaning that higher doses must be administered to achieve the desired efficacy of the drug &#039;&#039;in vivo&#039;&#039;.  &lt;br /&gt;
&lt;br /&gt;
== Removal of HSA in serum for biomarker studies ==&lt;br /&gt;
&lt;br /&gt;
Because HSA is very abundant in blood serum, most biomarker studies involving serum requires preliminary removal of HSA so that other non-abundant but otherwise important disease-indicating proteins can be detected.  In our group, we exploit several properties of HSA in order to efficiently remove it from serum prior to biomarker analysis. These properties include its low isoelectric point (pI of about 4.7) due to a number of &amp;lt;scene name=&#039;57/571397/Acidic_residues/1&#039;&amp;gt;acidic residues&amp;lt;/scene&amp;gt;, and its tendency to bind hydrophobic molecules through its hydrophobic pockets.&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== References ==&lt;br /&gt;
&lt;br /&gt;
[http://onlinelibrary.wiley.com/doi/10.1080/15216540500404093/pdf] Fasano, M., Curry, S., Terreno, E., Galliano, M., Fanali, G., Narciso, P., … Ascenzi, P. (2005). The extraordinary ligand binding properties of human serum albumin. IUBMB Life, 57(12), 787–96. &lt;br /&gt;
&lt;br /&gt;
[http://www.ncbi.nlm.nih.gov/pubmed/16169013] Ghuman, J., Zunszain, P. a, Petitpas, I., Bhattacharya, A. a, Otagiri, M., &amp;amp; Curry, S. (2005). Structural basis of the drug-binding specificity of human serum albumin. Journal of Molecular Biology, 353(1), 38–52.&lt;br /&gt;
&lt;br /&gt;
[http://www.ncbi.nlm.nih.gov/pubmed/15619298] Björhall, K., Miliotis, T., &amp;amp; Davidsson, P. (2005). Comparison of different depletion strategies for improved resolution in proteomic analysis of human serum samples. Proteomics, 5(1), 307–17.&lt;/div&gt;</summary>
		<author><name>Mahalia Serrano</name></author>
	</entry>
	<entry>
		<id>https://proteopedia.org/index.php?title=Molecular_Playground/Human_Serum_Albumin&amp;diff=2076010</id>
		<title>Molecular Playground/Human Serum Albumin</title>
		<link rel="alternate" type="text/html" href="https://proteopedia.org/index.php?title=Molecular_Playground/Human_Serum_Albumin&amp;diff=2076010"/>
		<updated>2014-12-04T23:05:51Z</updated>

		<summary type="html">&lt;p&gt;Mahalia Serrano: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;==&#039;&#039;&#039;HUMAN SERUM ALBUMIN (HSA)&#039;&#039;&#039;==&lt;br /&gt;
&amp;lt;StructureSection load=&#039;4K2C_all_domains_v2.pdb&#039; size=&#039;500&#039; side=&#039;right&#039; caption=&#039;Human serum albumin (PDB code [[4iw1]])&#039; scene=&#039;&#039;&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Human serum albumin&#039;&#039;&#039; (HSA) is the most abundant protein in the blood plasma, amounting to about 35 to 50 grams per liter of serum.  With a molecular weight of about 66.5 kDa, it functions mainly to maintain the pH and osmotic pressure of the blood and to transport a wide variety of endogenous and exogenous substances.&lt;br /&gt;
&lt;br /&gt;
== Structure ==&lt;br /&gt;
&lt;br /&gt;
HSA exists as a monomer that is comprised mostly of alpha helices. Each of the &amp;lt;scene name=&#039;57/571397/Different_domains_v2/1&#039;&amp;gt;three homologous helical domains&amp;lt;/scene&amp;gt; &lt;br /&gt;
(&amp;lt;B&amp;gt;&amp;lt;font color=&amp;quot;purple&amp;quot;&amp;gt;domain I&amp;lt;/font&amp;gt;&amp;lt;/B&amp;gt;, &amp;lt;B&amp;gt;&amp;lt;font color=&amp;quot;orange&amp;quot;&amp;gt;domain II&amp;lt;/font&amp;gt;&amp;lt;/B&amp;gt;, &amp;lt;B&amp;gt;&amp;lt;font color=&amp;quot;cyan&amp;quot;&amp;gt;domain III&amp;lt;/font&amp;gt;&amp;lt;/B&amp;gt;)&lt;br /&gt;
are further divided into subdomains A and B (A=darker shade, B=lighter shade), which form several hydrophobic pockets throughout the molecule. This multidomain structure of HSA allow it to bind many different classes of ligands at multiple sites.&lt;br /&gt;
&lt;br /&gt;
== Function ==&lt;br /&gt;
&lt;br /&gt;
Being the major protein in blood, HSA functions to maintain the osmotic pressure and the pH of the blood. Most importantly, it acts as a depot and carrier of various substances through the bloodstream.  HSA does not carry a specific cargo, although it does have preference for fat-soluble substances as it can bury the water-insoluble molecules into its hydrophobic core.  &amp;lt;scene name=&#039;57/571397/Hsa_with_myr_and_aspirin/5&#039;&amp;gt;Here&amp;lt;/scene&amp;gt;, we can see  HSA with both &amp;lt;B&amp;gt;&amp;lt;font color=&amp;quot;grey&amp;quot;&amp;gt;myristate&amp;lt;/font&amp;gt;&amp;lt;/B&amp;gt; (a fatty acid) and &amp;lt;B&amp;gt;&amp;lt;font color=&amp;quot;magenta&amp;quot;&amp;gt;aspirin&amp;lt;/font&amp;gt;&amp;lt;/B&amp;gt; (a common analgesic) bound to its hydrophobic pockets.  HSA transports a wide variety of substances through the bloodstream including carbohydrates (e.g &amp;lt;scene name=&#039;57/571397/Hsa_with_glucose/6&#039;&amp;gt;glucose&amp;lt;/scene&amp;gt;), fatty acids (e.g. &amp;lt;scene name=&#039;57/571397/Hsa_with_arachidonic_acid/3&#039;&amp;gt;arachidonic acid&amp;lt;/scene&amp;gt;), hormones (e.g. &amp;lt;scene name=&#039;57/571397/Hsa_with_thyroxine/6&#039;&amp;gt;thyroxine&amp;lt;/scene&amp;gt;, a thyroid hormone), and drugs (e.g. &amp;lt;scene name=&#039;57/571397/Hsa_with_ibp/3&#039;&amp;gt;ibuprofen&amp;lt;/scene&amp;gt;, an anti-inflammatory drug).&lt;br /&gt;
&lt;br /&gt;
       [[Image:Various HSA ligands small.png]]&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== Role in pharmacokinetics ==&lt;br /&gt;
&lt;br /&gt;
The affinity of HSA for various drugs affects their pharmacokinetics and efficacy. Although binding to HSA helps solubilize the drug in the plasma, too strong affinity to HSA limits the free/available forms of the drug, meaning that higher doses must be administered to achieve the desired efficacy of the drug &#039;&#039;in vivo&#039;&#039;.  &lt;br /&gt;
&lt;br /&gt;
== Removal of HSA in serum for biomarker studies ==&lt;br /&gt;
&lt;br /&gt;
Because HSA is very abundant in blood serum, most biomarker studies involving serum requires preliminary removal of HSA so that other non-abundant but otherwise important disease-indicating proteins can be detected.  In our group, we exploit several properties of HSA in order to efficiently remove it from serum prior to biomarker analysis. These properties include its low isoelectric point (pI of about 4.7) due to a number of &amp;lt;scene name=&#039;57/571397/Acidic_residues/1&#039;&amp;gt;acidic residues&amp;lt;/scene&amp;gt;, and its tendency to bind hydrophobic molecules through its hydrophobic pockets.&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== References ==&lt;br /&gt;
&lt;br /&gt;
[http://onlinelibrary.wiley.com/doi/10.1080/15216540500404093/pdf] Fasano, M., Curry, S., Terreno, E., Galliano, M., Fanali, G., Narciso, P., … Ascenzi, P. (2005). The extraordinary ligand binding properties of human serum albumin. IUBMB Life, 57(12), 787–96. &lt;br /&gt;
&lt;br /&gt;
[http://www.ncbi.nlm.nih.gov/pubmed/16169013] Ghuman, J., Zunszain, P. a, Petitpas, I., Bhattacharya, A. a, Otagiri, M., &amp;amp; Curry, S. (2005). Structural basis of the drug-binding specificity of human serum albumin. Journal of Molecular Biology, 353(1), 38–52.&lt;br /&gt;
&lt;br /&gt;
[http://www.ncbi.nlm.nih.gov/pubmed/15619298] Björhall, K., Miliotis, T., &amp;amp; Davidsson, P. (2005). Comparison of different depletion strategies for improved resolution in proteomic analysis of human serum samples. Proteomics, 5(1), 307–17.&lt;/div&gt;</summary>
		<author><name>Mahalia Serrano</name></author>
	</entry>
	<entry>
		<id>https://proteopedia.org/index.php?title=Molecular_Playground/Human_Serum_Albumin&amp;diff=2075872</id>
		<title>Molecular Playground/Human Serum Albumin</title>
		<link rel="alternate" type="text/html" href="https://proteopedia.org/index.php?title=Molecular_Playground/Human_Serum_Albumin&amp;diff=2075872"/>
		<updated>2014-12-04T07:01:44Z</updated>

		<summary type="html">&lt;p&gt;Mahalia Serrano: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;== &#039;&#039;&#039;HUMAN SERUM ALBUMIN (HSA)&#039;&#039;&#039; ==&lt;br /&gt;
&lt;br /&gt;
&amp;lt;Structure load=&#039;4K2C_all_domains_v2.pdb&#039; size=&#039;500&#039; frame=&#039;true&#039; align=&#039;right&#039; caption=&#039;Human serum albumin (PDB code [[4iw1]])&#039; scene=&#039;Insert optional scene name here&#039; /&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Human serum albumin&#039;&#039;&#039; (HSA) is the most abundant protein in the blood plasma, amounting to about 35 to 50 grams per liter of serum.  With a molecular weight of about 66.5 kDa, it functions mainly to maintain the pH and osmotic pressure of the blood and to transport a wide variety of endogenous and exogenous substances.&lt;br /&gt;
&lt;br /&gt;
== Structure ==&lt;br /&gt;
&lt;br /&gt;
HSA exists as a monomer that is comprised mostly of alpha helices. Each of the &amp;lt;scene name=&#039;57/571397/Different_domains_v2/1&#039;&amp;gt;three homologous helical domains&amp;lt;/scene&amp;gt; &lt;br /&gt;
(&amp;lt;B&amp;gt;&amp;lt;font color=&amp;quot;purple&amp;quot;&amp;gt;domain I&amp;lt;/font&amp;gt;&amp;lt;/B&amp;gt;, &amp;lt;B&amp;gt;&amp;lt;font color=&amp;quot;orange&amp;quot;&amp;gt;domain II&amp;lt;/font&amp;gt;&amp;lt;/B&amp;gt;, &amp;lt;B&amp;gt;&amp;lt;font color=&amp;quot;cyan&amp;quot;&amp;gt;domain III&amp;lt;/font&amp;gt;&amp;lt;/B&amp;gt;)&lt;br /&gt;
are further divided into subdomains A and B (A=darker shade, B=lighter shade), which form several hydrophobic pockets throughout the molecule. This multidomain structure of HSA allow it to bind many different classes of ligands at multiple sites.&lt;br /&gt;
&lt;br /&gt;
== Function ==&lt;br /&gt;
&lt;br /&gt;
Being the major protein in blood, HSA functions to maintain the osmotic pressure and the pH of the blood. Most importantly, it acts as a depot and carrier of various substances through the bloodstream.  HSA does not carry a specific cargo, although it does have preference for fat-soluble substances as it can bury the water-insoluble molecules into its hydrophobic core.  &amp;lt;scene name=&#039;57/571397/Hsa_with_myr_and_aspirin/5&#039;&amp;gt;Here&amp;lt;/scene&amp;gt;, we can see  HSA with both &amp;lt;B&amp;gt;&amp;lt;font color=&amp;quot;grey&amp;quot;&amp;gt;myristate&amp;lt;/font&amp;gt;&amp;lt;/B&amp;gt; (a fatty acid) and &amp;lt;B&amp;gt;&amp;lt;font color=&amp;quot;magenta&amp;quot;&amp;gt;aspirin&amp;lt;/font&amp;gt;&amp;lt;/B&amp;gt; (a common analgesic) bound to its hydrophobic pockets.  HSA transports a wide variety of substances through the bloodstream including carbohydrates (e.g &amp;lt;scene name=&#039;57/571397/Hsa_with_glucose/6&#039;&amp;gt;glucose&amp;lt;/scene&amp;gt;), fatty acids (e.g. &amp;lt;scene name=&#039;57/571397/Hsa_with_arachidonic_acid/3&#039;&amp;gt;arachidonic acid&amp;lt;/scene&amp;gt;), hormones (e.g. &amp;lt;scene name=&#039;57/571397/Hsa_with_thyroxine/6&#039;&amp;gt;thyroxine&amp;lt;/scene&amp;gt;, a thyroid hormone), and drugs (e.g. &amp;lt;scene name=&#039;57/571397/Hsa_with_ibp/3&#039;&amp;gt;ibuprofen&amp;lt;/scene&amp;gt;, an anti-inflammatory drug).&lt;br /&gt;
&lt;br /&gt;
       [[Image:Various HSA ligands small.png]]&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== Role in pharmacokinetics ==&lt;br /&gt;
&lt;br /&gt;
The affinity of HSA for various drugs affects their pharmacokinetics and efficacy. Although binding to HSA helps solubilize the drug in the plasma, too strong affinity to HSA limits the free/available forms of the drug, meaning that higher doses must be administered to achieve the desired efficacy of the drug &#039;&#039;in vivo&#039;&#039;.  &lt;br /&gt;
&lt;br /&gt;
== Removal of HSA in serum for biomarker studies ==&lt;br /&gt;
&lt;br /&gt;
Because HSA is very abundant in blood serum, most biomarker studies involving serum requires preliminary removal of HSA so that other non-abundant but otherwise important disease-indicating proteins can be detected.  In our group, we exploit several properties of HSA in order to efficiently remove it from serum prior to biomarker analysis. These properties include its low isoelectric point (pI of about 4.7) due to a number of &amp;lt;scene name=&#039;57/571397/Acidic_residues/1&#039;&amp;gt;acidic residues&amp;lt;/scene&amp;gt;, and its tendency to bind hydrophobic molecules through its hydrophobic pockets.&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== References ==&lt;br /&gt;
&lt;br /&gt;
[http://onlinelibrary.wiley.com/doi/10.1080/15216540500404093/pdf] Fasano, M., Curry, S., Terreno, E., Galliano, M., Fanali, G., Narciso, P., … Ascenzi, P. (2005). The extraordinary ligand binding properties of human serum albumin. IUBMB Life, 57(12), 787–96. &lt;br /&gt;
&lt;br /&gt;
[http://www.ncbi.nlm.nih.gov/pubmed/16169013] Ghuman, J., Zunszain, P. a, Petitpas, I., Bhattacharya, A. a, Otagiri, M., &amp;amp; Curry, S. (2005). Structural basis of the drug-binding specificity of human serum albumin. Journal of Molecular Biology, 353(1), 38–52.&lt;br /&gt;
&lt;br /&gt;
[http://www.ncbi.nlm.nih.gov/pubmed/15619298] Björhall, K., Miliotis, T., &amp;amp; Davidsson, P. (2005). Comparison of different depletion strategies for improved resolution in proteomic analysis of human serum samples. Proteomics, 5(1), 307–17.&lt;/div&gt;</summary>
		<author><name>Mahalia Serrano</name></author>
	</entry>
	<entry>
		<id>https://proteopedia.org/index.php?title=Molecular_Playground/Human_Serum_Albumin&amp;diff=2075871</id>
		<title>Molecular Playground/Human Serum Albumin</title>
		<link rel="alternate" type="text/html" href="https://proteopedia.org/index.php?title=Molecular_Playground/Human_Serum_Albumin&amp;diff=2075871"/>
		<updated>2014-12-04T06:50:03Z</updated>

		<summary type="html">&lt;p&gt;Mahalia Serrano: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;== &#039;&#039;&#039;HUMAN SERUM ALBUMIN (HSA)&#039;&#039;&#039; ==&lt;br /&gt;
&lt;br /&gt;
&amp;lt;Structure load=&#039;4K2C_all_domains_v2.pdb&#039; size=&#039;500&#039; frame=&#039;true&#039; align=&#039;right&#039; caption=&#039;Human serum albumin (PDB code [[4iw1]])&#039; scene=&#039;Insert optional scene name here&#039; /&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Human serum albumin&#039;&#039;&#039; (HSA) is the most abundant protein in the blood plasma, amounting to about 35 to 50 grams per liter of serum.  With a molecular weight of about 66.5 kDa, it functions mainly to maintain the pH and osmotic pressure of the blood and to transport a wide variety of endogenous and exogenous substances.&lt;br /&gt;
&lt;br /&gt;
== Structure ==&lt;br /&gt;
&lt;br /&gt;
HSA exists as a monomer that is comprised mostly of alpha helices. Each of the &amp;lt;scene name=&#039;57/571397/Different_domains_v2/1&#039;&amp;gt;three homologous helical domains&amp;lt;/scene&amp;gt; &lt;br /&gt;
(&amp;lt;B&amp;gt;&amp;lt;font color=&amp;quot;purple&amp;quot;&amp;gt;domain I&amp;lt;/font&amp;gt;&amp;lt;/B&amp;gt;, &amp;lt;B&amp;gt;&amp;lt;font color=&amp;quot;orange&amp;quot;&amp;gt;domain II&amp;lt;/font&amp;gt;&amp;lt;/B&amp;gt;, &amp;lt;B&amp;gt;&amp;lt;font color=&amp;quot;cyan&amp;quot;&amp;gt;domain III&amp;lt;/font&amp;gt;&amp;lt;/B&amp;gt;)&lt;br /&gt;
are further divided into subdomains A and B (A=darker shade, B=lighter shade), which form several hydrophobic pockets throughout the molecule. This multidomain structure of HSA allow it to bind many different classes of ligands at multiple sites.&lt;br /&gt;
&lt;br /&gt;
== Function ==&lt;br /&gt;
&lt;br /&gt;
Being the major protein in blood, HSA functions to maintain the osmotic pressure and the pH of the blood. Most importantly, it acts as a depot and carrier of various substances through the bloodstream.  HSA does not carry a specific cargo, although it does have preference for fat-soluble substances as it can bury the water-insoluble molecules into its hydrophobic core.  &amp;lt;scene name=&#039;57/571397/Hsa_with_myr_and_aspirin/5&#039;&amp;gt;Here&amp;lt;/scene&amp;gt;, we can see  HSA with both &amp;lt;B&amp;gt;&amp;lt;font color=&amp;quot;grey&amp;quot;&amp;gt;myristate&amp;lt;/font&amp;gt;&amp;lt;/B&amp;gt; (a fatty acid) and &amp;lt;B&amp;gt;&amp;lt;font color=&amp;quot;magenta&amp;quot;&amp;gt;aspirin&amp;lt;/font&amp;gt;&amp;lt;/B&amp;gt; (a common analgesic) bound to its hydrophobic pockets.  HSA transports a wide variety of substances through the bloodstream including carbohydrates (e.g &amp;lt;scene name=&#039;57/571397/Hsa_with_glucose/6&#039;&amp;gt;glucose&amp;lt;/scene&amp;gt;), fatty acids (e.g. &amp;lt;scene name=&#039;57/571397/Hsa_with_arachidonic_acid/3&#039;&amp;gt;arachidonic acid&amp;lt;/scene&amp;gt;), hormones (e.g. &amp;lt;scene name=&#039;57/571397/Hsa_with_thyroxine/6&#039;&amp;gt;thyroxine&amp;lt;/scene&amp;gt;, a thyroid hormone), and drugs (e.g. &amp;lt;scene name=&#039;57/571397/Hsa_with_ibp/3&#039;&amp;gt;ibuprofen&amp;lt;/scene&amp;gt;, an anti-inflammatory drug).&lt;br /&gt;
&lt;br /&gt;
       [[Image:Various HSA ligands small.png]]&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== Role in pharmacokinetics ==&lt;br /&gt;
&lt;br /&gt;
The affinity of HSA for various drugs affects their pharmacokinetics and efficacy. Although binding to HSA helps solubilize the drug in the plasma, too strong affinity to HSA limits the free/available forms of the drug, meaning that higher doses must be administered to achieve the desired efficacy of the drug &#039;&#039;in vivo&#039;&#039;.  &lt;br /&gt;
&lt;br /&gt;
== Removal of HSA in serum for biomarker studies ==&lt;br /&gt;
&lt;br /&gt;
Because HSA is very abundant in blood serum, most biomarker studies involving serum requires preliminary removal of HSA so that other non-abundant but otherwise important disease-indicating proteins can be detected.  In our group, we exploit several properties of HSA in order to efficiently remove it from serum prior to biomarker analysis. These properties include its low isoelectric point (pI of about 4.7) due to a number of &amp;lt;scene name=&#039;57/571397/Overall_structure_of_hsa/5&#039;&amp;gt;acidic residues&amp;lt;/scene&amp;gt;, and its tendency to bind hydrophobic molecules through its hydrophobic pockets.&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== References ==&lt;br /&gt;
&lt;br /&gt;
[http://onlinelibrary.wiley.com/doi/10.1080/15216540500404093/pdf] Fasano, M., Curry, S., Terreno, E., Galliano, M., Fanali, G., Narciso, P., … Ascenzi, P. (2005). The extraordinary ligand binding properties of human serum albumin. IUBMB Life, 57(12), 787–96. &lt;br /&gt;
&lt;br /&gt;
[http://www.ncbi.nlm.nih.gov/pubmed/16169013] Ghuman, J., Zunszain, P. a, Petitpas, I., Bhattacharya, A. a, Otagiri, M., &amp;amp; Curry, S. (2005). Structural basis of the drug-binding specificity of human serum albumin. Journal of Molecular Biology, 353(1), 38–52.&lt;br /&gt;
&lt;br /&gt;
[http://www.ncbi.nlm.nih.gov/pubmed/15619298] Björhall, K., Miliotis, T., &amp;amp; Davidsson, P. (2005). Comparison of different depletion strategies for improved resolution in proteomic analysis of human serum samples. Proteomics, 5(1), 307–17.&lt;/div&gt;</summary>
		<author><name>Mahalia Serrano</name></author>
	</entry>
	<entry>
		<id>https://proteopedia.org/index.php?title=Molecular_Playground/Human_Serum_Albumin&amp;diff=2075870</id>
		<title>Molecular Playground/Human Serum Albumin</title>
		<link rel="alternate" type="text/html" href="https://proteopedia.org/index.php?title=Molecular_Playground/Human_Serum_Albumin&amp;diff=2075870"/>
		<updated>2014-12-04T06:48:29Z</updated>

		<summary type="html">&lt;p&gt;Mahalia Serrano: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;== &#039;&#039;&#039;HUMAN SERUM ALBUMIN (HSA)&#039;&#039;&#039; ==&lt;br /&gt;
&lt;br /&gt;
&amp;lt;Structure load=&#039;4K2C_all_domains_v2.pdb&#039; size=&#039;500&#039; frame=&#039;true&#039; align=&#039;right&#039; caption=&#039;Human serum albumin (PDB code [[4iw1]])&#039; scene=&#039;Insert optional scene name here&#039; /&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Human serum albumin&#039;&#039;&#039; (HSA) is the most abundant protein in the blood plasma, amounting to about 35 to 50 grams per liter of serum.  With a molecular weight of about 66.5 kDa, it functions mainly to maintain the pH and osmotic pressure of the blood and to transport a wide variety of endogenous and exogenous substances.&lt;br /&gt;
&lt;br /&gt;
== Structure ==&lt;br /&gt;
&lt;br /&gt;
HSA exists as a monomer that is comprised mostly of alpha helices. Each of the &amp;lt;scene name=&#039;57/571397/Different_domains_v2/1&#039;&amp;gt;three homologous helical domains&amp;lt;/scene&amp;gt; &lt;br /&gt;
(&amp;lt;B&amp;gt;&amp;lt;font color=&amp;quot;purple&amp;quot;&amp;gt;domain I&amp;lt;/font&amp;gt;&amp;lt;/B&amp;gt;, &amp;lt;B&amp;gt;&amp;lt;font color=&amp;quot;orange&amp;quot;&amp;gt;domain II&amp;lt;/font&amp;gt;&amp;lt;/B&amp;gt;, &amp;lt;B&amp;gt;&amp;lt;font color=&amp;quot;cyan&amp;quot;&amp;gt;domain III&amp;lt;/font&amp;gt;&amp;lt;/B&amp;gt;)&lt;br /&gt;
are further divided into subdomains A and B (A=darker shade, B=lighter shade), which form several hydrophobic pockets throughout the molecule. This multidomain structure of HSA allow it to bind many different classes of ligands at multiple sites.&lt;br /&gt;
&lt;br /&gt;
== Function ==&lt;br /&gt;
&lt;br /&gt;
Being the major protein in blood, HSA functions to maintain the osmotic pressure and the pH of the blood. Most importantly, it acts as a depot and carrier of various substances through the bloodstream.  HSA does not carry a specific cargo, although it does have preference for fat-soluble substances as it can bury the water-insoluble molecules into its hydrophobic core.  &amp;lt;scene name=&#039;57/571397/Hsa_with_myr_and_aspirin/5&#039;&amp;gt;Here&amp;lt;/scene&amp;gt;, we can see  HSA with both &amp;lt;B&amp;gt;&amp;lt;font color=&amp;quot;grey&amp;quot;&amp;gt;myristate&amp;lt;/font&amp;gt;&amp;lt;/B&amp;gt; (a fatty acid) and &amp;lt;B&amp;gt;&amp;lt;font color=&amp;quot;magenta&amp;quot;&amp;gt;aspirin&amp;lt;/font&amp;gt;&amp;lt;/B&amp;gt; (a common analgesic) bound to its hydrophobic pockets.  HSA transports a wide variety of substances through the bloodstream including carbohydrates (e.g &amp;lt;scene name=&#039;57/571397/Hsa_with_glucose/6&#039;&amp;gt;glucose&amp;lt;/scene&amp;gt;), fatty acids (e.g. &amp;lt;scene name=&#039;57/571397/Hsa_with_arachidonic_acid/3&#039;&amp;gt;arachidonic acid&amp;lt;/scene&amp;gt;), hormones (e.g. &amp;lt;scene name=&#039;57/571397/Hsa_with_thyroxine/6&#039;&amp;gt;thyroxine&amp;lt;/scene&amp;gt;, a thyroid hormone), and drugs (e.g. &amp;lt;scene name=&#039;57/571397/Hsa_with_ibp/3&#039;&amp;gt;ibuprofen&amp;lt;/scene&amp;gt;, an anti-inflammatory drug).&lt;br /&gt;
&lt;br /&gt;
       [[Image:Various HSA ligands small.png]]&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== Role in pharmacokinetics ==&lt;br /&gt;
&lt;br /&gt;
The affinity of HSA for various drugs affects their pharmacokinetics and efficacy. Although binding to HSA helps solubilize the drug in the plasma, too strong affinity to HSA limits the free/available forms of the drug, meaning that higher doses must be administered to achieve the desired efficacy of the drug &#039;&#039;in vivo&#039;&#039;.  &lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== Removal of HSA in serum for biomarker studies ==&lt;br /&gt;
&lt;br /&gt;
Because HSA is very abundant in blood serum, most biomarker studies involving serum requires preliminary removal of HSA so that other non-abundant but otherwise important disease-indicating proteins can be detected.  In our group, we exploit several properties of HSA in order to efficiently remove it from serum prior to biomarker analysis. These properties include its low isoelectric point (pI of about 4.7) due to a number of &amp;lt;scene name=&#039;57/571397/Overall_structure_of_hsa/5&#039;&amp;gt;acidic residues&amp;lt;/scene&amp;gt;, and its tendency to bind hydrophobic molecules through its hydrophobic pockets.&lt;br /&gt;
&lt;br /&gt;
== References ==&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
[http://onlinelibrary.wiley.com/doi/10.1080/15216540500404093/pdf] Fasano, M., Curry, S., Terreno, E., Galliano, M., Fanali, G., Narciso, P., … Ascenzi, P. (2005). The extraordinary ligand binding properties of human serum albumin. IUBMB Life, 57(12), 787–96. &lt;br /&gt;
&lt;br /&gt;
[http://www.ncbi.nlm.nih.gov/pubmed/16169013] Ghuman, J., Zunszain, P. a, Petitpas, I., Bhattacharya, A. a, Otagiri, M., &amp;amp; Curry, S. (2005). Structural basis of the drug-binding specificity of human serum albumin. Journal of Molecular Biology, 353(1), 38–52.&lt;br /&gt;
&lt;br /&gt;
[http://www.ncbi.nlm.nih.gov/pubmed/15619298] Björhall, K., Miliotis, T., &amp;amp; Davidsson, P. (2005). Comparison of different depletion strategies for improved resolution in proteomic analysis of human serum samples. Proteomics, 5(1), 307–17.&lt;/div&gt;</summary>
		<author><name>Mahalia Serrano</name></author>
	</entry>
	<entry>
		<id>https://proteopedia.org/index.php?title=File:Various_HSA_ligands_small.png&amp;diff=2075869</id>
		<title>File:Various HSA ligands small.png</title>
		<link rel="alternate" type="text/html" href="https://proteopedia.org/index.php?title=File:Various_HSA_ligands_small.png&amp;diff=2075869"/>
		<updated>2014-12-04T06:46:39Z</updated>

		<summary type="html">&lt;p&gt;Mahalia Serrano: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;&lt;/div&gt;</summary>
		<author><name>Mahalia Serrano</name></author>
	</entry>
	<entry>
		<id>https://proteopedia.org/index.php?title=Molecular_Playground/Human_Serum_Albumin&amp;diff=2075867</id>
		<title>Molecular Playground/Human Serum Albumin</title>
		<link rel="alternate" type="text/html" href="https://proteopedia.org/index.php?title=Molecular_Playground/Human_Serum_Albumin&amp;diff=2075867"/>
		<updated>2014-12-04T06:26:31Z</updated>

		<summary type="html">&lt;p&gt;Mahalia Serrano: /* Removal of HSA in serum fro biomarker studies */&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;== &#039;&#039;&#039;HUMAN SERUM ALBUMIN (HSA)&#039;&#039;&#039; ==&lt;br /&gt;
&lt;br /&gt;
&amp;lt;Structure load=&#039;4K2C_all_domains_v2.pdb&#039; size=&#039;500&#039; frame=&#039;true&#039; align=&#039;right&#039; caption=&#039;Human serum albumin (PDB code [[4iw1]])&#039; scene=&#039;Insert optional scene name here&#039; /&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Human serum albumin&#039;&#039;&#039; (HSA) is the most abundant protein in the blood plasma, amounting to about 35 to 50 grams per liter of serum.  With a molecular weight of about 66.5 kDa, it functions mainly to maintain the pH and osmotic pressure of the blood and to transport a wide variety of endogenous and exogenous substances.&lt;br /&gt;
&lt;br /&gt;
== Structure ==&lt;br /&gt;
&lt;br /&gt;
HSA exists as a monomer that is comprised mostly of alpha helices. Each of the &amp;lt;scene name=&#039;57/571397/Different_domains_v2/1&#039;&amp;gt;three homologous helical domains&amp;lt;/scene&amp;gt; &lt;br /&gt;
(&amp;lt;B&amp;gt;&amp;lt;font color=&amp;quot;purple&amp;quot;&amp;gt;domain I&amp;lt;/font&amp;gt;&amp;lt;/B&amp;gt;, &amp;lt;B&amp;gt;&amp;lt;font color=&amp;quot;orange&amp;quot;&amp;gt;domain II&amp;lt;/font&amp;gt;&amp;lt;/B&amp;gt;, &amp;lt;B&amp;gt;&amp;lt;font color=&amp;quot;cyan&amp;quot;&amp;gt;domain III&amp;lt;/font&amp;gt;&amp;lt;/B&amp;gt;)&lt;br /&gt;
are further divided into subdomains A and B (A=darker shade, B=lighter shade), which form several hydrophobic pockets throughout the molecule. This multidomain structure of HSA allow it to bind many different classes of ligands at multiple sites.&lt;br /&gt;
&lt;br /&gt;
== Function ==&lt;br /&gt;
&lt;br /&gt;
Being the major protein in blood, HSA functions to maintain the osmotic pressure and the pH of the blood. Most importantly, it acts as a depot and carrier of various substances through the bloodstream.  HSA does not carry a specific cargo, although it does have preference for fat-soluble substances as it can bury the water-insoluble molecules into its hydrophobic core.  &amp;lt;scene name=&#039;57/571397/Hsa_with_myr_and_aspirin/5&#039;&amp;gt;Here&amp;lt;/scene&amp;gt;, we can see  HSA with both &amp;lt;B&amp;gt;&amp;lt;font color=&amp;quot;grey&amp;quot;&amp;gt;myristate&amp;lt;/font&amp;gt;&amp;lt;/B&amp;gt; (a fatty acid) and &amp;lt;B&amp;gt;&amp;lt;font color=&amp;quot;magenta&amp;quot;&amp;gt;aspirin&amp;lt;/font&amp;gt;&amp;lt;/B&amp;gt; (a common analgesic) bound to its hydrophobic pockets.  HSA transports a wide variety of substances through the bloodstream including carbohydrates (e.g &amp;lt;scene name=&#039;57/571397/Hsa_with_glucose/6&#039;&amp;gt;glucose&amp;lt;/scene&amp;gt;), fatty acids (e.g. &amp;lt;scene name=&#039;57/571397/Hsa_with_arachidonic_acid/3&#039;&amp;gt;arachidonic acid&amp;lt;/scene&amp;gt;), hormones (e.g. &amp;lt;scene name=&#039;57/571397/Hsa_with_thyroxine/6&#039;&amp;gt;thyroxine&amp;lt;/scene&amp;gt;, a thyroid hormone), and drugs (e.g. &amp;lt;scene name=&#039;57/571397/Hsa_with_ibp/3&#039;&amp;gt;ibuprofen&amp;lt;/scene&amp;gt;, an anti-inflammatory drug).&lt;br /&gt;
&lt;br /&gt;
== Role in pharmacokinetics ==&lt;br /&gt;
&lt;br /&gt;
The affinity of HSA for various drugs affects their pharmacokinetics and efficacy. Although binding to HSA helps solubilize the drug in the plasma, too strong affinity to HSA limits the free/available forms of the drug, meaning that higher doses must be administered to achieve the desired efficacy of the drug &#039;&#039;in vivo&#039;&#039;.  &lt;br /&gt;
&lt;br /&gt;
== Removal of HSA in serum for biomarker studies ==&lt;br /&gt;
&lt;br /&gt;
Because HSA is very abundant in blood serum, most biomarker studies involving serum requires preliminary removal of HSA so that other non-abundant but otherwise important disease-indicating proteins can be detected.  In our group, we exploit several properties of HSA in order to efficiently remove it from serum prior to biomarker analysis. These properties include its low isoelectric point (pI of about 4.7) due to a number of &amp;lt;scene name=&#039;57/571397/Overall_structure_of_hsa/5&#039;&amp;gt;acidic residues&amp;lt;/scene&amp;gt;, and its tendency to bind hydrophobic molecules through its hydrophobic pockets.&lt;br /&gt;
&lt;br /&gt;
== References ==&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
[http://onlinelibrary.wiley.com/doi/10.1080/15216540500404093/pdf] Fasano, M., Curry, S., Terreno, E., Galliano, M., Fanali, G., Narciso, P., … Ascenzi, P. (2005). The extraordinary ligand binding properties of human serum albumin. IUBMB Life, 57(12), 787–96. &lt;br /&gt;
&lt;br /&gt;
[http://www.ncbi.nlm.nih.gov/pubmed/16169013] Ghuman, J., Zunszain, P. a, Petitpas, I., Bhattacharya, A. a, Otagiri, M., &amp;amp; Curry, S. (2005). Structural basis of the drug-binding specificity of human serum albumin. Journal of Molecular Biology, 353(1), 38–52.&lt;br /&gt;
&lt;br /&gt;
[http://www.ncbi.nlm.nih.gov/pubmed/15619298] Björhall, K., Miliotis, T., &amp;amp; Davidsson, P. (2005). Comparison of different depletion strategies for improved resolution in proteomic analysis of human serum samples. Proteomics, 5(1), 307–17.&lt;/div&gt;</summary>
		<author><name>Mahalia Serrano</name></author>
	</entry>
	<entry>
		<id>https://proteopedia.org/index.php?title=Molecular_Playground/Human_Serum_Albumin&amp;diff=2075866</id>
		<title>Molecular Playground/Human Serum Albumin</title>
		<link rel="alternate" type="text/html" href="https://proteopedia.org/index.php?title=Molecular_Playground/Human_Serum_Albumin&amp;diff=2075866"/>
		<updated>2014-12-04T06:25:13Z</updated>

		<summary type="html">&lt;p&gt;Mahalia Serrano: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;== &#039;&#039;&#039;HUMAN SERUM ALBUMIN (HSA)&#039;&#039;&#039; ==&lt;br /&gt;
&lt;br /&gt;
&amp;lt;Structure load=&#039;4K2C_all_domains_v2.pdb&#039; size=&#039;500&#039; frame=&#039;true&#039; align=&#039;right&#039; caption=&#039;Human serum albumin (PDB code [[4iw1]])&#039; scene=&#039;Insert optional scene name here&#039; /&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Human serum albumin&#039;&#039;&#039; (HSA) is the most abundant protein in the blood plasma, amounting to about 35 to 50 grams per liter of serum.  With a molecular weight of about 66.5 kDa, it functions mainly to maintain the pH and osmotic pressure of the blood and to transport a wide variety of endogenous and exogenous substances.&lt;br /&gt;
&lt;br /&gt;
== Structure ==&lt;br /&gt;
&lt;br /&gt;
HSA exists as a monomer that is comprised mostly of alpha helices. Each of the &amp;lt;scene name=&#039;57/571397/Different_domains_v2/1&#039;&amp;gt;three homologous helical domains&amp;lt;/scene&amp;gt; &lt;br /&gt;
(&amp;lt;B&amp;gt;&amp;lt;font color=&amp;quot;purple&amp;quot;&amp;gt;domain I&amp;lt;/font&amp;gt;&amp;lt;/B&amp;gt;, &amp;lt;B&amp;gt;&amp;lt;font color=&amp;quot;orange&amp;quot;&amp;gt;domain II&amp;lt;/font&amp;gt;&amp;lt;/B&amp;gt;, &amp;lt;B&amp;gt;&amp;lt;font color=&amp;quot;cyan&amp;quot;&amp;gt;domain III&amp;lt;/font&amp;gt;&amp;lt;/B&amp;gt;)&lt;br /&gt;
are further divided into subdomains A and B (A=darker shade, B=lighter shade), which form several hydrophobic pockets throughout the molecule. This multidomain structure of HSA allow it to bind many different classes of ligands at multiple sites.&lt;br /&gt;
&lt;br /&gt;
== Function ==&lt;br /&gt;
&lt;br /&gt;
Being the major protein in blood, HSA functions to maintain the osmotic pressure and the pH of the blood. Most importantly, it acts as a depot and carrier of various substances through the bloodstream.  HSA does not carry a specific cargo, although it does have preference for fat-soluble substances as it can bury the water-insoluble molecules into its hydrophobic core.  &amp;lt;scene name=&#039;57/571397/Hsa_with_myr_and_aspirin/5&#039;&amp;gt;Here&amp;lt;/scene&amp;gt;, we can see  HSA with both &amp;lt;B&amp;gt;&amp;lt;font color=&amp;quot;grey&amp;quot;&amp;gt;myristate&amp;lt;/font&amp;gt;&amp;lt;/B&amp;gt; (a fatty acid) and &amp;lt;B&amp;gt;&amp;lt;font color=&amp;quot;magenta&amp;quot;&amp;gt;aspirin&amp;lt;/font&amp;gt;&amp;lt;/B&amp;gt; (a common analgesic) bound to its hydrophobic pockets.  HSA transports a wide variety of substances through the bloodstream including carbohydrates (e.g &amp;lt;scene name=&#039;57/571397/Hsa_with_glucose/6&#039;&amp;gt;glucose&amp;lt;/scene&amp;gt;), fatty acids (e.g. &amp;lt;scene name=&#039;57/571397/Hsa_with_arachidonic_acid/3&#039;&amp;gt;arachidonic acid&amp;lt;/scene&amp;gt;), hormones (e.g. &amp;lt;scene name=&#039;57/571397/Hsa_with_thyroxine/6&#039;&amp;gt;thyroxine&amp;lt;/scene&amp;gt;, a thyroid hormone), and drugs (e.g. &amp;lt;scene name=&#039;57/571397/Hsa_with_ibp/3&#039;&amp;gt;ibuprofen&amp;lt;/scene&amp;gt;, an anti-inflammatory drug).&lt;br /&gt;
&lt;br /&gt;
== Role in pharmacokinetics ==&lt;br /&gt;
&lt;br /&gt;
The affinity of HSA for various drugs affects their pharmacokinetics and efficacy. Although binding to HSA helps solubilize the drug in the plasma, too strong affinity to HSA limits the free/available forms of the drug, meaning that higher doses must be administered to achieve the desired efficacy of the drug &#039;&#039;in vivo&#039;&#039;.  &lt;br /&gt;
&lt;br /&gt;
== Removal of HSA in serum fro biomarker studies ==&lt;br /&gt;
&lt;br /&gt;
Because HSA is very abundant in blood serum, most biomarker studies involving serum requires preliminary removal of HSA so that other non-abundant but otherwise important disease-indicating proteins can be detected.  In our group, we exploit several properties of HSA in order to efficiently remove it from serum prior to biomarker analysis. These properties include its low isoelectric point (pI of about 4.7) due to a number of &amp;lt;scene name=&#039;57/571397/Overall_structure_of_hsa/5&#039;&amp;gt;acidic residues&amp;lt;/scene&amp;gt;, and its tendency to bind hydrophobic molecules through its hydrophobic pockets.&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== References ==&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
[http://onlinelibrary.wiley.com/doi/10.1080/15216540500404093/pdf] Fasano, M., Curry, S., Terreno, E., Galliano, M., Fanali, G., Narciso, P., … Ascenzi, P. (2005). The extraordinary ligand binding properties of human serum albumin. IUBMB Life, 57(12), 787–96. &lt;br /&gt;
&lt;br /&gt;
[http://www.ncbi.nlm.nih.gov/pubmed/16169013] Ghuman, J., Zunszain, P. a, Petitpas, I., Bhattacharya, A. a, Otagiri, M., &amp;amp; Curry, S. (2005). Structural basis of the drug-binding specificity of human serum albumin. Journal of Molecular Biology, 353(1), 38–52.&lt;br /&gt;
&lt;br /&gt;
[http://www.ncbi.nlm.nih.gov/pubmed/15619298] Björhall, K., Miliotis, T., &amp;amp; Davidsson, P. (2005). Comparison of different depletion strategies for improved resolution in proteomic analysis of human serum samples. Proteomics, 5(1), 307–17.&lt;/div&gt;</summary>
		<author><name>Mahalia Serrano</name></author>
	</entry>
	<entry>
		<id>https://proteopedia.org/index.php?title=CBI_Molecules&amp;diff=2075865</id>
		<title>CBI Molecules</title>
		<link rel="alternate" type="text/html" href="https://proteopedia.org/index.php?title=CBI_Molecules&amp;diff=2075865"/>
		<updated>2014-12-04T06:14:28Z</updated>

		<summary type="html">&lt;p&gt;Mahalia Serrano: /* Molecules */&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;These are molecules under study by members of the [http://www.umass.edu/cbi/ University of Massachusetts Amherst Chemistry-Biology Interface Program].&lt;br /&gt;
Many of the  molecules we study are featured at the [http://www.molecularplayground.org/ Molecular Playground] (see also [[Molecular Playground|Molecular Playground in Proteopedia]]). Follow the links below to read nontechnical descriptions, in Proteopedia, of these molecules.&lt;br /&gt;
&lt;br /&gt;
UMass CBI Members, add your molecules to the list (which is alphabetical by CBI research mentor); follow the instructions below the list.&lt;br /&gt;
&lt;br /&gt;
Fall 2014: CBI Molecules are due 12/3/14 and should be added at the TOP of the list from your lab. Label it as &amp;quot;in progress&amp;quot; until you are finished, and then as &amp;quot;New 2014&amp;quot; or &amp;quot;Revised 2014&amp;quot;. For those editing an existing CBI Molecule, start by making a copy of that entry (leaving the original intact) so that it retains the full author list of all authors that contributed (or include credits and a link to the original page and authors if it does not).&lt;br /&gt;
Follow the instructions at the bottom of this page.&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
==Molecules==&lt;br /&gt;
&#039;&#039;&#039;** Designates CBI Molecules Featured on [http://www.umass.edu/cbi/ CBI website]&#039;&#039;&#039;&lt;br /&gt;
&lt;br /&gt;
[http://chamberslab.com/wp/ Chambers Lab]&lt;br /&gt;
&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular Playground/Glutamate Receptor]]&#039;&#039;&#039;,  Amanda Hussey, Steve McCarron, Rosie Combs-Bachmann, Mariel Feliciano&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
[http://www.chem.umass.edu/~chenlab/index.HTML Chen Lab]&lt;br /&gt;
&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular Playground/ClyA]]&#039;&#039;&#039;, Bib Yang&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular Playground/OmpG]]&#039;&#039;&#039;, Christina Chisholm&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
[http://openwetware.org/wiki/Chien Chien Lab]&lt;br /&gt;
&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular Playground/ClpP]]&#039;&#039;&#039;, Lisa Hernandez, Rob Vass &#039;&#039;&#039;New 2014&#039;&#039;&#039;&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular Playground/Homo-dimeric RcdA]]&#039;&#039;&#039;, Kamal K. Joshi &lt;br /&gt;
: **&#039;&#039;&#039;[[Molecular Playground/Hexameric ClpX]]&#039;&#039;&#039;, Joanne Lau &#039;&#039;&#039;Best CBI Molecule 2011&#039;&#039;&#039;&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular Playground/DNA replication initiator DnaA]]&#039;&#039;&#039;, Jing Liu&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Farkas Lab&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular Playground/CLOCK:BMAL1 heterodimer complex]]&#039;&#039;&#039;, Hui-Hsien Lin, Joseph Hardie, Michael Mingroni &#039;&#039;&#039;New 2014&#039;&#039;&#039; &lt;br /&gt;
&lt;br /&gt;
Forbes Lab&lt;br /&gt;
&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular Playground/CheR]]&#039;&#039;&#039;,  Miaomin Zhang&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular Playground/RBP]]&#039;&#039;&#039;,  Jan Panteli&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular Playground/TRAIL]]&#039;&#039;&#039;,  Charley Swofford&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
[http://www.biochem.umass.edu/garman/index.html Garman Lab]&lt;br /&gt;
&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular Playground/Human Protective Protein Cathepsin A]]&#039;&#039;&#039;, Yadilette Rivera-Colon&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular Playground/Human PPCA]]&#039;&#039;&#039;, Nilima Kolli&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
[http://people.chem.umass.edu/gieraschlab/ Gierasch Lab]&lt;br /&gt;
&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular_Playground/DnaK]]&#039;&#039;&#039;, Joseph Tilitsky, New 2014&lt;br /&gt;
: &#039;&#039;&#039;[[CRABP I ( Cellular Retinoic Acid Binding Protein )|Molecular Playground/CRABP I]]&#039;&#039;&#039;, Kristine Faye Pobre, Mylene Ferrolino,Mangai Periasamy  &#039;&#039;&#039;Best Overall CBI Molecule 2010&#039;&#039;&#039;&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular Playground/CRABP I (Cellular Retinoic Acid Binding Protein)]]&#039;&#039;&#039;, Gustavo Elberto Epalza Sanchez&lt;br /&gt;
: **&#039;&#039;&#039;[[Molecular_Playground/DHFR]]&#039;&#039;&#039;, Karan Hingorani &#039;&#039;&#039;Best CBI Molecule 2012&#039;&#039;&#039;&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
[http://people.chem.umass.edu/jhardy/ Hardy Lab]&lt;br /&gt;
&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular Playground/Executioner Caspase-7]]&#039;&#039;&#039;, Derek MacPherson, Maureen E. Hill&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular Playground/Caspase-3 Regulatory Mechanisms]]&#039;&#039;&#039;, Scott Eron, Bay Serrano, Yunlong Zhao&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular Playground/Caspase-6 and neurodegeneration]]&#039;&#039;&#039;, Kevin Buadlart Dagbay&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular Playground/Caspase-7 Dynamics]]&#039;&#039;&#039;&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular Playground/Caspase-9 Regulation]]&#039;&#039;&#039;, Kristen Huber&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular Playground/Caspase-6 (new)]]&#039;&#039;&#039;, Elih Velazquez&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular Playground/Influenza A M2 transmembrane domain]]&#039;&#039;&#039;, Samantha Nicholls&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular Playground/Dengue Virus Protease]]&#039;&#039;&#039;, Muslum Yildiz&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Hebert Lab&lt;br /&gt;
&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular_Playground/Hsp70-Hsp90]]&#039;&#039;&#039;,  Jill Graham&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular_Playground/ERDj5]]&#039;&#039;&#039;,  Lydia Lamriben&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular Playground/Saposin C]]&#039;&#039;&#039;, Abla Tannous&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular_Playground/ERMan1]]&#039;&#039;&#039;,  Johan Sunryd&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
[http://people.biochem.umass.edu/aheuck/aph.html Heuck Lab]&lt;br /&gt;
&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular_Playground/Pcr H]]&#039;&#039;&#039;,  Fabian Romano, Carolina Morell-Pérez, Yuzhou Tang&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
[http://people.chem.umass.edu/mholden/ Holden Lab]&lt;br /&gt;
&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular Playground/Protective Antigen]]&#039;&#039;&#039;,  Jing Huang&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
[http://www.chem.umass.edu/people/kaltashovlab/ Kaltashov Lab]&lt;br /&gt;
&lt;br /&gt;
: &#039;&#039;&#039;[http://proteopedia.org/wiki/index.php/Chengfeng_Ren Molecular Playground/Inteferon]&#039;&#039;&#039;[Revised], Chengfeng Ren&lt;br /&gt;
: &#039;&#039;&#039; [[Molecular Playground/Transferrin]]&#039;&#039;&#039;, Khaja Muneeruddin, Jake Pawlowski&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular Playground/Velaglucerase]]&#039;&#039;&#039;, Adriana Kita&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular Playground/Antithrombin-Heparin]]&#039;&#039;&#039;, Yunlong Zhao&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
[http://people.chem.umass.edu/knapplab/?q=knappchem/index.html/ Knapp Lab]&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular Playground/Prolyl Hydroxylase Domain (PHD) Enzyme]]&#039;&#039;&#039;, Cristina Martin, Serap Pektas &#039;&#039;&#039;Best CBI Molecule Proteopedia Page 2010&#039;&#039;&#039; &#039;&#039;&#039;***New Fall 2014***&#039;&#039;&#039;&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular Playground/FIH]]&#039;&#039;&#039;, Vanessa Chaplin, Cornelius Taabazuing, Breanne Holmes, John Hangasky&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
[http://people.chem.umass.edu/mmaroney/ Maroney Lab]&lt;br /&gt;
&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular Playground/UreE]]&#039;&#039;&#039;, Priyanka Basak, &#039;&#039;&#039;New 2014&#039;&#039;&#039;&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular Playground/Nickel Superoxide Dismutase]]&#039;&#039;&#039;, Carolyn Carr&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular Playground/CsoR and RcnR]]&#039;&#039;&#039;, Heidi Hu, Carolyn Carr, Hsin-Ting (Tiffany )Huang, &#039;&#039;&#039;Revised 2014&#039;&#039;&#039;&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular Playground/HypA]]&#039;&#039;&#039;, Heidi Hu&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
[http://www.chem.umass.edu/~cmartin/ Martin Lab]&lt;br /&gt;
&lt;br /&gt;
: **&#039;&#039;&#039;[[Molecular Playground/T7 RNAP Conformations]]&#039;&#039;&#039;, Luis E. Ramirez-Tapia &#039;&#039;&#039;Best CBI Molecule 2011&#039;&#039;&#039;&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular Playground/T7 RNA Polymerase (7 mer int)]]&#039;&#039;&#039;, Ankit Vahia&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular Playground/Human mtRNA pol]]&#039;&#039;&#039;, Ketan Mathavan &lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
[http://www.peytonlab.org/ Peyton Lab]&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular Playground/IntegrinBeta1]]&#039;&#039;&#039;, Lauren Jansen, Lauren Barney, Elizabeth Brooks, Alyssa Schwartz ***&#039;&#039;&#039;NEW FALL 2014&#039;&#039;&#039;&#039;***&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular Playground/MMP14]]&#039;&#039;&#039;, Lauren Jansen&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular Playground/C-Raf]]&#039;&#039;&#039;, Thuy Nguyen&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular Playground/FAK]]&#039;&#039;&#039;, Dannielle Ryman&lt;br /&gt;
&lt;br /&gt;
[http://roberts.openwetware.org/ Roberts Lab]&lt;br /&gt;
&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular Playground/Taxol]]&#039;&#039;&#039;,  Rohan Patil, Sarah Wilson&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular Playground/Insulin]]&#039;&#039;&#039;, Whitney Stoppel&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
[http://www.umass.edu/rotellogroup/ Rotello Lab]&lt;br /&gt;
&lt;br /&gt;
: &#039;&#039;&#039;[[Reverse transcriptase|Molecular Playground/Reverse Transcriptase]]&#039;&#039;&#039;, Daniel Moyano-Marino&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular Playground/Pancreatic Lipase]]&#039;&#039;&#039;,  Rui Tang&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular playground/Chymotrypsin]]&#039;&#039;&#039;,  Brad&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular Playground/Targeting Peptide]]&#039;&#039;&#039;, David Solfiell&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
[http://http://www.umass.edu/schiffman/  Schiffman Lab]&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular Playground/Streptavidin]]&#039;&#039;&#039;, Katrina Rieger&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
[http://www.biochem.umass.edu/faculty/danny-j-schnell Schnell Lab]&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular Playground/Tic40]]&#039;&#039;&#039;, Mine Canakci&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Tew Lab&lt;br /&gt;
&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular Playground/HIV Tat]]&#039;&#039;&#039;, Brittany deRonde&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Thayumanavan Lab&lt;br /&gt;
: &#039;&#039;&#039;[[Interleukin-1 beta]]&#039;&#039;&#039;, Huan He&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular Playground/Lysozyme ]]&#039;&#039;&#039;, Daniella Gonzalez&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular Playground/Beta-galactosidase]]&#039;&#039;&#039;, Judy Ventura&lt;br /&gt;
: &#039;&#039;&#039;[[User:Krishna Reddy Ragupathi|Molecular Playground/Carbonic Anhydrase]]&#039;&#039;&#039;, Krishna Reddy Raghupathi&lt;br /&gt;
: &#039;&#039;&#039;[[User:Rami Rajasekhar Reddy|Molecular Playground/Avidin]]&#039;&#039;&#039;, Rami Rajasekar Reddy&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular Playground/Biotin binding avidin]]&#039;&#039;&#039;, Diego Amado &lt;br /&gt;
: &#039;&#039;&#039;[[User:Jiaming Zhuang|Molecular Playground/MMP12]]&#039;&#039;&#039;, Jiaming Zhuang&lt;br /&gt;
: &#039;&#039;&#039; [[User:Jing Guo|Molecular Playground/Gluconase]]&#039;&#039;&#039;, Jing Guo&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular Playground/Glutathione Reductase]]&#039;&#039;&#039;, Reuben Chacko&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Thayumanavan &amp;amp; Vachet Labs&lt;br /&gt;
&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular Playground/Trypsin]]&#039;&#039;&#039;, Gladys Murage&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
[http://people.chem.umass.edu/thompson/index.html Thompson Lab]&lt;br /&gt;
&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular Playground/Bacterial Chemotaxis Complex]]&#039;&#039;&#039;, Elizabeth R. Haglin, Maryam Kashefi&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular Playground/CheA]]&#039;&#039;&#039;, Elizabeth R. Haglin&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular Playground/Bacterial Chemotaxis Receptors]]&#039;&#039;&#039;, Lynmarie K. Thompson, Shiela M. Jones&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular Playground/Cytoplasmic domain of chemoreceptor of Thermotoga maritima]]&#039;&#039;&#039;,  Xuni Li&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
[http://www.chem.umass.edu/~vachet/index.html Vachet Lab]&lt;br /&gt;
&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular Playground/Human Serum Albumin]]&#039;&#039;&#039;, Mahalia Serrano &#039;&#039;*Revised 2014*&#039;&#039;&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular playground/beta 2 microglobulin]]&#039;&#039;&#039;,  Nick Borotto &#039;&#039;&#039;Best CBI Molecule Jmol scenes 2010&#039;&#039;&#039;&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular Playground/Myoglobin]]&#039;&#039;&#039;,  Yuping Zhou &lt;br /&gt;
:&#039;&#039;&#039;[[Molecular Playground/ Copper-Zinc Superoxide Dismutase]]&#039;&#039;&#039;, Shaynah Browne&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular Playground/Ubiquitin salt bridge discussion]]&#039;&#039;&#039;, Zhe Zhang&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Other Molecules of interest&lt;br /&gt;
&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular Playground/PcrA Helicase]]&#039;&#039;&#039;, Luis E Ramirez-Tapia, [http://www.chem.umass.edu/~cmartin/ Martin Lab]&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Other Laboratories&lt;br /&gt;
&lt;br /&gt;
:&#039;&#039;&#039;[[Molecular Playground/4&#039;-PHOSPHOPANTETHEINYL TRANSFERASE (Sfp)]]&#039;&#039;&#039;, Jon Amoroso, Gitanjeli Prasad, Lawrence Sheringham Borketey, Schnarr lab&lt;br /&gt;
: &#039;&#039;&#039;[[6-deoxyerythronolide_B_synthase_(DEBS)|Molecular Playground/6-Deoxyerythronolide B Synthase]]&#039;&#039;&#039;, Tsung-Yi Lin, Jon Amoroso, Lawrence Sheringham Borketey, Schnarr lab&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular Playground/ACP apo]]&#039;&#039;&#039;, Gitanjeli Prasad,  Schnarr lab&lt;br /&gt;
&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular Playground/cytoplasmic domain of a serine chemotaxis receptor]]&#039;&#039;&#039;,  Meili Yang, Weis lab&lt;br /&gt;
&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular Playground/Alginate-Fall2011]]&#039;&#039;&#039;, Joe White, David Griffi, Bhatia Lab&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular Playground/Poly(ethylene glycol)]]&#039;&#039;&#039;, Erika M. Saffer, Bhatia Lab&lt;br /&gt;
&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular Playground/YKL-40]]&#039;&#039;&#039;, Ralph A. Francescone III, [http://www.bio.umass.edu/mcb/faculty/Shao.html Shao Lab]&lt;br /&gt;
&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular Playground/BLG|Molecular Playground/β-lactoglobulin]]&#039;&#039;&#039;, Daniel Seeman, Dubin Lab&lt;br /&gt;
&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular Playground/ADAM13]]&#039;&#039;&#039;, Genevieve Abbruzzese, Alfandari Lab&lt;br /&gt;
&lt;br /&gt;
==Instructions==&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;The goal is for students to work collaboratively to create one excellent CBI Molecule for each CBI research group, to be featured on the CBI website.&#039;&#039;&#039;&lt;br /&gt;
&lt;br /&gt;
Fall 2014: Complete steps 1-3 before the CBI Molecule Workshop on 11/19; bring your computer to the CBI Molecule Workshop in ISB 321. You will be able to start work on your CBI Molecule at the workshop. You should plan to stay and finish your molecule after the workshop (or as soon as possible) while the instructions and ideas are fresh in your mind.&lt;br /&gt;
&lt;br /&gt;
A successful CBI Molecule is an interesting, nontechnical description of a molecule related to your group&#039;s research. It should tell an interesting story with few words and many green scenes. Green scenes should be clear and attractive illustrations that tell your story. It&#039;s great if you can end with a brief statement about how it relates to your group&#039;s research goals.&lt;br /&gt;
&lt;br /&gt;
1. If you don&#039;t already have one, request a Proteopedia account and log in. &lt;br /&gt;
&lt;br /&gt;
2. Read through the rest of the instructions, do the tutorials below, and look at any existing CBI Molecules from your research group. Talk with other CBI students in your research group and decide how you will collaborate to make an improved CBI Molecule related to your group&#039;s research. Develop ideas for the scenes that each of you will make.&lt;br /&gt;
&lt;br /&gt;
3. Get started working in Proteopedia. Make yourself a sandbox page: Enter &amp;quot;User:Your Name/Sandbox 1&amp;quot; (omit quotes) in the search box, then follow instructions to edit this page. Practice entering text, inserting a structure window with scrolling text (green 4-square button on the right), and creating a green scene. Explore the HELP links below to learn how to make a green scene. You can look at other Proteopedia pages in edit mode to see how different effects (like colored text) are achieved (but this won&#039;t show you how the scene effects are made). &lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Complete the above steps before the CBI Molecule Workshop.&#039;&#039;&#039;&lt;br /&gt;
&lt;br /&gt;
4. When editing an existing CBI Molecule, leave the original intact and make a copy that you will edit so that it retains the full author list of all authors that contributed. You are encouraged to collaborate on the CBI Molecules, but everyone will need to log in as themself and create a green scene to get credit for their work and to appear as authors on the final list. If you are the sole student from your group enrolled in Chalk Talk and have not previously made a CBI Molecule, try to convince another group member who has previously made a CBI Molecule (see  list above) to join us for the workshop so that you can work together.&lt;br /&gt;
&lt;br /&gt;
5. Your final pages should be called &amp;quot;Molecular Playground/your molecule&amp;quot; and should have links on this CBI Molecule page -- put the new ones first on the list from your research group. Label them &amp;quot;in progress&amp;quot; until you are finished, and then &amp;quot;new 2014&amp;quot; or &amp;quot;revised 2014&amp;quot;. Minimize text; tell your story with green scenes!&lt;br /&gt;
&lt;br /&gt;
6. When your CBI Molecule is complete, send Lynmarie an email to nominate a cool scene/clever caption you would like to feature at the Molecular Playground (include a link to your CBI Molecule, name of the green scene, and caption).&lt;br /&gt;
&lt;br /&gt;
==Links to HELP pages==&lt;br /&gt;
Overview at [[Help:Contents ]]&lt;br /&gt;
&lt;br /&gt;
See also [[Help:Getting_Started_in_Proteopedia]] &lt;br /&gt;
&lt;br /&gt;
Videos showing how to use Proteopedia:&lt;br /&gt;
[[Proteopedia:Video_Guide]]&lt;br /&gt;
(Sometimes slow -- if you pause the video and wait awhile it will download and then you can play it without interruptions)&lt;br /&gt;
&lt;br /&gt;
[[Proteopedia:DIY:Scenes|Proteopedia Scenes: Do It Yourself]]&lt;br /&gt;
gives succinct step by step instructions on how to create a molecular scene.&lt;br /&gt;
&lt;br /&gt;
A powerpoint-like set of slides that walks a user through the process of creating a new page and a new molecular scene/green link.&lt;br /&gt;
[http://www.proteopedia.org/wiki/images/1/1b/2009_07_13_Proteopedia_Workshop.pdf Proteopedia Workshop Slides]&lt;br /&gt;
&lt;br /&gt;
[[Proteopedia:Guidelines for Ethical Writing]].&lt;br /&gt;
Please pay attention to the section about images. There are links to examples of images re-used with explicit permission.&lt;br /&gt;
&lt;br /&gt;
For other help resources, click on [[Help:Contents|Help]] in the &#039;&#039;navigation&#039;&#039; box at the upper left of every page in Proteopedia.&lt;/div&gt;</summary>
		<author><name>Mahalia Serrano</name></author>
	</entry>
	<entry>
		<id>https://proteopedia.org/index.php?title=CBI_Molecules&amp;diff=2075864</id>
		<title>CBI Molecules</title>
		<link rel="alternate" type="text/html" href="https://proteopedia.org/index.php?title=CBI_Molecules&amp;diff=2075864"/>
		<updated>2014-12-04T06:13:51Z</updated>

		<summary type="html">&lt;p&gt;Mahalia Serrano: /* Molecules */&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;These are molecules under study by members of the [http://www.umass.edu/cbi/ University of Massachusetts Amherst Chemistry-Biology Interface Program].&lt;br /&gt;
Many of the  molecules we study are featured at the [http://www.molecularplayground.org/ Molecular Playground] (see also [[Molecular Playground|Molecular Playground in Proteopedia]]). Follow the links below to read nontechnical descriptions, in Proteopedia, of these molecules.&lt;br /&gt;
&lt;br /&gt;
UMass CBI Members, add your molecules to the list (which is alphabetical by CBI research mentor); follow the instructions below the list.&lt;br /&gt;
&lt;br /&gt;
Fall 2014: CBI Molecules are due 12/3/14 and should be added at the TOP of the list from your lab. Label it as &amp;quot;in progress&amp;quot; until you are finished, and then as &amp;quot;New 2014&amp;quot; or &amp;quot;Revised 2014&amp;quot;. For those editing an existing CBI Molecule, start by making a copy of that entry (leaving the original intact) so that it retains the full author list of all authors that contributed (or include credits and a link to the original page and authors if it does not).&lt;br /&gt;
Follow the instructions at the bottom of this page.&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
==Molecules==&lt;br /&gt;
&#039;&#039;&#039;** Designates CBI Molecules Featured on [http://www.umass.edu/cbi/ CBI website]&#039;&#039;&#039;&lt;br /&gt;
&lt;br /&gt;
[http://chamberslab.com/wp/ Chambers Lab]&lt;br /&gt;
&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular Playground/Glutamate Receptor]]&#039;&#039;&#039;,  Amanda Hussey, Steve McCarron, Rosie Combs-Bachmann, Mariel Feliciano&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
[http://www.chem.umass.edu/~chenlab/index.HTML Chen Lab]&lt;br /&gt;
&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular Playground/ClyA]]&#039;&#039;&#039;, Bib Yang&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular Playground/OmpG]]&#039;&#039;&#039;, Christina Chisholm&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
[http://openwetware.org/wiki/Chien Chien Lab]&lt;br /&gt;
&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular Playground/ClpP]]&#039;&#039;&#039;, Lisa Hernandez, Rob Vass &#039;&#039;&#039;New 2014&#039;&#039;&#039;&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular Playground/Homo-dimeric RcdA]]&#039;&#039;&#039;, Kamal K. Joshi &lt;br /&gt;
: **&#039;&#039;&#039;[[Molecular Playground/Hexameric ClpX]]&#039;&#039;&#039;, Joanne Lau &#039;&#039;&#039;Best CBI Molecule 2011&#039;&#039;&#039;&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular Playground/DNA replication initiator DnaA]]&#039;&#039;&#039;, Jing Liu&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Farkas Lab&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular Playground/CLOCK:BMAL1 heterodimer complex]]&#039;&#039;&#039;, Hui-Hsien Lin, Joseph Hardie, Michael Mingroni &#039;&#039;&#039;New 2014&#039;&#039;&#039; &lt;br /&gt;
&lt;br /&gt;
Forbes Lab&lt;br /&gt;
&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular Playground/CheR]]&#039;&#039;&#039;,  Miaomin Zhang&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular Playground/RBP]]&#039;&#039;&#039;,  Jan Panteli&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular Playground/TRAIL]]&#039;&#039;&#039;,  Charley Swofford&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
[http://www.biochem.umass.edu/garman/index.html Garman Lab]&lt;br /&gt;
&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular Playground/Human Protective Protein Cathepsin A]]&#039;&#039;&#039;, Yadilette Rivera-Colon&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular Playground/Human PPCA]]&#039;&#039;&#039;, Nilima Kolli&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
[http://people.chem.umass.edu/gieraschlab/ Gierasch Lab]&lt;br /&gt;
&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular_Playground/DnaK]]&#039;&#039;&#039;, Joseph Tilitsky, New 2014&lt;br /&gt;
: &#039;&#039;&#039;[[CRABP I ( Cellular Retinoic Acid Binding Protein )|Molecular Playground/CRABP I]]&#039;&#039;&#039;, Kristine Faye Pobre, Mylene Ferrolino,Mangai Periasamy  &#039;&#039;&#039;Best Overall CBI Molecule 2010&#039;&#039;&#039;&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular Playground/CRABP I (Cellular Retinoic Acid Binding Protein)]]&#039;&#039;&#039;, Gustavo Elberto Epalza Sanchez&lt;br /&gt;
: **&#039;&#039;&#039;[[Molecular_Playground/DHFR]]&#039;&#039;&#039;, Karan Hingorani &#039;&#039;&#039;Best CBI Molecule 2012&#039;&#039;&#039;&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
[http://people.chem.umass.edu/jhardy/ Hardy Lab]&lt;br /&gt;
&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular Playground/Executioner Caspase-7]]&#039;&#039;&#039;, Derek MacPherson, Maureen E. Hill&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular Playground/Caspase-3 Regulatory Mechanisms]]&#039;&#039;&#039;, Scott Eron, Bay Serrano, Yunlong Zhao&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular Playground/Caspase-6 and neurodegeneration]]&#039;&#039;&#039;, Kevin Buadlart Dagbay&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular Playground/Caspase-7 Dynamics]]&#039;&#039;&#039;&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular Playground/Caspase-9 Regulation]]&#039;&#039;&#039;, Kristen Huber&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular Playground/Caspase-6 (new)]]&#039;&#039;&#039;, Elih Velazquez&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular Playground/Influenza A M2 transmembrane domain]]&#039;&#039;&#039;, Samantha Nicholls&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular Playground/Dengue Virus Protease]]&#039;&#039;&#039;, Muslum Yildiz&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Hebert Lab&lt;br /&gt;
&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular_Playground/Hsp70-Hsp90]]&#039;&#039;&#039;,  Jill Graham&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular_Playground/ERDj5]]&#039;&#039;&#039;,  Lydia Lamriben&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular Playground/Saposin C]]&#039;&#039;&#039;, Abla Tannous&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular_Playground/ERMan1]]&#039;&#039;&#039;,  Johan Sunryd&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
[http://people.biochem.umass.edu/aheuck/aph.html Heuck Lab]&lt;br /&gt;
&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular_Playground/Pcr H]]&#039;&#039;&#039;,  Fabian Romano, Carolina Morell-Pérez, Yuzhou Tang&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
[http://people.chem.umass.edu/mholden/ Holden Lab]&lt;br /&gt;
&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular Playground/Protective Antigen]]&#039;&#039;&#039;,  Jing Huang&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
[http://www.chem.umass.edu/people/kaltashovlab/ Kaltashov Lab]&lt;br /&gt;
&lt;br /&gt;
: &#039;&#039;&#039;[http://proteopedia.org/wiki/index.php/Chengfeng_Ren Molecular Playground/Inteferon]&#039;&#039;&#039;[Revised], Chengfeng Ren&lt;br /&gt;
: &#039;&#039;&#039; [[Molecular Playground/Transferrin]]&#039;&#039;&#039;, Khaja Muneeruddin, Jake Pawlowski&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular Playground/Velaglucerase]]&#039;&#039;&#039;, Adriana Kita&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular Playground/Antithrombin-Heparin]]&#039;&#039;&#039;, Yunlong Zhao&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
[http://people.chem.umass.edu/knapplab/?q=knappchem/index.html/ Knapp Lab]&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular Playground/Prolyl Hydroxylase Domain (PHD) Enzyme]]&#039;&#039;&#039;, Cristina Martin, Serap Pektas &#039;&#039;&#039;Best CBI Molecule Proteopedia Page 2010&#039;&#039;&#039; &#039;&#039;&#039;***New Fall 2014***&#039;&#039;&#039;&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular Playground/FIH]]&#039;&#039;&#039;, Vanessa Chaplin, Cornelius Taabazuing, Breanne Holmes, John Hangasky&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
[http://people.chem.umass.edu/mmaroney/ Maroney Lab]&lt;br /&gt;
&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular Playground/UreE]]&#039;&#039;&#039;, Priyanka Basak, &#039;&#039;&#039;New 2014&#039;&#039;&#039;&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular Playground/Nickel Superoxide Dismutase]]&#039;&#039;&#039;, Carolyn Carr&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular Playground/CsoR and RcnR]]&#039;&#039;&#039;, Heidi Hu, Carolyn Carr, Hsin-Ting (Tiffany )Huang, &#039;&#039;&#039;Revised 2014&#039;&#039;&#039;&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular Playground/HypA]]&#039;&#039;&#039;, Heidi Hu&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
[http://www.chem.umass.edu/~cmartin/ Martin Lab]&lt;br /&gt;
&lt;br /&gt;
: **&#039;&#039;&#039;[[Molecular Playground/T7 RNAP Conformations]]&#039;&#039;&#039;, Luis E. Ramirez-Tapia &#039;&#039;&#039;Best CBI Molecule 2011&#039;&#039;&#039;&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular Playground/T7 RNA Polymerase (7 mer int)]]&#039;&#039;&#039;, Ankit Vahia&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular Playground/Human mtRNA pol]]&#039;&#039;&#039;, Ketan Mathavan &lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
[http://www.peytonlab.org/ Peyton Lab]&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular Playground/IntegrinBeta1]]&#039;&#039;&#039;, Lauren Jansen, Lauren Barney, Elizabeth Brooks, Alyssa Schwartz ***&#039;&#039;&#039;NEW FALL 2014&#039;&#039;&#039;&#039;***&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular Playground/MMP14]]&#039;&#039;&#039;, Lauren Jansen&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular Playground/C-Raf]]&#039;&#039;&#039;, Thuy Nguyen&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular Playground/FAK]]&#039;&#039;&#039;, Dannielle Ryman&lt;br /&gt;
&lt;br /&gt;
[http://roberts.openwetware.org/ Roberts Lab]&lt;br /&gt;
&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular Playground/Taxol]]&#039;&#039;&#039;,  Rohan Patil, Sarah Wilson&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular Playground/Insulin]]&#039;&#039;&#039;, Whitney Stoppel&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
[http://www.umass.edu/rotellogroup/ Rotello Lab]&lt;br /&gt;
&lt;br /&gt;
: &#039;&#039;&#039;[[Reverse transcriptase|Molecular Playground/Reverse Transcriptase]]&#039;&#039;&#039;, Daniel Moyano-Marino&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular Playground/Pancreatic Lipase]]&#039;&#039;&#039;,  Rui Tang&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular playground/Chymotrypsin]]&#039;&#039;&#039;,  Brad&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular Playground/Targeting Peptide]]&#039;&#039;&#039;, David Solfiell&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
[http://http://www.umass.edu/schiffman/  Schiffman Lab]&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular Playground/Streptavidin]]&#039;&#039;&#039;, Katrina Rieger&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
[http://www.biochem.umass.edu/faculty/danny-j-schnell Schnell Lab]&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular Playground/Tic40]]&#039;&#039;&#039;, Mine Canakci&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Tew Lab&lt;br /&gt;
&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular Playground/HIV Tat]]&#039;&#039;&#039;, Brittany deRonde&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Thayumanavan Lab&lt;br /&gt;
: &#039;&#039;&#039;[[Interleukin-1 beta]]&#039;&#039;&#039;, Huan He&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular Playground/Lysozyme ]]&#039;&#039;&#039;, Daniella Gonzalez&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular Playground/Beta-galactosidase]]&#039;&#039;&#039;, Judy Ventura&lt;br /&gt;
: &#039;&#039;&#039;[[User:Krishna Reddy Ragupathi|Molecular Playground/Carbonic Anhydrase]]&#039;&#039;&#039;, Krishna Reddy Raghupathi&lt;br /&gt;
: &#039;&#039;&#039;[[User:Rami Rajasekhar Reddy|Molecular Playground/Avidin]]&#039;&#039;&#039;, Rami Rajasekar Reddy&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular Playground/Biotin binding avidin]]&#039;&#039;&#039;, Diego Amado &lt;br /&gt;
: &#039;&#039;&#039;[[User:Jiaming Zhuang|Molecular Playground/MMP12]]&#039;&#039;&#039;, Jiaming Zhuang&lt;br /&gt;
: &#039;&#039;&#039; [[User:Jing Guo|Molecular Playground/Gluconase]]&#039;&#039;&#039;, Jing Guo&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular Playground/Glutathione Reductase]]&#039;&#039;&#039;, Reuben Chacko&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Thayumanavan &amp;amp; Vachet Labs&lt;br /&gt;
&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular Playground/Trypsin]]&#039;&#039;&#039;, Gladys Murage&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
[http://people.chem.umass.edu/thompson/index.html Thompson Lab]&lt;br /&gt;
&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular Playground/Bacterial Chemotaxis Complex]]&#039;&#039;&#039;, Elizabeth R. Haglin, Maryam Kashefi&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular Playground/CheA]]&#039;&#039;&#039;, Elizabeth R. Haglin&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular Playground/Bacterial Chemotaxis Receptors]]&#039;&#039;&#039;, Lynmarie K. Thompson, Shiela M. Jones&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular Playground/Cytoplasmic domain of chemoreceptor of Thermotoga maritima]]&#039;&#039;&#039;,  Xuni Li&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
[http://www.chem.umass.edu/~vachet/index.html Vachet Lab]&lt;br /&gt;
&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular Playground/Human Serum Albumin]]&#039;&#039;&#039;, Mahalia Serrano &#039;&#039;Revised 2014&#039;&#039;&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular playground/beta 2 microglobulin]]&#039;&#039;&#039;,  Nick Borotto &#039;&#039;&#039;Best CBI Molecule Jmol scenes 2010&#039;&#039;&#039;&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular Playground/Myoglobin]]&#039;&#039;&#039;,  Yuping Zhou &lt;br /&gt;
:&#039;&#039;&#039;[[Molecular Playground/ Copper-Zinc Superoxide Dismutase]]&#039;&#039;&#039;, Shaynah Browne&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular Playground/Ubiquitin salt bridge discussion]]&#039;&#039;&#039;, Zhe Zhang&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Other Molecules of interest&lt;br /&gt;
&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular Playground/PcrA Helicase]]&#039;&#039;&#039;, Luis E Ramirez-Tapia, [http://www.chem.umass.edu/~cmartin/ Martin Lab]&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Other Laboratories&lt;br /&gt;
&lt;br /&gt;
:&#039;&#039;&#039;[[Molecular Playground/4&#039;-PHOSPHOPANTETHEINYL TRANSFERASE (Sfp)]]&#039;&#039;&#039;, Jon Amoroso, Gitanjeli Prasad, Lawrence Sheringham Borketey, Schnarr lab&lt;br /&gt;
: &#039;&#039;&#039;[[6-deoxyerythronolide_B_synthase_(DEBS)|Molecular Playground/6-Deoxyerythronolide B Synthase]]&#039;&#039;&#039;, Tsung-Yi Lin, Jon Amoroso, Lawrence Sheringham Borketey, Schnarr lab&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular Playground/ACP apo]]&#039;&#039;&#039;, Gitanjeli Prasad,  Schnarr lab&lt;br /&gt;
&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular Playground/cytoplasmic domain of a serine chemotaxis receptor]]&#039;&#039;&#039;,  Meili Yang, Weis lab&lt;br /&gt;
&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular Playground/Alginate-Fall2011]]&#039;&#039;&#039;, Joe White, David Griffi, Bhatia Lab&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular Playground/Poly(ethylene glycol)]]&#039;&#039;&#039;, Erika M. Saffer, Bhatia Lab&lt;br /&gt;
&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular Playground/YKL-40]]&#039;&#039;&#039;, Ralph A. Francescone III, [http://www.bio.umass.edu/mcb/faculty/Shao.html Shao Lab]&lt;br /&gt;
&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular Playground/BLG|Molecular Playground/β-lactoglobulin]]&#039;&#039;&#039;, Daniel Seeman, Dubin Lab&lt;br /&gt;
&lt;br /&gt;
: &#039;&#039;&#039;[[Molecular Playground/ADAM13]]&#039;&#039;&#039;, Genevieve Abbruzzese, Alfandari Lab&lt;br /&gt;
&lt;br /&gt;
==Instructions==&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;The goal is for students to work collaboratively to create one excellent CBI Molecule for each CBI research group, to be featured on the CBI website.&#039;&#039;&#039;&lt;br /&gt;
&lt;br /&gt;
Fall 2014: Complete steps 1-3 before the CBI Molecule Workshop on 11/19; bring your computer to the CBI Molecule Workshop in ISB 321. You will be able to start work on your CBI Molecule at the workshop. You should plan to stay and finish your molecule after the workshop (or as soon as possible) while the instructions and ideas are fresh in your mind.&lt;br /&gt;
&lt;br /&gt;
A successful CBI Molecule is an interesting, nontechnical description of a molecule related to your group&#039;s research. It should tell an interesting story with few words and many green scenes. Green scenes should be clear and attractive illustrations that tell your story. It&#039;s great if you can end with a brief statement about how it relates to your group&#039;s research goals.&lt;br /&gt;
&lt;br /&gt;
1. If you don&#039;t already have one, request a Proteopedia account and log in. &lt;br /&gt;
&lt;br /&gt;
2. Read through the rest of the instructions, do the tutorials below, and look at any existing CBI Molecules from your research group. Talk with other CBI students in your research group and decide how you will collaborate to make an improved CBI Molecule related to your group&#039;s research. Develop ideas for the scenes that each of you will make.&lt;br /&gt;
&lt;br /&gt;
3. Get started working in Proteopedia. Make yourself a sandbox page: Enter &amp;quot;User:Your Name/Sandbox 1&amp;quot; (omit quotes) in the search box, then follow instructions to edit this page. Practice entering text, inserting a structure window with scrolling text (green 4-square button on the right), and creating a green scene. Explore the HELP links below to learn how to make a green scene. You can look at other Proteopedia pages in edit mode to see how different effects (like colored text) are achieved (but this won&#039;t show you how the scene effects are made). &lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Complete the above steps before the CBI Molecule Workshop.&#039;&#039;&#039;&lt;br /&gt;
&lt;br /&gt;
4. When editing an existing CBI Molecule, leave the original intact and make a copy that you will edit so that it retains the full author list of all authors that contributed. You are encouraged to collaborate on the CBI Molecules, but everyone will need to log in as themself and create a green scene to get credit for their work and to appear as authors on the final list. If you are the sole student from your group enrolled in Chalk Talk and have not previously made a CBI Molecule, try to convince another group member who has previously made a CBI Molecule (see  list above) to join us for the workshop so that you can work together.&lt;br /&gt;
&lt;br /&gt;
5. Your final pages should be called &amp;quot;Molecular Playground/your molecule&amp;quot; and should have links on this CBI Molecule page -- put the new ones first on the list from your research group. Label them &amp;quot;in progress&amp;quot; until you are finished, and then &amp;quot;new 2014&amp;quot; or &amp;quot;revised 2014&amp;quot;. Minimize text; tell your story with green scenes!&lt;br /&gt;
&lt;br /&gt;
6. When your CBI Molecule is complete, send Lynmarie an email to nominate a cool scene/clever caption you would like to feature at the Molecular Playground (include a link to your CBI Molecule, name of the green scene, and caption).&lt;br /&gt;
&lt;br /&gt;
==Links to HELP pages==&lt;br /&gt;
Overview at [[Help:Contents ]]&lt;br /&gt;
&lt;br /&gt;
See also [[Help:Getting_Started_in_Proteopedia]] &lt;br /&gt;
&lt;br /&gt;
Videos showing how to use Proteopedia:&lt;br /&gt;
[[Proteopedia:Video_Guide]]&lt;br /&gt;
(Sometimes slow -- if you pause the video and wait awhile it will download and then you can play it without interruptions)&lt;br /&gt;
&lt;br /&gt;
[[Proteopedia:DIY:Scenes|Proteopedia Scenes: Do It Yourself]]&lt;br /&gt;
gives succinct step by step instructions on how to create a molecular scene.&lt;br /&gt;
&lt;br /&gt;
A powerpoint-like set of slides that walks a user through the process of creating a new page and a new molecular scene/green link.&lt;br /&gt;
[http://www.proteopedia.org/wiki/images/1/1b/2009_07_13_Proteopedia_Workshop.pdf Proteopedia Workshop Slides]&lt;br /&gt;
&lt;br /&gt;
[[Proteopedia:Guidelines for Ethical Writing]].&lt;br /&gt;
Please pay attention to the section about images. There are links to examples of images re-used with explicit permission.&lt;br /&gt;
&lt;br /&gt;
For other help resources, click on [[Help:Contents|Help]] in the &#039;&#039;navigation&#039;&#039; box at the upper left of every page in Proteopedia.&lt;/div&gt;</summary>
		<author><name>Mahalia Serrano</name></author>
	</entry>
	<entry>
		<id>https://proteopedia.org/index.php?title=Molecular_Playground/Human_Serum_Albumin&amp;diff=2075863</id>
		<title>Molecular Playground/Human Serum Albumin</title>
		<link rel="alternate" type="text/html" href="https://proteopedia.org/index.php?title=Molecular_Playground/Human_Serum_Albumin&amp;diff=2075863"/>
		<updated>2014-12-04T06:10:08Z</updated>

		<summary type="html">&lt;p&gt;Mahalia Serrano: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;== &#039;&#039;&#039;HUMAN SERUM ALBUMIN (HSA)&#039;&#039;&#039; ==&lt;br /&gt;
&lt;br /&gt;
&amp;lt;Structure load=&#039;4K2C_all_domains_v2.pdb&#039; size=&#039;500&#039; frame=&#039;true&#039; align=&#039;right&#039; caption=&#039;Human serum albumin (PDB code [[4iw1]])&#039; scene=&#039;Insert optional scene name here&#039; /&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Human serum albumin&#039;&#039;&#039; (HSA) is the most abundant protein in the blood plasma, amounting to about 35 to 50 grams per liter of serum.  With a molecular weight of about 66.5 kDa, it functions mainly to maintain the pH and osmotic pressure of the blood and to transport a wide variety of endogenous and exogenous substances.&lt;br /&gt;
&lt;br /&gt;
== Structure ==&lt;br /&gt;
&lt;br /&gt;
HSA exists as a monomer that is comprised mostly of alpha helices. Each of the &amp;lt;scene name=&#039;57/571397/Different_domains_v2/1&#039;&amp;gt;three homologous helical domains&amp;lt;/scene&amp;gt; &lt;br /&gt;
(&amp;lt;B&amp;gt;&amp;lt;font color=&amp;quot;purple&amp;quot;&amp;gt;domain I&amp;lt;/font&amp;gt;&amp;lt;/B&amp;gt;, &amp;lt;B&amp;gt;&amp;lt;font color=&amp;quot;orange&amp;quot;&amp;gt;domain II&amp;lt;/font&amp;gt;&amp;lt;/B&amp;gt;, &amp;lt;B&amp;gt;&amp;lt;font color=&amp;quot;cyan&amp;quot;&amp;gt;domain III&amp;lt;/font&amp;gt;&amp;lt;/B&amp;gt;)&lt;br /&gt;
are further divided into subdomains A and B (A=darker shade, B=lighter shade), which form several hydrophobic pockets throughout the molecule. This multidomain structure of HSA allow it to bind many different classes of ligands at multiple sites.&lt;br /&gt;
&lt;br /&gt;
== Function ==&lt;br /&gt;
&lt;br /&gt;
Being the major protein in blood, HSA functions to maintain the osmotic pressure and the pH of the blood. Most importantly, it acts as a depot and carrier of various substances through the bloodstream.  HSA does not carry a specific cargo, although it does have preference for fat-soluble substances as it can bury the water-insoluble molecules into its hydrophobic core.  &amp;lt;scene name=&#039;57/571397/Hsa_with_myr_and_aspirin/5&#039;&amp;gt;Here&amp;lt;/scene&amp;gt;, we can see  HSA with both &amp;lt;B&amp;gt;&amp;lt;font color=&amp;quot;grey&amp;quot;&amp;gt;myristate&amp;lt;/font&amp;gt;&amp;lt;/B&amp;gt; (a fatty acid) and &amp;lt;B&amp;gt;&amp;lt;font color=&amp;quot;magenta&amp;quot;&amp;gt;aspirin&amp;lt;/font&amp;gt;&amp;lt;/B&amp;gt; (a common analgesic) bound to its hydrophobic pockets.  HSA transports a wide variety of substances through the bloodstream including carbohydrates (e.g &amp;lt;scene name=&#039;57/571397/Hsa_with_glucose/6&#039;&amp;gt;glucose&amp;lt;/scene&amp;gt;), fatty acids (e.g. &amp;lt;scene name=&#039;57/571397/Hsa_with_arachidonic_acid/3&#039;&amp;gt;arachidonic acid&amp;lt;/scene&amp;gt;), hormones (e.g. &amp;lt;scene name=&#039;57/571397/Hsa_with_thyroxine/6&#039;&amp;gt;thyroxine&amp;lt;/scene&amp;gt;, a thyroid hormone), and drugs (e.g. &amp;lt;scene name=&#039;57/571397/Hsa_with_ibp/1&#039;&amp;gt;ibuprofen&amp;lt;/scene&amp;gt;, an anti-inflammatory drug).&lt;br /&gt;
&lt;br /&gt;
== Role in pharmacokinetics ==&lt;br /&gt;
&lt;br /&gt;
The affinity of HSA for various drugs affects their pharmacokinetics and efficacy. Although binding to HSA helps solubilize the drug in the plasma, too strong affinity to HSA limits the free/available forms of the drug, meaning that higher doses must be administered to achieve the desired efficacy of the drug &#039;&#039;in vivo&#039;&#039;.  &lt;br /&gt;
&lt;br /&gt;
== Removal of HSA in serum fro biomarker studies ==&lt;br /&gt;
&lt;br /&gt;
Because HSA is very abundant in blood serum, most biomarker studies involving serum requires preliminary removal of HSA so that other non-abundant but otherwise important disease-indicating proteins can be detected.  In our group, we exploit several properties of HSA in order to efficiently remove it from serum prior to biomarker analysis. These properties include its low isoelectric point (pI of about 4.7) due to a number of &amp;lt;scene name=&#039;57/571397/Overall_structure_of_hsa/5&#039;&amp;gt;acidic residues&amp;lt;/scene&amp;gt;, and its tendency to bind hydrophobic molecules through its hydrophobic pockets.&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== References ==&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
[http://onlinelibrary.wiley.com/doi/10.1080/15216540500404093/pdf] Fasano, M., Curry, S., Terreno, E., Galliano, M., Fanali, G., Narciso, P., … Ascenzi, P. (2005). The extraordinary ligand binding properties of human serum albumin. IUBMB Life, 57(12), 787–96. &lt;br /&gt;
&lt;br /&gt;
[http://www.ncbi.nlm.nih.gov/pubmed/16169013] Ghuman, J., Zunszain, P. a, Petitpas, I., Bhattacharya, A. a, Otagiri, M., &amp;amp; Curry, S. (2005). Structural basis of the drug-binding specificity of human serum albumin. Journal of Molecular Biology, 353(1), 38–52.&lt;br /&gt;
&lt;br /&gt;
[http://www.ncbi.nlm.nih.gov/pubmed/15619298] Björhall, K., Miliotis, T., &amp;amp; Davidsson, P. (2005). Comparison of different depletion strategies for improved resolution in proteomic analysis of human serum samples. Proteomics, 5(1), 307–17.&lt;/div&gt;</summary>
		<author><name>Mahalia Serrano</name></author>
	</entry>
	<entry>
		<id>https://proteopedia.org/index.php?title=Molecular_Playground/Human_Serum_Albumin&amp;diff=2075862</id>
		<title>Molecular Playground/Human Serum Albumin</title>
		<link rel="alternate" type="text/html" href="https://proteopedia.org/index.php?title=Molecular_Playground/Human_Serum_Albumin&amp;diff=2075862"/>
		<updated>2014-12-04T06:08:26Z</updated>

		<summary type="html">&lt;p&gt;Mahalia Serrano: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;== &#039;&#039;&#039;HUMAN SERUM ALBUMIN (HSA)&#039;&#039;&#039; ==&lt;br /&gt;
&lt;br /&gt;
&amp;lt;Structure load=&#039;4K2C_all_domains_v2.pdb&#039; size=&#039;500&#039; frame=&#039;true&#039; align=&#039;right&#039; caption=&#039;Human serum albumin (PDB code [[4iw1]])&#039; scene=&#039;Insert optional scene name here&#039; /&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Human serum albumin&#039;&#039;&#039; (HSA) is the most abundant protein in the blood plasma, amounting to about 35 to 50 grams per liter of serum.  With a molecular weight of about 66.5 kDa, it functions mainly to maintain the pH and osmotic pressure of the blood and to transport a wide variety of endogenous and exogenous substances.&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== Structure ==&lt;br /&gt;
&lt;br /&gt;
HSA exists as a monomer that is comprised mostly of alpha helices. Each of the &amp;lt;scene name=&#039;57/571397/Different_domains_v2/1&#039;&amp;gt;three homologous helical domains&amp;lt;/scene&amp;gt; &lt;br /&gt;
(&amp;lt;B&amp;gt;&amp;lt;font color=&amp;quot;purple&amp;quot;&amp;gt;domain I&amp;lt;/font&amp;gt;&amp;lt;/B&amp;gt;, &amp;lt;B&amp;gt;&amp;lt;font color=&amp;quot;orange&amp;quot;&amp;gt;domain II&amp;lt;/font&amp;gt;&amp;lt;/B&amp;gt;, &amp;lt;B&amp;gt;&amp;lt;font color=&amp;quot;cyan&amp;quot;&amp;gt;domain III&amp;lt;/font&amp;gt;&amp;lt;/B&amp;gt;)&lt;br /&gt;
are further divided into subdomains A and B (A=darker shade, B=lighter shade), which form several hydrophobic pockets throughout the molecule. This multidomain structure of HSA allow it to bind many different classes of ligands at multiple sites.&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== Function ==&lt;br /&gt;
&lt;br /&gt;
Being the major protein in blood, HSA functions to maintain the osmotic pressure and the pH of the blood. Most importantly, it acts as a depot and carrier of various substances through the bloodstream.  HSA does not carry a specific cargo, although it does have preference for fat-soluble substances as it can bury the water-insoluble molecules into its hydrophobic core.  &amp;lt;scene name=&#039;57/571397/Hsa_with_myr_and_aspirin/5&#039;&amp;gt;Here&amp;lt;/scene&amp;gt;, we can see  HSA with both &amp;lt;B&amp;gt;&amp;lt;font color=&amp;quot;grey&amp;quot;&amp;gt;myristate&amp;lt;/font&amp;gt;&amp;lt;/B&amp;gt; (a fatty acid) and &amp;lt;B&amp;gt;&amp;lt;font color=&amp;quot;magenta&amp;quot;&amp;gt;aspirin&amp;lt;/font&amp;gt;&amp;lt;/B&amp;gt; (a common analgesic) bound to its hydrophobic pockets.  HSA transports a wide variety of substances through the bloodstream including carbohydrates (e.g &amp;lt;scene name=&#039;57/571397/Hsa_with_glucose/6&#039;&amp;gt;glucose&amp;lt;/scene&amp;gt;), fatty acids (e.g. &amp;lt;scene name=&#039;57/571397/Hsa_with_arachidonic_acid/3&#039;&amp;gt;arachidonic acid&amp;lt;/scene&amp;gt;), hormones (e.g. &amp;lt;scene name=&#039;57/571397/Hsa_with_thyroxine/6&#039;&amp;gt;thyroxine&amp;lt;/scene&amp;gt;, a thyroid hormone), and drugs (e.g. &amp;lt;scene name=&#039;57/571397/Hsa_with_ibp/1&#039;&amp;gt;ibuprofen&amp;lt;/scene&amp;gt;, an anti-inflammatory drug).&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== Role in pharmacokinetics ==&lt;br /&gt;
&lt;br /&gt;
The affinity of HSA for various drugs affects their pharmacokinetics and efficacy. Although binding to HSA helps solubilize the drug in the plasma, too strong affinity to HSA limits the free/available forms of the drug, meaning that higher doses must be administered to achieve the desired efficacy of the drug &#039;&#039;in vivo&#039;&#039;.  &lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== Removal of HSA in serum fro biomarker studies ==&lt;br /&gt;
&lt;br /&gt;
Because HSA is very abundant in blood serum, most biomarker studies involving serum requires preliminary removal of HSA so that other non-abundant but otherwise important disease-indicating proteins can be detected.  In our group, we exploit several properties of HSA in order to efficiently remove it from serum prior to biomarker analysis. These properties include its low isoelectric point (pI of about 4.7) due to a number of &amp;lt;scene name=&#039;57/571397/Overall_structure_of_hsa/5&#039;&amp;gt;acidic residues&amp;lt;/scene&amp;gt;, and its tendency to bind hydrophobic molecules through its hydrophobic pockets.&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== References ==&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
[http://onlinelibrary.wiley.com/doi/10.1080/15216540500404093/pdf] Fasano, M., Curry, S., Terreno, E., Galliano, M., Fanali, G., Narciso, P., … Ascenzi, P. (2005). The extraordinary ligand binding properties of human serum albumin. IUBMB Life, 57(12), 787–96. &lt;br /&gt;
&lt;br /&gt;
[http://www.ncbi.nlm.nih.gov/pubmed/16169013] Ghuman, J., Zunszain, P. a, Petitpas, I., Bhattacharya, A. a, Otagiri, M., &amp;amp; Curry, S. (2005). Structural basis of the drug-binding specificity of human serum albumin. Journal of Molecular Biology, 353(1), 38–52.&lt;br /&gt;
&lt;br /&gt;
[http://www.ncbi.nlm.nih.gov/pubmed/15619298] Björhall, K., Miliotis, T., &amp;amp; Davidsson, P. (2005). Comparison of different depletion strategies for improved resolution in proteomic analysis of human serum samples. Proteomics, 5(1), 307–17.&lt;/div&gt;</summary>
		<author><name>Mahalia Serrano</name></author>
	</entry>
	<entry>
		<id>https://proteopedia.org/index.php?title=Molecular_Playground/Human_Serum_Albumin&amp;diff=2075861</id>
		<title>Molecular Playground/Human Serum Albumin</title>
		<link rel="alternate" type="text/html" href="https://proteopedia.org/index.php?title=Molecular_Playground/Human_Serum_Albumin&amp;diff=2075861"/>
		<updated>2014-12-04T05:48:03Z</updated>

		<summary type="html">&lt;p&gt;Mahalia Serrano: /* Function */&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;== &#039;&#039;&#039;HUMAN SERUM ALBUMIN (HSA)&#039;&#039;&#039; ==&lt;br /&gt;
&lt;br /&gt;
&amp;lt;Structure load=&#039;4K2C_all_domains_v2.pdb&#039; size=&#039;500&#039; frame=&#039;true&#039; align=&#039;right&#039; caption=&#039;Human serum albumin (PDB code [[4iw1]])&#039; scene=&#039;Insert optional scene name here&#039; /&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Human serum albumin&#039;&#039;&#039; (HSA) is the most abundant protein in the blood plasma, amounting to about 35 to 50 grams per liter of serum.  With a molecular weight of about 66.5 kDa, it functions mainly to maintain the pH and osmotic pressure of the blood and to transport a wide variety of endogenous and exogenous substances.&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== Structure ==&lt;br /&gt;
&lt;br /&gt;
HSA exists as a monomer that is comprised mostly of alpha helices. Each of the &amp;lt;scene name=&#039;57/571397/Different_domains_v2/1&#039;&amp;gt;three homologous helical domains&amp;lt;/scene&amp;gt; &lt;br /&gt;
(&amp;lt;B&amp;gt;&amp;lt;font color=&amp;quot;purple&amp;quot;&amp;gt;domain I&amp;lt;/font&amp;gt;&amp;lt;/B&amp;gt;, &amp;lt;B&amp;gt;&amp;lt;font color=&amp;quot;orange&amp;quot;&amp;gt;domain II&amp;lt;/font&amp;gt;&amp;lt;/B&amp;gt;, &amp;lt;B&amp;gt;&amp;lt;font color=&amp;quot;cyan&amp;quot;&amp;gt;domain III&amp;lt;/font&amp;gt;&amp;lt;/B&amp;gt;)&lt;br /&gt;
are further divided into subdomains A and B (A=darker shade, B=lighter shade), which form several hydrophobic pockets throughout the molecule. This multidomain structure of HSA allow it to bind many different classes of ligands at multiple sites.&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== Function ==&lt;br /&gt;
&lt;br /&gt;
Being the major protein in blood, HSA functions to maintain the osmotic pressure and the pH of the blood. Most importantly, it acts as a depot and carrier of various substances through the bloodstream.  HSA does not carry a specific cargo, although it does have preference for fat-soluble substances as it can bury the water-insoluble molecules into its hydrophobic core.  &amp;lt;scene name=&#039;57/571397/Hsa_with_myr_and_aspirin/5&#039;&amp;gt;Here&amp;lt;/scene&amp;gt;, we can see  HSA with both &amp;lt;B&amp;gt;&amp;lt;font color=&amp;quot;grey&amp;quot;&amp;gt;myristate&amp;lt;/font&amp;gt;&amp;lt;/B&amp;gt; (a fatty acid) and &amp;lt;B&amp;gt;&amp;lt;font color=&amp;quot;magenta&amp;quot;&amp;gt;aspirin&amp;lt;/font&amp;gt;&amp;lt;/B&amp;gt; (a common analgesic) bound to its hydrophobic pockets.  HSA transports a wide variety of substances through the bloodstream including carbohydrates (e.g &amp;lt;scene name=&#039;57/571397/Hsa_with_glucose/6&#039;&amp;gt;glucose&amp;lt;/scene&amp;gt;), fatty acids (e.g. &amp;lt;scene name=&#039;57/571397/Hsa_with_arachidonic_acid/3&#039;&amp;gt;arachidonic acid&amp;lt;/scene&amp;gt;), hormones (e.g. &amp;lt;scene name=&#039;57/571397/Hsa_with_thyroxine/6&#039;&amp;gt;thyroxine&amp;lt;/scene&amp;gt;, a thyroid hormone), and drugs (e.g. &amp;lt;scene name=&#039;57/571397/Hsa_with_ibp/1&#039;&amp;gt;ibuprofen&amp;lt;/scene&amp;gt;, an anti-inflammatory drug).&lt;br /&gt;
&lt;br /&gt;
== Removal of HSA in serum fro biomarker studies ==&lt;br /&gt;
&lt;br /&gt;
Because HSA is very abundant in blood serum, most biomarker studies involving serum requires preliminary removal of HSA so that other non-abundant but otherwise important disease-indicating proteins can be detected.  In our group, we exploit several properties of HSA in order to efficiently remove it from serum prior to biomarker analysis. These properties include its low isoelectric point (pI of about 4.7) due to a number of &amp;lt;scene name=&#039;57/571397/Overall_structure_of_hsa/5&#039;&amp;gt;acidic residues&amp;lt;/scene&amp;gt;, and its tendency to bind hydrophobic molecules through its hydrophobic pockets.&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== References ==&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
[http://onlinelibrary.wiley.com/doi/10.1080/15216540500404093/pdf] Fasano, M., Curry, S., Terreno, E., Galliano, M., Fanali, G., Narciso, P., … Ascenzi, P. (2005). The extraordinary ligand binding properties of human serum albumin. IUBMB Life, 57(12), 787–96. &lt;br /&gt;
&lt;br /&gt;
[http://www.ncbi.nlm.nih.gov/pubmed/16169013] Ghuman, J., Zunszain, P. a, Petitpas, I., Bhattacharya, A. a, Otagiri, M., &amp;amp; Curry, S. (2005). Structural basis of the drug-binding specificity of human serum albumin. Journal of Molecular Biology, 353(1), 38–52.&lt;br /&gt;
&lt;br /&gt;
[http://www.ncbi.nlm.nih.gov/pubmed/15619298] Björhall, K., Miliotis, T., &amp;amp; Davidsson, P. (2005). Comparison of different depletion strategies for improved resolution in proteomic analysis of human serum samples. Proteomics, 5(1), 307–17.&lt;/div&gt;</summary>
		<author><name>Mahalia Serrano</name></author>
	</entry>
	<entry>
		<id>https://proteopedia.org/index.php?title=Molecular_Playground/Human_Serum_Albumin&amp;diff=2075860</id>
		<title>Molecular Playground/Human Serum Albumin</title>
		<link rel="alternate" type="text/html" href="https://proteopedia.org/index.php?title=Molecular_Playground/Human_Serum_Albumin&amp;diff=2075860"/>
		<updated>2014-12-04T05:40:03Z</updated>

		<summary type="html">&lt;p&gt;Mahalia Serrano: /* References */&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;== &#039;&#039;&#039;HUMAN SERUM ALBUMIN (HSA)&#039;&#039;&#039; ==&lt;br /&gt;
&lt;br /&gt;
&amp;lt;Structure load=&#039;4K2C_all_domains_v2.pdb&#039; size=&#039;500&#039; frame=&#039;true&#039; align=&#039;right&#039; caption=&#039;Human serum albumin (PDB code [[4iw1]])&#039; scene=&#039;Insert optional scene name here&#039; /&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Human serum albumin&#039;&#039;&#039; (HSA) is the most abundant protein in the blood plasma, amounting to about 35 to 50 grams per liter of serum.  With a molecular weight of about 66.5 kDa, it functions mainly to maintain the pH and osmotic pressure of the blood and to transport a wide variety of endogenous and exogenous substances.&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== Structure ==&lt;br /&gt;
&lt;br /&gt;
HSA exists as a monomer that is comprised mostly of alpha helices. Each of the &amp;lt;scene name=&#039;57/571397/Different_domains_v2/1&#039;&amp;gt;three homologous helical domains&amp;lt;/scene&amp;gt; &lt;br /&gt;
(&amp;lt;B&amp;gt;&amp;lt;font color=&amp;quot;purple&amp;quot;&amp;gt;domain I&amp;lt;/font&amp;gt;&amp;lt;/B&amp;gt;, &amp;lt;B&amp;gt;&amp;lt;font color=&amp;quot;orange&amp;quot;&amp;gt;domain II&amp;lt;/font&amp;gt;&amp;lt;/B&amp;gt;, &amp;lt;B&amp;gt;&amp;lt;font color=&amp;quot;cyan&amp;quot;&amp;gt;domain III&amp;lt;/font&amp;gt;&amp;lt;/B&amp;gt;)&lt;br /&gt;
are further divided into subdomains A and B (A=darker shade, B=lighter shade), which form several hydrophobic pockets throughout the molecule. This multidomain structure of HSA allow it to bind many different classes of ligands at multiple sites.&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== Function ==&lt;br /&gt;
&lt;br /&gt;
Being the major protein in blood, HSA functions to maintain the osmotic pressure and the pH of the blood. But most importantly, it acts as a depot and transports various substances through the bloodstream.  HSA does not carry a specific cargo, although it does have preference for fat-soluble substances as it can bury the water-insoluble molecules into its hydrophobic core.  &amp;lt;scene name=&#039;57/571397/Hsa_with_myr_and_aspirin/5&#039;&amp;gt;Here&amp;lt;/scene&amp;gt;, we can see  HSA with both &amp;lt;B&amp;gt;&amp;lt;font color=&amp;quot;grey&amp;quot;&amp;gt;myristate&amp;lt;/font&amp;gt;&amp;lt;/B&amp;gt; (a fatty acid) and &amp;lt;B&amp;gt;&amp;lt;font color=&amp;quot;magenta&amp;quot;&amp;gt;aspirin&amp;lt;/font&amp;gt;&amp;lt;/B&amp;gt; (a common analgesic) bound to its hydrophobic pockets.  HSA transports a wide variety of substances through the bloodstream including carbohydrates (e.g &amp;lt;scene name=&#039;57/571397/Hsa_with_glucose/6&#039;&amp;gt;glucose&amp;lt;/scene&amp;gt;), fatty acids (e.g. &amp;lt;scene name=&#039;57/571397/Hsa_with_arachidonic_acid/3&#039;&amp;gt;arachidonic acid&amp;lt;/scene&amp;gt;), hormones (e.g. &amp;lt;scene name=&#039;57/571397/Hsa_with_thyroxine/6&#039;&amp;gt;thyroxine&amp;lt;/scene&amp;gt;, a thyroid hormone), and drugs (e.g. &amp;lt;scene name=&#039;57/571397/Hsa_with_ibp/1&#039;&amp;gt;ibuprofen&amp;lt;/scene&amp;gt;, an anti-inflammatory drug).  &lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== Removal of HSA in serum fro biomarker studies ==&lt;br /&gt;
&lt;br /&gt;
Because HSA is very abundant in blood serum, most biomarker studies involving serum requires preliminary removal of HSA so that other non-abundant but otherwise important disease-indicating proteins can be detected.  In our group, we exploit several properties of HSA in order to efficiently remove it from serum prior to biomarker analysis. These properties include its low isoelectric point (pI of about 4.7) due to a number of &amp;lt;scene name=&#039;57/571397/Overall_structure_of_hsa/5&#039;&amp;gt;acidic residues&amp;lt;/scene&amp;gt;, and its tendency to bind hydrophobic molecules through its hydrophobic pockets.&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== References ==&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
[http://onlinelibrary.wiley.com/doi/10.1080/15216540500404093/pdf] Fasano, M., Curry, S., Terreno, E., Galliano, M., Fanali, G., Narciso, P., … Ascenzi, P. (2005). The extraordinary ligand binding properties of human serum albumin. IUBMB Life, 57(12), 787–96. &lt;br /&gt;
&lt;br /&gt;
[http://www.ncbi.nlm.nih.gov/pubmed/16169013] Ghuman, J., Zunszain, P. a, Petitpas, I., Bhattacharya, A. a, Otagiri, M., &amp;amp; Curry, S. (2005). Structural basis of the drug-binding specificity of human serum albumin. Journal of Molecular Biology, 353(1), 38–52.&lt;br /&gt;
&lt;br /&gt;
[http://www.ncbi.nlm.nih.gov/pubmed/15619298] Björhall, K., Miliotis, T., &amp;amp; Davidsson, P. (2005). Comparison of different depletion strategies for improved resolution in proteomic analysis of human serum samples. Proteomics, 5(1), 307–17.&lt;/div&gt;</summary>
		<author><name>Mahalia Serrano</name></author>
	</entry>
	<entry>
		<id>https://proteopedia.org/index.php?title=Molecular_Playground/Human_Serum_Albumin&amp;diff=2075859</id>
		<title>Molecular Playground/Human Serum Albumin</title>
		<link rel="alternate" type="text/html" href="https://proteopedia.org/index.php?title=Molecular_Playground/Human_Serum_Albumin&amp;diff=2075859"/>
		<updated>2014-12-04T05:39:35Z</updated>

		<summary type="html">&lt;p&gt;Mahalia Serrano: /* References */&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;== &#039;&#039;&#039;HUMAN SERUM ALBUMIN (HSA)&#039;&#039;&#039; ==&lt;br /&gt;
&lt;br /&gt;
&amp;lt;Structure load=&#039;4K2C_all_domains_v2.pdb&#039; size=&#039;500&#039; frame=&#039;true&#039; align=&#039;right&#039; caption=&#039;Human serum albumin (PDB code [[4iw1]])&#039; scene=&#039;Insert optional scene name here&#039; /&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Human serum albumin&#039;&#039;&#039; (HSA) is the most abundant protein in the blood plasma, amounting to about 35 to 50 grams per liter of serum.  With a molecular weight of about 66.5 kDa, it functions mainly to maintain the pH and osmotic pressure of the blood and to transport a wide variety of endogenous and exogenous substances.&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== Structure ==&lt;br /&gt;
&lt;br /&gt;
HSA exists as a monomer that is comprised mostly of alpha helices. Each of the &amp;lt;scene name=&#039;57/571397/Different_domains_v2/1&#039;&amp;gt;three homologous helical domains&amp;lt;/scene&amp;gt; &lt;br /&gt;
(&amp;lt;B&amp;gt;&amp;lt;font color=&amp;quot;purple&amp;quot;&amp;gt;domain I&amp;lt;/font&amp;gt;&amp;lt;/B&amp;gt;, &amp;lt;B&amp;gt;&amp;lt;font color=&amp;quot;orange&amp;quot;&amp;gt;domain II&amp;lt;/font&amp;gt;&amp;lt;/B&amp;gt;, &amp;lt;B&amp;gt;&amp;lt;font color=&amp;quot;cyan&amp;quot;&amp;gt;domain III&amp;lt;/font&amp;gt;&amp;lt;/B&amp;gt;)&lt;br /&gt;
are further divided into subdomains A and B (A=darker shade, B=lighter shade), which form several hydrophobic pockets throughout the molecule. This multidomain structure of HSA allow it to bind many different classes of ligands at multiple sites.&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== Function ==&lt;br /&gt;
&lt;br /&gt;
Being the major protein in blood, HSA functions to maintain the osmotic pressure and the pH of the blood. But most importantly, it acts as a depot and transports various substances through the bloodstream.  HSA does not carry a specific cargo, although it does have preference for fat-soluble substances as it can bury the water-insoluble molecules into its hydrophobic core.  &amp;lt;scene name=&#039;57/571397/Hsa_with_myr_and_aspirin/5&#039;&amp;gt;Here&amp;lt;/scene&amp;gt;, we can see  HSA with both &amp;lt;B&amp;gt;&amp;lt;font color=&amp;quot;grey&amp;quot;&amp;gt;myristate&amp;lt;/font&amp;gt;&amp;lt;/B&amp;gt; (a fatty acid) and &amp;lt;B&amp;gt;&amp;lt;font color=&amp;quot;magenta&amp;quot;&amp;gt;aspirin&amp;lt;/font&amp;gt;&amp;lt;/B&amp;gt; (a common analgesic) bound to its hydrophobic pockets.  HSA transports a wide variety of substances through the bloodstream including carbohydrates (e.g &amp;lt;scene name=&#039;57/571397/Hsa_with_glucose/6&#039;&amp;gt;glucose&amp;lt;/scene&amp;gt;), fatty acids (e.g. &amp;lt;scene name=&#039;57/571397/Hsa_with_arachidonic_acid/3&#039;&amp;gt;arachidonic acid&amp;lt;/scene&amp;gt;), hormones (e.g. &amp;lt;scene name=&#039;57/571397/Hsa_with_thyroxine/6&#039;&amp;gt;thyroxine&amp;lt;/scene&amp;gt;, a thyroid hormone), and drugs (e.g. &amp;lt;scene name=&#039;57/571397/Hsa_with_ibp/1&#039;&amp;gt;ibuprofen&amp;lt;/scene&amp;gt;, an anti-inflammatory drug).  &lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== Removal of HSA in serum fro biomarker studies ==&lt;br /&gt;
&lt;br /&gt;
Because HSA is very abundant in blood serum, most biomarker studies involving serum requires preliminary removal of HSA so that other non-abundant but otherwise important disease-indicating proteins can be detected.  In our group, we exploit several properties of HSA in order to efficiently remove it from serum prior to biomarker analysis. These properties include its low isoelectric point (pI of about 4.7) due to a number of &amp;lt;scene name=&#039;57/571397/Overall_structure_of_hsa/5&#039;&amp;gt;acidic residues&amp;lt;/scene&amp;gt;, and its tendency to bind hydrophobic molecules through its hydrophobic pockets.&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== References ==&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
[http://onlinelibrary.wiley.com/doi/10.1080/15216540500404093/pdf] Fasano, M., Curry, S., Terreno, E., Galliano, M., Fanali, G., Narciso, P., … Ascenzi, P. (2005). The extraordinary ligand binding properties of human serum albumin. IUBMB Life, 57(12), 787–96. &lt;br /&gt;
&lt;br /&gt;
[http://www.ncbi.nlm.nih.gov/pubmed/16169013] Ghuman, J., Zunszain, P. a, Petitpas, I., Bhattacharya, A. a, Otagiri, M., &amp;amp; Curry, S. (2005). Structural basis of the drug-binding specificity of human serum albumin. Journal of Molecular Biology, 353(1), 38–52.&lt;br /&gt;
&lt;br /&gt;
[http://www.ncbi.nlm.nih.gov/pubmed/15619298] Björhall, K., Miliotis, T., &amp;amp; Davidsson, P. (2005). Comparison of different depletion strategies for improved resolution in proteomic analysis of human serum samples. Proteomics, 5(1), 307–17. doi:10.1002/pmic.200400900&lt;/div&gt;</summary>
		<author><name>Mahalia Serrano</name></author>
	</entry>
	<entry>
		<id>https://proteopedia.org/index.php?title=Molecular_Playground/Human_Serum_Albumin&amp;diff=2075858</id>
		<title>Molecular Playground/Human Serum Albumin</title>
		<link rel="alternate" type="text/html" href="https://proteopedia.org/index.php?title=Molecular_Playground/Human_Serum_Albumin&amp;diff=2075858"/>
		<updated>2014-12-04T05:34:49Z</updated>

		<summary type="html">&lt;p&gt;Mahalia Serrano: /* References */&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;== &#039;&#039;&#039;HUMAN SERUM ALBUMIN (HSA)&#039;&#039;&#039; ==&lt;br /&gt;
&lt;br /&gt;
&amp;lt;Structure load=&#039;4K2C_all_domains_v2.pdb&#039; size=&#039;500&#039; frame=&#039;true&#039; align=&#039;right&#039; caption=&#039;Human serum albumin (PDB code [[4iw1]])&#039; scene=&#039;Insert optional scene name here&#039; /&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Human serum albumin&#039;&#039;&#039; (HSA) is the most abundant protein in the blood plasma, amounting to about 35 to 50 grams per liter of serum.  With a molecular weight of about 66.5 kDa, it functions mainly to maintain the pH and osmotic pressure of the blood and to transport a wide variety of endogenous and exogenous substances.&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== Structure ==&lt;br /&gt;
&lt;br /&gt;
HSA exists as a monomer that is comprised mostly of alpha helices. Each of the &amp;lt;scene name=&#039;57/571397/Different_domains_v2/1&#039;&amp;gt;three homologous helical domains&amp;lt;/scene&amp;gt; &lt;br /&gt;
(&amp;lt;B&amp;gt;&amp;lt;font color=&amp;quot;purple&amp;quot;&amp;gt;domain I&amp;lt;/font&amp;gt;&amp;lt;/B&amp;gt;, &amp;lt;B&amp;gt;&amp;lt;font color=&amp;quot;orange&amp;quot;&amp;gt;domain II&amp;lt;/font&amp;gt;&amp;lt;/B&amp;gt;, &amp;lt;B&amp;gt;&amp;lt;font color=&amp;quot;cyan&amp;quot;&amp;gt;domain III&amp;lt;/font&amp;gt;&amp;lt;/B&amp;gt;)&lt;br /&gt;
are further divided into subdomains A and B (A=darker shade, B=lighter shade), which form several hydrophobic pockets throughout the molecule. This multidomain structure of HSA allow it to bind many different classes of ligands at multiple sites.&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== Function ==&lt;br /&gt;
&lt;br /&gt;
Being the major protein in blood, HSA functions to maintain the osmotic pressure and the pH of the blood. But most importantly, it acts as a depot and transports various substances through the bloodstream.  HSA does not carry a specific cargo, although it does have preference for fat-soluble substances as it can bury the water-insoluble molecules into its hydrophobic core.  &amp;lt;scene name=&#039;57/571397/Hsa_with_myr_and_aspirin/5&#039;&amp;gt;Here&amp;lt;/scene&amp;gt;, we can see  HSA with both &amp;lt;B&amp;gt;&amp;lt;font color=&amp;quot;grey&amp;quot;&amp;gt;myristate&amp;lt;/font&amp;gt;&amp;lt;/B&amp;gt; (a fatty acid) and &amp;lt;B&amp;gt;&amp;lt;font color=&amp;quot;magenta&amp;quot;&amp;gt;aspirin&amp;lt;/font&amp;gt;&amp;lt;/B&amp;gt; (a common analgesic) bound to its hydrophobic pockets.  HSA transports a wide variety of substances through the bloodstream including carbohydrates (e.g &amp;lt;scene name=&#039;57/571397/Hsa_with_glucose/6&#039;&amp;gt;glucose&amp;lt;/scene&amp;gt;), fatty acids (e.g. &amp;lt;scene name=&#039;57/571397/Hsa_with_arachidonic_acid/3&#039;&amp;gt;arachidonic acid&amp;lt;/scene&amp;gt;), hormones (e.g. &amp;lt;scene name=&#039;57/571397/Hsa_with_thyroxine/6&#039;&amp;gt;thyroxine&amp;lt;/scene&amp;gt;, a thyroid hormone), and drugs (e.g. &amp;lt;scene name=&#039;57/571397/Hsa_with_ibp/1&#039;&amp;gt;ibuprofen&amp;lt;/scene&amp;gt;, an anti-inflammatory drug).  &lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== Removal of HSA in serum fro biomarker studies ==&lt;br /&gt;
&lt;br /&gt;
Because HSA is very abundant in blood serum, most biomarker studies involving serum requires preliminary removal of HSA so that other non-abundant but otherwise important disease-indicating proteins can be detected.  In our group, we exploit several properties of HSA in order to efficiently remove it from serum prior to biomarker analysis. These properties include its low isoelectric point (pI of about 4.7) due to a number of &amp;lt;scene name=&#039;57/571397/Overall_structure_of_hsa/5&#039;&amp;gt;acidic residues&amp;lt;/scene&amp;gt;, and its tendency to bind hydrophobic molecules through its hydrophobic pockets.&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== References ==&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
[http://onlinelibrary.wiley.com/doi/10.1080/15216540500404093/pdf] Fasano, M., Curry, S., Terreno, E., Galliano, M., Fanali, G., Narciso, P., … Ascenzi, P. (2005). The extraordinary ligand binding properties of human serum albumin. IUBMB Life, 57(12), 787–96. &lt;br /&gt;
&lt;br /&gt;
[http://www.ncbi.nlm.nih.gov/pubmed/16169013] Ghuman, J., Zunszain, P. a, Petitpas, I., Bhattacharya, A. a, Otagiri, M., &amp;amp; Curry, S. (2005). Structural basis of the drug-binding specificity of human serum albumin. Journal of Molecular Biology, 353(1), 38–52.&lt;/div&gt;</summary>
		<author><name>Mahalia Serrano</name></author>
	</entry>
	<entry>
		<id>https://proteopedia.org/index.php?title=Molecular_Playground/Human_Serum_Albumin&amp;diff=2075857</id>
		<title>Molecular Playground/Human Serum Albumin</title>
		<link rel="alternate" type="text/html" href="https://proteopedia.org/index.php?title=Molecular_Playground/Human_Serum_Albumin&amp;diff=2075857"/>
		<updated>2014-12-04T05:30:34Z</updated>

		<summary type="html">&lt;p&gt;Mahalia Serrano: /* References */&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;== &#039;&#039;&#039;HUMAN SERUM ALBUMIN (HSA)&#039;&#039;&#039; ==&lt;br /&gt;
&lt;br /&gt;
&amp;lt;Structure load=&#039;4K2C_all_domains_v2.pdb&#039; size=&#039;500&#039; frame=&#039;true&#039; align=&#039;right&#039; caption=&#039;Human serum albumin (PDB code [[4iw1]])&#039; scene=&#039;Insert optional scene name here&#039; /&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Human serum albumin&#039;&#039;&#039; (HSA) is the most abundant protein in the blood plasma, amounting to about 35 to 50 grams per liter of serum.  With a molecular weight of about 66.5 kDa, it functions mainly to maintain the pH and osmotic pressure of the blood and to transport a wide variety of endogenous and exogenous substances.&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== Structure ==&lt;br /&gt;
&lt;br /&gt;
HSA exists as a monomer that is comprised mostly of alpha helices. Each of the &amp;lt;scene name=&#039;57/571397/Different_domains_v2/1&#039;&amp;gt;three homologous helical domains&amp;lt;/scene&amp;gt; &lt;br /&gt;
(&amp;lt;B&amp;gt;&amp;lt;font color=&amp;quot;purple&amp;quot;&amp;gt;domain I&amp;lt;/font&amp;gt;&amp;lt;/B&amp;gt;, &amp;lt;B&amp;gt;&amp;lt;font color=&amp;quot;orange&amp;quot;&amp;gt;domain II&amp;lt;/font&amp;gt;&amp;lt;/B&amp;gt;, &amp;lt;B&amp;gt;&amp;lt;font color=&amp;quot;cyan&amp;quot;&amp;gt;domain III&amp;lt;/font&amp;gt;&amp;lt;/B&amp;gt;)&lt;br /&gt;
are further divided into subdomains A and B (A=darker shade, B=lighter shade), which form several hydrophobic pockets throughout the molecule. This multidomain structure of HSA allow it to bind many different classes of ligands at multiple sites.&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== Function ==&lt;br /&gt;
&lt;br /&gt;
Being the major protein in blood, HSA functions to maintain the osmotic pressure and the pH of the blood. But most importantly, it acts as a depot and transports various substances through the bloodstream.  HSA does not carry a specific cargo, although it does have preference for fat-soluble substances as it can bury the water-insoluble molecules into its hydrophobic core.  &amp;lt;scene name=&#039;57/571397/Hsa_with_myr_and_aspirin/5&#039;&amp;gt;Here&amp;lt;/scene&amp;gt;, we can see  HSA with both &amp;lt;B&amp;gt;&amp;lt;font color=&amp;quot;grey&amp;quot;&amp;gt;myristate&amp;lt;/font&amp;gt;&amp;lt;/B&amp;gt; (a fatty acid) and &amp;lt;B&amp;gt;&amp;lt;font color=&amp;quot;magenta&amp;quot;&amp;gt;aspirin&amp;lt;/font&amp;gt;&amp;lt;/B&amp;gt; (a common analgesic) bound to its hydrophobic pockets.  HSA transports a wide variety of substances through the bloodstream including carbohydrates (e.g &amp;lt;scene name=&#039;57/571397/Hsa_with_glucose/6&#039;&amp;gt;glucose&amp;lt;/scene&amp;gt;), fatty acids (e.g. &amp;lt;scene name=&#039;57/571397/Hsa_with_arachidonic_acid/3&#039;&amp;gt;arachidonic acid&amp;lt;/scene&amp;gt;), hormones (e.g. &amp;lt;scene name=&#039;57/571397/Hsa_with_thyroxine/6&#039;&amp;gt;thyroxine&amp;lt;/scene&amp;gt;, a thyroid hormone), and drugs (e.g. &amp;lt;scene name=&#039;57/571397/Hsa_with_ibp/1&#039;&amp;gt;ibuprofen&amp;lt;/scene&amp;gt;, an anti-inflammatory drug).  &lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== Removal of HSA in serum fro biomarker studies ==&lt;br /&gt;
&lt;br /&gt;
Because HSA is very abundant in blood serum, most biomarker studies involving serum requires preliminary removal of HSA so that other non-abundant but otherwise important disease-indicating proteins can be detected.  In our group, we exploit several properties of HSA in order to efficiently remove it from serum prior to biomarker analysis. These properties include its low isoelectric point (pI of about 4.7) due to a number of &amp;lt;scene name=&#039;57/571397/Overall_structure_of_hsa/5&#039;&amp;gt;acidic residues&amp;lt;/scene&amp;gt;, and its tendency to bind hydrophobic molecules through its hydrophobic pockets.&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== References ==&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Fasano, M., Curry, S., Terreno, E., Galliano, M., Fanali, G., Narciso, P., … Ascenzi, P. (2005). The extraordinary ligand binding properties of human serum albumin. IUBMB Life, 57(12), 787–96. [doi:10.1080/15216540500404093]&lt;br /&gt;
&lt;br /&gt;
Ghuman, J., Zunszain, P. a, Petitpas, I., Bhattacharya, A. a, Otagiri, M., &amp;amp; Curry, S. (2005). Structural basis of the drug-binding specificity of human serum albumin. Journal of Molecular Biology, 353(1), 38–52. [doi:10.1016/j.jmb.2005.07.075]&lt;/div&gt;</summary>
		<author><name>Mahalia Serrano</name></author>
	</entry>
	<entry>
		<id>https://proteopedia.org/index.php?title=Molecular_Playground/Human_Serum_Albumin&amp;diff=2075856</id>
		<title>Molecular Playground/Human Serum Albumin</title>
		<link rel="alternate" type="text/html" href="https://proteopedia.org/index.php?title=Molecular_Playground/Human_Serum_Albumin&amp;diff=2075856"/>
		<updated>2014-12-04T05:24:26Z</updated>

		<summary type="html">&lt;p&gt;Mahalia Serrano: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;== &#039;&#039;&#039;HUMAN SERUM ALBUMIN (HSA)&#039;&#039;&#039; ==&lt;br /&gt;
&lt;br /&gt;
&amp;lt;Structure load=&#039;4K2C_all_domains_v2.pdb&#039; size=&#039;500&#039; frame=&#039;true&#039; align=&#039;right&#039; caption=&#039;Human serum albumin (PDB code [[4iw1]])&#039; scene=&#039;Insert optional scene name here&#039; /&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Human serum albumin&#039;&#039;&#039; (HSA) is the most abundant protein in the blood plasma, amounting to about 35 to 50 grams per liter of serum.  With a molecular weight of about 66.5 kDa, it functions mainly to maintain the pH and osmotic pressure of the blood and to transport a wide variety of endogenous and exogenous substances.&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== Structure ==&lt;br /&gt;
&lt;br /&gt;
HSA exists as a monomer that is comprised mostly of alpha helices. Each of the &amp;lt;scene name=&#039;57/571397/Different_domains_v2/1&#039;&amp;gt;three homologous helical domains&amp;lt;/scene&amp;gt; &lt;br /&gt;
(&amp;lt;B&amp;gt;&amp;lt;font color=&amp;quot;purple&amp;quot;&amp;gt;domain I&amp;lt;/font&amp;gt;&amp;lt;/B&amp;gt;, &amp;lt;B&amp;gt;&amp;lt;font color=&amp;quot;orange&amp;quot;&amp;gt;domain II&amp;lt;/font&amp;gt;&amp;lt;/B&amp;gt;, &amp;lt;B&amp;gt;&amp;lt;font color=&amp;quot;cyan&amp;quot;&amp;gt;domain III&amp;lt;/font&amp;gt;&amp;lt;/B&amp;gt;)&lt;br /&gt;
are further divided into subdomains A and B (A=darker shade, B=lighter shade), which form several hydrophobic pockets throughout the molecule. This multidomain structure of HSA allow it to bind many different classes of ligands at multiple sites.&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== Function ==&lt;br /&gt;
&lt;br /&gt;
Being the major protein in blood, HSA functions to maintain the osmotic pressure and the pH of the blood. But most importantly, it acts as a depot and transports various substances through the bloodstream.  HSA does not carry a specific cargo, although it does have preference for fat-soluble substances as it can bury the water-insoluble molecules into its hydrophobic core.  &amp;lt;scene name=&#039;57/571397/Hsa_with_myr_and_aspirin/5&#039;&amp;gt;Here&amp;lt;/scene&amp;gt;, we can see  HSA with both &amp;lt;B&amp;gt;&amp;lt;font color=&amp;quot;grey&amp;quot;&amp;gt;myristate&amp;lt;/font&amp;gt;&amp;lt;/B&amp;gt; (a fatty acid) and &amp;lt;B&amp;gt;&amp;lt;font color=&amp;quot;magenta&amp;quot;&amp;gt;aspirin&amp;lt;/font&amp;gt;&amp;lt;/B&amp;gt; (a common analgesic) bound to its hydrophobic pockets.  HSA transports a wide variety of substances through the bloodstream including carbohydrates (e.g &amp;lt;scene name=&#039;57/571397/Hsa_with_glucose/6&#039;&amp;gt;glucose&amp;lt;/scene&amp;gt;), fatty acids (e.g. &amp;lt;scene name=&#039;57/571397/Hsa_with_arachidonic_acid/3&#039;&amp;gt;arachidonic acid&amp;lt;/scene&amp;gt;), hormones (e.g. &amp;lt;scene name=&#039;57/571397/Hsa_with_thyroxine/6&#039;&amp;gt;thyroxine&amp;lt;/scene&amp;gt;, a thyroid hormone), and drugs (e.g. &amp;lt;scene name=&#039;57/571397/Hsa_with_ibp/1&#039;&amp;gt;ibuprofen&amp;lt;/scene&amp;gt;, an anti-inflammatory drug).  &lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== Removal of HSA in serum fro biomarker studies ==&lt;br /&gt;
&lt;br /&gt;
Because HSA is very abundant in blood serum, most biomarker studies involving serum requires preliminary removal of HSA so that other non-abundant but otherwise important disease-indicating proteins can be detected.  In our group, we exploit several properties of HSA in order to efficiently remove it from serum prior to biomarker analysis. These properties include its low isoelectric point (pI of about 4.7) due to a number of &amp;lt;scene name=&#039;57/571397/Overall_structure_of_hsa/5&#039;&amp;gt;acidic residues&amp;lt;/scene&amp;gt;, and its tendency to bind hydrophobic molecules through its hydrophobic pockets.&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== References ==&lt;/div&gt;</summary>
		<author><name>Mahalia Serrano</name></author>
	</entry>
	<entry>
		<id>https://proteopedia.org/index.php?title=Molecular_Playground/Human_Serum_Albumin&amp;diff=2075855</id>
		<title>Molecular Playground/Human Serum Albumin</title>
		<link rel="alternate" type="text/html" href="https://proteopedia.org/index.php?title=Molecular_Playground/Human_Serum_Albumin&amp;diff=2075855"/>
		<updated>2014-12-04T05:19:58Z</updated>

		<summary type="html">&lt;p&gt;Mahalia Serrano: /* Function */&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;== &#039;&#039;&#039;HUMAN SERUM ALBUMIN (HSA)&#039;&#039;&#039; ==&lt;br /&gt;
&lt;br /&gt;
&amp;lt;Structure load=&#039;4K2C_all_domains_v2.pdb&#039; size=&#039;500&#039; frame=&#039;true&#039; align=&#039;right&#039; caption=&#039;Human serum albumin (PDB code [[4iw1]])&#039; scene=&#039;Insert optional scene name here&#039; /&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Human serum albumin&#039;&#039;&#039; (HSA) is the most abundant protein in the blood plasma, amounting to about 35 to 50 grams per liter of serum.  With a molecular weight of about 66.5 kDa, it functions mainly to maintain the pH and osmotic pressure of the blood and to transport a wide variety of endogenous and exogenous substances.&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== Structure ==&lt;br /&gt;
&lt;br /&gt;
HSA exists as a monomer that is comprised mostly of alpha helices. Each of the &amp;lt;scene name=&#039;57/571397/Different_domains_v2/1&#039;&amp;gt;three homologous helical domains&amp;lt;/scene&amp;gt; &lt;br /&gt;
(&amp;lt;B&amp;gt;&amp;lt;font color=&amp;quot;purple&amp;quot;&amp;gt;domain I&amp;lt;/font&amp;gt;&amp;lt;/B&amp;gt;, &amp;lt;B&amp;gt;&amp;lt;font color=&amp;quot;orange&amp;quot;&amp;gt;domain II&amp;lt;/font&amp;gt;&amp;lt;/B&amp;gt;, &amp;lt;B&amp;gt;&amp;lt;font color=&amp;quot;cyan&amp;quot;&amp;gt;domain III&amp;lt;/font&amp;gt;&amp;lt;/B&amp;gt;)&lt;br /&gt;
are further divided into subdomains A and B (A=darker shade, B=lighter shade), which form several hydrophobic pockets throughout the molecule. This multidomain structure of HSA allow it to bind many different classes of ligands at multiple sites.&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== Function ==&lt;br /&gt;
&lt;br /&gt;
Being the major protein in blood, HSA functions to maintain the osmotic pressure and the pH of the blood. But most importantly, it acts as a depot and transports various substances through the bloodstream.  HSA does not carry a specific cargo, although it does have preference for fat-soluble substances as it can bury the water-insoluble molecules into its hydrophobic core.  &amp;lt;scene name=&#039;57/571397/Hsa_with_myr_and_aspirin/5&#039;&amp;gt;Here&amp;lt;/scene&amp;gt;, we can see  HSA with both &amp;lt;B&amp;gt;&amp;lt;font color=&amp;quot;grey&amp;quot;&amp;gt;myristate&amp;lt;/font&amp;gt;&amp;lt;/B&amp;gt; (a fatty acid) and &amp;lt;B&amp;gt;&amp;lt;font color=&amp;quot;magenta&amp;quot;&amp;gt;aspirin&amp;lt;/font&amp;gt;&amp;lt;/B&amp;gt; (a common analgesic) bound to its hydrophobic pockets.  HSA transports a wide variety of substances through the bloodstream including carbohydrates (e.g &amp;lt;scene name=&#039;57/571397/Hsa_with_glucose/6&#039;&amp;gt;glucose&amp;lt;/scene&amp;gt;), fatty acids (e.g. &amp;lt;scene name=&#039;57/571397/Hsa_with_arachidonic_acid/3&#039;&amp;gt;arachidonic acid&amp;lt;/scene&amp;gt;), hormones (e.g. &amp;lt;scene name=&#039;57/571397/Hsa_with_thyroxine/6&#039;&amp;gt;thyroxine&amp;lt;/scene&amp;gt;, a thyroid hormone), and drugs (e.g. &amp;lt;scene name=&#039;57/571397/Hsa_with_ibp/1&#039;&amp;gt;ibuprofen&amp;lt;/scene&amp;gt;, an anti-inflammatory drug).  &lt;br /&gt;
&lt;br /&gt;
Because HSA is very abundant in blood serum, most biomarker studies involving serum requires preliminary removal of HSA so that other non-abundant but otherwise important disease-indicating proteins can be detected.  In our group, we exploit several properties of HSA in order to efficiently remove it from serum prior to biomarker analysis. These properties include its low isoelectric point (pI of about 4.7) due to a number of &amp;lt;scene name=&#039;57/571397/Overall_structure_of_hsa/5&#039;&amp;gt;acidic residues&amp;lt;/scene&amp;gt;, and its tendency to bind hydrophobic molecules through its hydrophobic pockets.&lt;/div&gt;</summary>
		<author><name>Mahalia Serrano</name></author>
	</entry>
	<entry>
		<id>https://proteopedia.org/index.php?title=Molecular_Playground/Human_Serum_Albumin&amp;diff=2075854</id>
		<title>Molecular Playground/Human Serum Albumin</title>
		<link rel="alternate" type="text/html" href="https://proteopedia.org/index.php?title=Molecular_Playground/Human_Serum_Albumin&amp;diff=2075854"/>
		<updated>2014-12-04T05:19:00Z</updated>

		<summary type="html">&lt;p&gt;Mahalia Serrano: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;== &#039;&#039;&#039;HUMAN SERUM ALBUMIN (HSA)&#039;&#039;&#039; ==&lt;br /&gt;
&lt;br /&gt;
&amp;lt;Structure load=&#039;4K2C_all_domains_v2.pdb&#039; size=&#039;500&#039; frame=&#039;true&#039; align=&#039;right&#039; caption=&#039;Human serum albumin (PDB code [[4iw1]])&#039; scene=&#039;Insert optional scene name here&#039; /&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Human serum albumin&#039;&#039;&#039; (HSA) is the most abundant protein in the blood plasma, amounting to about 35 to 50 grams per liter of serum.  With a molecular weight of about 66.5 kDa, it functions mainly to maintain the pH and osmotic pressure of the blood and to transport a wide variety of endogenous and exogenous substances.&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== Structure ==&lt;br /&gt;
&lt;br /&gt;
HSA exists as a monomer that is comprised mostly of alpha helices. Each of the &amp;lt;scene name=&#039;57/571397/Different_domains_v2/1&#039;&amp;gt;three homologous helical domains&amp;lt;/scene&amp;gt; &lt;br /&gt;
(&amp;lt;B&amp;gt;&amp;lt;font color=&amp;quot;purple&amp;quot;&amp;gt;domain I&amp;lt;/font&amp;gt;&amp;lt;/B&amp;gt;, &amp;lt;B&amp;gt;&amp;lt;font color=&amp;quot;orange&amp;quot;&amp;gt;domain II&amp;lt;/font&amp;gt;&amp;lt;/B&amp;gt;, &amp;lt;B&amp;gt;&amp;lt;font color=&amp;quot;cyan&amp;quot;&amp;gt;domain III&amp;lt;/font&amp;gt;&amp;lt;/B&amp;gt;)&lt;br /&gt;
are further divided into subdomains A and B (A=darker shade, B=lighter shade), which form several hydrophobic pockets throughout the molecule. This multidomain structure of HSA allow it to bind many different classes of ligands at multiple sites.&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== Function ==&lt;br /&gt;
&lt;br /&gt;
Being the major protein in blood, HSA functions to maintain the osmotic pressure and the pH of the blood. But most importantly, it acts as a depot and transports various substances through the bloodstream.  HSA does not carry a specific cargo, although it does have preference for fat-soluble substances as it can bury the water-insoluble molecules into its hydrophobic core.  &amp;lt;scene name=&#039;57/571397/Hsa_with_myr_and_aspirin/5&#039;&amp;gt;Here&amp;lt;/scene&amp;gt;, we can see  HSA with both &amp;lt;B&amp;gt;&amp;lt;font color=&amp;quot;grey&amp;quot;&amp;gt;myristate&amp;lt;/font&amp;gt;&amp;lt;/B&amp;gt; (a fatty acid) and &amp;lt;B&amp;gt;&amp;lt;font color=&amp;quot;pink&amp;quot;&amp;gt;domain I&amp;lt;/font&amp;gt;&amp;lt;/B&amp;gt; (a common analgesic) bound to its hydrophobic pockets.  HSA transports a wide variety of substances through the bloodstream including carbohydrates (e.g &amp;lt;scene name=&#039;57/571397/Hsa_with_glucose/6&#039;&amp;gt;glucose&amp;lt;/scene&amp;gt;), fatty acids (e.g. &amp;lt;scene name=&#039;57/571397/Hsa_with_arachidonic_acid/3&#039;&amp;gt;arachidonic acid&amp;lt;/scene&amp;gt;), hormones (e.g. &amp;lt;scene name=&#039;57/571397/Hsa_with_thyroxine/6&#039;&amp;gt;thyroxine&amp;lt;/scene&amp;gt;, a thyroid hormone), and drugs (e.g. &amp;lt;scene name=&#039;57/571397/Hsa_with_ibp/1&#039;&amp;gt;ibuprofen&amp;lt;/scene&amp;gt;, an anti-inflammatory drug).  &lt;br /&gt;
&lt;br /&gt;
Because HSA is very abundant in blood serum, most biomarker studies involving serum requires preliminary removal of HSA so that other non-abundant but otherwise important disease-indicating proteins can be detected.  In our group, we exploit several properties of HSA in order to efficiently remove it from serum prior to biomarker analysis. These properties include its low isoelectric point (pI of about 4.7) due to a number of &amp;lt;scene name=&#039;57/571397/Overall_structure_of_hsa/5&#039;&amp;gt;acidic residues&amp;lt;/scene&amp;gt;, and its tendency to bind hydrophobic molecules through its hydrophobic pockets.&lt;/div&gt;</summary>
		<author><name>Mahalia Serrano</name></author>
	</entry>
	<entry>
		<id>https://proteopedia.org/index.php?title=Molecular_Playground/Human_Serum_Albumin&amp;diff=2075853</id>
		<title>Molecular Playground/Human Serum Albumin</title>
		<link rel="alternate" type="text/html" href="https://proteopedia.org/index.php?title=Molecular_Playground/Human_Serum_Albumin&amp;diff=2075853"/>
		<updated>2014-12-04T05:06:44Z</updated>

		<summary type="html">&lt;p&gt;Mahalia Serrano: /* Structure */&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;== &#039;&#039;&#039;HUMAN SERUM ALBUMIN (HSA)&#039;&#039;&#039; ==&lt;br /&gt;
&lt;br /&gt;
&amp;lt;Structure load=&#039;4K2C_all_domains_v2.pdb&#039; size=&#039;500&#039; frame=&#039;true&#039; align=&#039;right&#039; caption=&#039;Human serum albumin (PDB code [[4iw1]])&#039; scene=&#039;Insert optional scene name here&#039; /&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Human serum albumin&#039;&#039;&#039; (HSA) is the most abundant protein in the blood plasma, amounting to about 35 to 50 grams per liter of serum.  With a molecular weight of about 66.5 kDa, it functions mainly to maintain the pH and osmotic pressure of the blood and to transport a wide variety of endogenous and exogenous substances.&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== Structure ==&lt;br /&gt;
&lt;br /&gt;
HSA exists as a monomer that is comprised mostly of alpha helices. Each of the &amp;lt;scene name=&#039;57/571397/Different_domains_v2/1&#039;&amp;gt;three homologous helical domains&amp;lt;/scene&amp;gt; &lt;br /&gt;
(&amp;lt;B&amp;gt;&amp;lt;font color=&amp;quot;purple&amp;quot;&amp;gt;domain I&amp;lt;/font&amp;gt;&amp;lt;/B&amp;gt;, &amp;lt;B&amp;gt;&amp;lt;font color=&amp;quot;orange&amp;quot;&amp;gt;domain II&amp;lt;/font&amp;gt;&amp;lt;/B&amp;gt;, &amp;lt;B&amp;gt;&amp;lt;font color=&amp;quot;cyan&amp;quot;&amp;gt;domain III&amp;lt;/font&amp;gt;&amp;lt;/B&amp;gt;)&lt;br /&gt;
are further divided into subdomains A and B (A=darker shade, B=lighter shade), which form several hydrophobic pockets throughout the molecule.&lt;br /&gt;
&lt;br /&gt;
== Function ==&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Being the major protein in blood, it functions to maintain the osmotic pressure and the pH of the blood. But most importantly, it functions to transport various substances through the bloodstream.  HSA does not carry a specific cargo, although it does have preference for fat-soluble substances as it can bury the water-insoluble molecules into its hydrophobic core.  Here, we can see &amp;lt;scene name=&#039;57/571397/Hsa_with_myr_and_aspirin/5&#039;&amp;gt;HSA with both myristate (a fatty acid, shown in grey spheres) and aspirin (a common analgesic, shown in pink) bound&amp;lt;/scene&amp;gt; to its hydrophobic pockets.  HSA transports a wide variety of substances through the bloodstream including carbohydrates (e.g &amp;lt;scene name=&#039;57/571397/Hsa_with_glucose/6&#039;&amp;gt;glucose&amp;lt;/scene&amp;gt;), fatty acids (e.g. &amp;lt;scene name=&#039;57/571397/Hsa_with_arachidonic_acid/3&#039;&amp;gt;arachidonic acid&amp;lt;/scene&amp;gt;), hormones (e.g. &amp;lt;scene name=&#039;57/571397/Hsa_with_thyroxine/6&#039;&amp;gt;thyroxine&amp;lt;/scene&amp;gt;, a thyroid hormone), and drugs (e.g. &amp;lt;scene name=&#039;57/571397/Hsa_with_ibp/1&#039;&amp;gt;ibuprofen&amp;lt;/scene&amp;gt;, an anti-inflammatory drug).  &lt;br /&gt;
&lt;br /&gt;
Because HSA is very abundant in blood serum, most biomarker studies involving serum requires preliminary removal of HSA so that other non-abundant but otherwise important disease-indicating proteins can be detected.  In our group, we exploit several properties of HSA in order to efficiently remove it from serum prior to biomarker analysis. These properties include its low isoelectric point (pI of about 4.7) due to a number of &amp;lt;scene name=&#039;57/571397/Overall_structure_of_hsa/5&#039;&amp;gt;acidic residues&amp;lt;/scene&amp;gt;, and its tendency to bind hydrophobic molecules through its hydrophobic pockets.&lt;/div&gt;</summary>
		<author><name>Mahalia Serrano</name></author>
	</entry>
	<entry>
		<id>https://proteopedia.org/index.php?title=Molecular_Playground/Human_Serum_Albumin&amp;diff=2075852</id>
		<title>Molecular Playground/Human Serum Albumin</title>
		<link rel="alternate" type="text/html" href="https://proteopedia.org/index.php?title=Molecular_Playground/Human_Serum_Albumin&amp;diff=2075852"/>
		<updated>2014-12-04T05:04:40Z</updated>

		<summary type="html">&lt;p&gt;Mahalia Serrano: /* Structure */&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;== &#039;&#039;&#039;HUMAN SERUM ALBUMIN (HSA)&#039;&#039;&#039; ==&lt;br /&gt;
&lt;br /&gt;
&amp;lt;Structure load=&#039;4K2C_all_domains_v2.pdb&#039; size=&#039;500&#039; frame=&#039;true&#039; align=&#039;right&#039; caption=&#039;Human serum albumin (PDB code [[4iw1]])&#039; scene=&#039;Insert optional scene name here&#039; /&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Human serum albumin&#039;&#039;&#039; (HSA) is the most abundant protein in the blood plasma, amounting to about 35 to 50 grams per liter of serum.  With a molecular weight of about 66.5 kDa, it functions mainly to maintain the pH and osmotic pressure of the blood and to transport a wide variety of endogenous and exogenous substances.&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== Structure ==&lt;br /&gt;
&lt;br /&gt;
HSA exists as a monomer that is comprised mostly of alpha helices. Each of the &amp;lt;scene name=&#039;57/571397/Different_domains_v2/1&#039;&amp;gt;three homologous helical domains&amp;lt;/scene&amp;gt; &lt;br /&gt;
(&amp;lt;B&amp;gt;&amp;lt;font color=&amp;quot;purple&amp;quot;&amp;gt;domain I&amp;lt;/font&amp;gt;&amp;lt;/B&amp;gt;, &amp;lt;B&amp;gt;&amp;lt;font color=&amp;quot;orange&amp;quot;&amp;gt;domain II&amp;lt;/font&amp;gt;&amp;lt;/B&amp;gt;, &amp;lt;B&amp;gt;&amp;lt;font color=&amp;quot;lightblue&amp;quot;&amp;gt;domain III&amp;lt;/font&amp;gt;&amp;lt;/B&amp;gt;)&lt;br /&gt;
are further divided into subdomains A and B (A=darker shade, B=lighter shade), which form several hydrophobic pockets throughout the molecule.&lt;br /&gt;
&lt;br /&gt;
== Function ==&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Being the major protein in blood, it functions to maintain the osmotic pressure and the pH of the blood. But most importantly, it functions to transport various substances through the bloodstream.  HSA does not carry a specific cargo, although it does have preference for fat-soluble substances as it can bury the water-insoluble molecules into its hydrophobic core.  Here, we can see &amp;lt;scene name=&#039;57/571397/Hsa_with_myr_and_aspirin/5&#039;&amp;gt;HSA with both myristate (a fatty acid, shown in grey spheres) and aspirin (a common analgesic, shown in pink) bound&amp;lt;/scene&amp;gt; to its hydrophobic pockets.  HSA transports a wide variety of substances through the bloodstream including carbohydrates (e.g &amp;lt;scene name=&#039;57/571397/Hsa_with_glucose/6&#039;&amp;gt;glucose&amp;lt;/scene&amp;gt;), fatty acids (e.g. &amp;lt;scene name=&#039;57/571397/Hsa_with_arachidonic_acid/3&#039;&amp;gt;arachidonic acid&amp;lt;/scene&amp;gt;), hormones (e.g. &amp;lt;scene name=&#039;57/571397/Hsa_with_thyroxine/6&#039;&amp;gt;thyroxine&amp;lt;/scene&amp;gt;, a thyroid hormone), and drugs (e.g. &amp;lt;scene name=&#039;57/571397/Hsa_with_ibp/1&#039;&amp;gt;ibuprofen&amp;lt;/scene&amp;gt;, an anti-inflammatory drug).  &lt;br /&gt;
&lt;br /&gt;
Because HSA is very abundant in blood serum, most biomarker studies involving serum requires preliminary removal of HSA so that other non-abundant but otherwise important disease-indicating proteins can be detected.  In our group, we exploit several properties of HSA in order to efficiently remove it from serum prior to biomarker analysis. These properties include its low isoelectric point (pI of about 4.7) due to a number of &amp;lt;scene name=&#039;57/571397/Overall_structure_of_hsa/5&#039;&amp;gt;acidic residues&amp;lt;/scene&amp;gt;, and its tendency to bind hydrophobic molecules through its hydrophobic pockets.&lt;/div&gt;</summary>
		<author><name>Mahalia Serrano</name></author>
	</entry>
	<entry>
		<id>https://proteopedia.org/index.php?title=Molecular_Playground/Human_Serum_Albumin&amp;diff=2075851</id>
		<title>Molecular Playground/Human Serum Albumin</title>
		<link rel="alternate" type="text/html" href="https://proteopedia.org/index.php?title=Molecular_Playground/Human_Serum_Albumin&amp;diff=2075851"/>
		<updated>2014-12-04T04:49:09Z</updated>

		<summary type="html">&lt;p&gt;Mahalia Serrano: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;== &#039;&#039;&#039;HUMAN SERUM ALBUMIN (HSA)&#039;&#039;&#039; ==&lt;br /&gt;
&lt;br /&gt;
&amp;lt;Structure load=&#039;4K2C_all_domains_v2.pdb&#039; size=&#039;500&#039; frame=&#039;true&#039; align=&#039;right&#039; caption=&#039;Human serum albumin (PDB code [[4iw1]])&#039; scene=&#039;Insert optional scene name here&#039; /&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Human serum albumin&#039;&#039;&#039; (HSA) is the most abundant protein in the blood plasma, amounting to about 35 to 50 grams per liter of serum.  With a molecular weight of about 66.5 kDa, it functions mainly to maintain the pH and osmotic pressure of the blood and to transport a wide variety of endogenous and exogenous substances.&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== Structure ==&lt;br /&gt;
&lt;br /&gt;
HSA exists as a monomer that is comprised mostly of alpha helices. Each of the &amp;lt;scene name=&#039;57/571397/Different_domains/1&#039;&amp;gt;three homologous helical domains&amp;lt;/scene&amp;gt; &lt;br /&gt;
(&amp;lt;B&amp;gt;&amp;lt;font color=&amp;quot;purple&amp;quot;&amp;gt;domain I&amp;lt;/font&amp;gt;&amp;lt;/B&amp;gt;, &amp;lt;B&amp;gt;&amp;lt;font color=&amp;quot;orange&amp;quot;&amp;gt;domain II&amp;lt;/font&amp;gt;&amp;lt;/B&amp;gt;, &amp;lt;B&amp;gt;&amp;lt;font color=&amp;quot;green&amp;quot;&amp;gt;domain III&amp;lt;/font&amp;gt;&amp;lt;/B&amp;gt;)&lt;br /&gt;
are further divided into subdomains A and B (A=darker shade, B=lighter shade), which form several hydrophobic pockets throughout the molecule.&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== Function ==&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Being the major protein in blood, it functions to maintain the osmotic pressure and the pH of the blood. But most importantly, it functions to transport various substances through the bloodstream.  HSA does not carry a specific cargo, although it does have preference for fat-soluble substances as it can bury the water-insoluble molecules into its hydrophobic core.  Here, we can see &amp;lt;scene name=&#039;57/571397/Hsa_with_myr_and_aspirin/5&#039;&amp;gt;HSA with both myristate (a fatty acid, shown in grey spheres) and aspirin (a common analgesic, shown in pink) bound&amp;lt;/scene&amp;gt; to its hydrophobic pockets.  HSA transports a wide variety of substances through the bloodstream including carbohydrates (e.g &amp;lt;scene name=&#039;57/571397/Hsa_with_glucose/6&#039;&amp;gt;glucose&amp;lt;/scene&amp;gt;), fatty acids (e.g. &amp;lt;scene name=&#039;57/571397/Hsa_with_arachidonic_acid/3&#039;&amp;gt;arachidonic acid&amp;lt;/scene&amp;gt;), hormones (e.g. &amp;lt;scene name=&#039;57/571397/Hsa_with_thyroxine/6&#039;&amp;gt;thyroxine&amp;lt;/scene&amp;gt;, a thyroid hormone), and drugs (e.g. &amp;lt;scene name=&#039;57/571397/Hsa_with_ibp/1&#039;&amp;gt;ibuprofen&amp;lt;/scene&amp;gt;, an anti-inflammatory drug).  &lt;br /&gt;
&lt;br /&gt;
Because HSA is very abundant in blood serum, most biomarker studies involving serum requires preliminary removal of HSA so that other non-abundant but otherwise important disease-indicating proteins can be detected.  In our group, we exploit several properties of HSA in order to efficiently remove it from serum prior to biomarker analysis. These properties include its low isoelectric point (pI of about 4.7) due to a number of &amp;lt;scene name=&#039;57/571397/Overall_structure_of_hsa/5&#039;&amp;gt;acidic residues&amp;lt;/scene&amp;gt;, and its tendency to bind hydrophobic molecules through its hydrophobic pockets.&lt;/div&gt;</summary>
		<author><name>Mahalia Serrano</name></author>
	</entry>
	<entry>
		<id>https://proteopedia.org/index.php?title=Mahalia_Serrano/Sandbox1&amp;diff=2075850</id>
		<title>Mahalia Serrano/Sandbox1</title>
		<link rel="alternate" type="text/html" href="https://proteopedia.org/index.php?title=Mahalia_Serrano/Sandbox1&amp;diff=2075850"/>
		<updated>2014-12-04T04:47:43Z</updated>

		<summary type="html">&lt;p&gt;Mahalia Serrano: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;== &#039;&#039;&#039;HUMAN SERUM ALBUMIN (HSA)&#039;&#039;&#039; ==&lt;br /&gt;
&lt;br /&gt;
&amp;lt;Structure load=&#039;4K2C_all_domains_v2.pdb&#039; size=&#039;500&#039; frame=&#039;true&#039; align=&#039;right&#039; caption=&#039;Human serum albumin (PDB code [[4iw1]])&#039; scene=&#039;Insert optional scene name here&#039; /&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Human serum albumin&#039;&#039;&#039; (HSA) is the most abundant protein in the blood plasma, amounting to about 35 to 50 grams per liter of serum.  With a molecular weight of about 66.5 kDa, it functions mainly to maintain the pH and osmotic pressure of the blood and to transport a wide variety of endogenous and exogenous substances.&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== Structure ==&lt;br /&gt;
&lt;br /&gt;
HSA exists as a monomer that is comprised mostly of alpha helices. Each of the &amp;lt;scene name=&#039;57/571397/Different_domains/1&#039;&amp;gt;three homologous helical domains&amp;lt;/scene&amp;gt; &lt;br /&gt;
(&amp;lt;B&amp;gt;&amp;lt;font color=&amp;quot;purple&amp;quot;&amp;gt;domain I&amp;lt;/font&amp;gt;&amp;lt;/B&amp;gt;, &amp;lt;B&amp;gt;&amp;lt;font color=&amp;quot;orange&amp;quot;&amp;gt;domain II&amp;lt;/font&amp;gt;&amp;lt;/B&amp;gt;, &amp;lt;B&amp;gt;&amp;lt;font color=&amp;quot;green&amp;quot;&amp;gt;domain III&amp;lt;/font&amp;gt;&amp;lt;/B&amp;gt;)&lt;br /&gt;
are further divided into subdomains A and B (A=darker shade, B=lighter shade), which form several hydrophobic pockets throughout the molecule.&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== Function ==&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Being the major protein in blood, it functions to maintain the osmotic pressure and the pH of the blood. But most importantly, it functions to transport various substances through the bloodstream.  HSA does not carry a specific cargo, although it does have preference for fat-soluble substances as it can bury the water-insoluble molecules into its hydrophobic core.  Here, we can see &amp;lt;scene name=&#039;57/571397/Hsa_with_myr_and_aspirin/5&#039;&amp;gt;HSA with both myristate (a fatty acid, shown in grey spheres) and aspirin (a common analgesic, shown in pink) bound&amp;lt;/scene&amp;gt; to its hydrophobic pockets.  HSA transports a wide variety of substances through the bloodstream including carbohydrates (e.g &amp;lt;scene name=&#039;57/571397/Hsa_with_glucose/6&#039;&amp;gt;glucose&amp;lt;/scene&amp;gt;), fatty acids (e.g. &amp;lt;scene name=&#039;57/571397/Hsa_with_arachidonic_acid/3&#039;&amp;gt;arachidonic acid&amp;lt;/scene&amp;gt;), hormones (e.g. &amp;lt;scene name=&#039;57/571397/Hsa_with_thyroxine/6&#039;&amp;gt;thyroxine&amp;lt;/scene&amp;gt;, a thyroid hormone), and drugs (e.g. &amp;lt;scene name=&#039;57/571397/Hsa_with_ibp/1&#039;&amp;gt;ibuprofen&amp;lt;/scene&amp;gt;, an anti-inflammatory drug).  &lt;br /&gt;
&lt;br /&gt;
Because HSA is very abundant in blood serum, most biomarker studies involving serum requires preliminary removal of HSA so that other non-abundant but otherwise important disease-indicating proteins can be detected.  In our group, we exploit several properties of HSA in order to efficiently remove it from serum prior to biomarker analysis. These properties include its low isoelectric point (pI of about 4.7) due to a number of &amp;lt;scene name=&#039;57/571397/Overall_structure_of_hsa/5&#039;&amp;gt;acidic residues&amp;lt;/scene&amp;gt;, and its tendency to bind hydrophobic molecules through its hydrophobic pockets.&lt;/div&gt;</summary>
		<author><name>Mahalia Serrano</name></author>
	</entry>
	<entry>
		<id>https://proteopedia.org/index.php?title=Mahalia_Serrano/Sandbox1&amp;diff=2075849</id>
		<title>Mahalia Serrano/Sandbox1</title>
		<link rel="alternate" type="text/html" href="https://proteopedia.org/index.php?title=Mahalia_Serrano/Sandbox1&amp;diff=2075849"/>
		<updated>2014-12-04T04:29:42Z</updated>

		<summary type="html">&lt;p&gt;Mahalia Serrano: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;== &#039;&#039;&#039;HUMAN SERUM ALBUMIN (HSA)&#039;&#039;&#039; ==&lt;br /&gt;
&lt;br /&gt;
&amp;lt;Structure load=&#039;4K2C_all_domains_v2.pdb&#039; size=&#039;500&#039; frame=&#039;true&#039; align=&#039;right&#039; caption=&#039;Human serum albumin (PDB code [[4iw1]])&#039; scene=&#039;Insert optional scene name here&#039; /&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Human serum albumin&#039;&#039;&#039; (HSA) is the most abundant protein in the blood plasma, amounting to about 35 to 50 grams per liter of serum.  With a molecular weight of about 66.5 kDa, it functions mainly to maintain the pH and osmotic pressure of the blood and to transport a wide variety of endogenous and exogenous substances.&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== Structure ==&lt;br /&gt;
&lt;br /&gt;
HSA exists as a monomer that is comprised mostly of alpha helices that form several hydrophobic binding pockets throughout the molecule. Each of the &amp;lt;scene name=&#039;57/571397/Different_domains/1&#039;&amp;gt;three homologous helical domains&amp;lt;/scene&amp;gt; &lt;br /&gt;
(&amp;lt;B&amp;gt;&amp;lt;font color=&amp;quot;purple&amp;quot;&amp;gt;domain I&amp;lt;/font&amp;gt;&amp;lt;/B&amp;gt;, &amp;lt;B&amp;gt;&amp;lt;font color=&amp;quot;orange&amp;quot;&amp;gt;domain II&amp;lt;/font&amp;gt;&amp;lt;/B&amp;gt;, &amp;lt;B&amp;gt;&amp;lt;font color=&amp;quot;green&amp;quot;&amp;gt;domain III&amp;lt;/font&amp;gt;&amp;lt;/B&amp;gt;)&lt;br /&gt;
are further divided into subdomains A and B (A=darker shade, B=lighter shade)&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== Function ==&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Being the major protein in blood, it functions to maintain the osmotic pressure and the pH of the blood. But most importantly, it functions to transport various substances through the bloodstream.  HSA does not carry a specific cargo, although it does have preference for fat-soluble substances as it can bury the water-insoluble molecules into its hydrophobic core.  Here, we can see &amp;lt;scene name=&#039;57/571397/Hsa_with_myr_and_aspirin/5&#039;&amp;gt;HSA with both myristate (a fatty acid, shown in grey spheres) and aspirin (a common analgesic, shown in pink) bound&amp;lt;/scene&amp;gt; to its hydrophobic pockets.  HSA transports a wide variety of substances through the bloodstream including carbohydrates (e.g &amp;lt;scene name=&#039;57/571397/Hsa_with_glucose/6&#039;&amp;gt;glucose&amp;lt;/scene&amp;gt;), fatty acids (e.g. &amp;lt;scene name=&#039;57/571397/Hsa_with_arachidonic_acid/3&#039;&amp;gt;arachidonic acid&amp;lt;/scene&amp;gt;), hormones (e.g. &amp;lt;scene name=&#039;57/571397/Hsa_with_thyroxine/6&#039;&amp;gt;thyroxine&amp;lt;/scene&amp;gt;, a thyroid hormone), and drugs (e.g. &amp;lt;scene name=&#039;57/571397/Hsa_with_ibp/1&#039;&amp;gt;ibuprofen&amp;lt;/scene&amp;gt;, an anti-inflammatory drug).  &lt;br /&gt;
&lt;br /&gt;
Because HSA is very abundant in blood serum, most biomarker studies involving serum requires preliminary removal of HSA so that other non-abundant but otherwise important disease-indicating proteins can be detected.  In our group, we exploit several properties of HSA in order to efficiently remove it from serum prior to biomarker analysis. These properties include its low isoelectric point (pI of about 4.7) due to a number of &amp;lt;scene name=&#039;57/571397/Overall_structure_of_hsa/5&#039;&amp;gt;acidic residues&amp;lt;/scene&amp;gt;, and its tendency to bind hydrophobic molecules through its hydrophobic pockets.&lt;/div&gt;</summary>
		<author><name>Mahalia Serrano</name></author>
	</entry>
	<entry>
		<id>https://proteopedia.org/index.php?title=Mahalia_Serrano/Sandbox1&amp;diff=2075848</id>
		<title>Mahalia Serrano/Sandbox1</title>
		<link rel="alternate" type="text/html" href="https://proteopedia.org/index.php?title=Mahalia_Serrano/Sandbox1&amp;diff=2075848"/>
		<updated>2014-12-04T04:27:56Z</updated>

		<summary type="html">&lt;p&gt;Mahalia Serrano: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;== &#039;&#039;&#039;HUMAN SERUM ALBUMIN (HSA)&#039;&#039;&#039; ==&lt;br /&gt;
&lt;br /&gt;
&amp;lt;Structure load=&#039;4K2C_all_domains_v2.pdb&#039; size=&#039;500&#039; frame=&#039;true&#039; align=&#039;right&#039; caption=&#039;Human serum albumin (PDB code [[4iw1]])&#039; scene=&#039;Insert optional scene name here&#039; /&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Human serum albumin&#039;&#039;&#039; (HSA) is the most abundant protein in the blood plasma, amounting to about 35 to 50 grams per liter of serum.  With a molecular weight of about 66.5 kDa, it functions mainly to maintain the pH and osmotic pressure of the blood and to transport a wide variety of endogenous and exogenous substances.&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== Structure ==&lt;br /&gt;
&lt;br /&gt;
HSA exists as a monomer that is comprised mostly of alpha helices that form several hydrophobic binding pockets throughout the molecule. Each of the &amp;lt;scene name=&#039;57/571397/Different_domains/1&#039;&amp;gt;three homologous helical domains&amp;lt;/scene&amp;gt; &lt;br /&gt;
(&amp;lt;B&amp;gt;&amp;lt;font color=&amp;quot;purple&amp;quot;&amp;gt;IA&amp;lt;/font&amp;gt;&amp;lt;/B&amp;gt;, &amp;lt;B&amp;gt;&amp;lt;font color=&amp;quot;light purple&amp;quot;&amp;gt;IB&amp;lt;/font&amp;gt;&amp;lt;/B&amp;gt;&lt;br /&gt;
are further divided into subdomains A and B (A=darker shade, B=lighter shade)&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== Function ==&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Being the major protein in blood, it functions to maintain the osmotic pressure and the pH of the blood. But most importantly, it functions to transport various substances through the bloodstream.  HSA does not carry a specific cargo, although it does have preference for fat-soluble substances as it can bury the water-insoluble molecules into its hydrophobic core.  Here, we can see &amp;lt;scene name=&#039;57/571397/Hsa_with_myr_and_aspirin/5&#039;&amp;gt;HSA with both myristate (a fatty acid, shown in grey spheres) and aspirin (a common analgesic, shown in pink) bound&amp;lt;/scene&amp;gt; to its hydrophobic pockets.  HSA transports a wide variety of substances through the bloodstream including carbohydrates (e.g &amp;lt;scene name=&#039;57/571397/Hsa_with_glucose/6&#039;&amp;gt;glucose&amp;lt;/scene&amp;gt;), fatty acids (e.g. &amp;lt;scene name=&#039;57/571397/Hsa_with_arachidonic_acid/3&#039;&amp;gt;arachidonic acid&amp;lt;/scene&amp;gt;), hormones (e.g. &amp;lt;scene name=&#039;57/571397/Hsa_with_thyroxine/6&#039;&amp;gt;thyroxine&amp;lt;/scene&amp;gt;, a thyroid hormone), and drugs (e.g. &amp;lt;scene name=&#039;57/571397/Hsa_with_ibp/1&#039;&amp;gt;ibuprofen&amp;lt;/scene&amp;gt;, an anti-inflammatory drug).  &lt;br /&gt;
&lt;br /&gt;
Because HSA is very abundant in blood serum, most biomarker studies involving serum requires preliminary removal of HSA so that other non-abundant but otherwise important disease-indicating proteins can be detected.  In our group, we exploit several properties of HSA in order to efficiently remove it from serum prior to biomarker analysis. These properties include its low isoelectric point (pI of about 4.7) due to a number of &amp;lt;scene name=&#039;57/571397/Overall_structure_of_hsa/5&#039;&amp;gt;acidic residues&amp;lt;/scene&amp;gt;, and its tendency to bind hydrophobic molecules through its hydrophobic pockets.&lt;/div&gt;</summary>
		<author><name>Mahalia Serrano</name></author>
	</entry>
	<entry>
		<id>https://proteopedia.org/index.php?title=Molecular_Playground/Human_Serum_Albumin&amp;diff=2075847</id>
		<title>Molecular Playground/Human Serum Albumin</title>
		<link rel="alternate" type="text/html" href="https://proteopedia.org/index.php?title=Molecular_Playground/Human_Serum_Albumin&amp;diff=2075847"/>
		<updated>2014-12-04T04:22:55Z</updated>

		<summary type="html">&lt;p&gt;Mahalia Serrano: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;== &#039;&#039;&#039;HUMAN SERUM ALBUMIN (HSA)&#039;&#039;&#039; ==&lt;br /&gt;
&lt;br /&gt;
&amp;lt;Structure load=&#039;4K2C_all_domains_v2.pdb&#039; size=&#039;500&#039; frame=&#039;true&#039; align=&#039;right&#039; caption=&#039;Human serum albumin (PDB code [[4iw1]])&#039; scene=&#039;Insert optional scene name here&#039; /&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Human serum albumin&#039;&#039;&#039; (HSA) is the most abundant protein in the blood plasma, amounting to about 35 to 50 grams per liter of serum.  With a molecular weight of about 66.5 kDa, it functions mainly to maintain the pH and osmotic pressure of the blood and to transport a wide variety of endogenous and exogenous substances.&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== Structure ==&lt;br /&gt;
&amp;lt;B&amp;gt;&amp;lt;font color=&amp;quot;blue&amp;quot;&amp;gt;N-terminus&amp;lt;/font&amp;gt;&amp;lt;/B&amp;gt;&lt;br /&gt;
HSA exists as a monomer that is comprised mostly of homologous &amp;lt;scene name=&#039;57/571397/Alpha_helices/1&#039;&amp;gt;alpha helices&amp;lt;/scene&amp;gt; that form several hydrophobic binding pockets throughout the molecule. &lt;br /&gt;
&lt;br /&gt;
&amp;lt;scene name=&#039;57/571397/Different_domains/1&#039;&amp;gt;subdomains: IA, IB, IIA, IIB, IIIA, IIIB&amp;lt;/scene&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Being the major protein in blood, it functions to maintain the osmotic pressure and the pH of the blood. But most importantly, it functions to transport various substances through the bloodstream.  HSA does not carry a specific cargo, although it does have preference for fat-soluble substances as it can bury the water-insoluble molecules into its hydrophobic core.  Here, we can see &amp;lt;scene name=&#039;57/571397/Hsa_with_myr_and_aspirin/5&#039;&amp;gt;HSA with both myristate (a fatty acid, shown in grey spheres) and aspirin (a common analgesic, shown in pink) bound&amp;lt;/scene&amp;gt; to its hydrophobic pockets.  HSA transports a wide variety of substances through the bloodstream including carbohydrates (e.g &amp;lt;scene name=&#039;57/571397/Hsa_with_glucose/6&#039;&amp;gt;glucose&amp;lt;/scene&amp;gt;), fatty acids (e.g. &amp;lt;scene name=&#039;57/571397/Hsa_with_arachidonic_acid/3&#039;&amp;gt;arachidonic acid&amp;lt;/scene&amp;gt;), hormones (e.g. &amp;lt;scene name=&#039;57/571397/Hsa_with_thyroxine/6&#039;&amp;gt;thyroxine&amp;lt;/scene&amp;gt;, a thyroid hormone), and drugs (e.g. &amp;lt;scene name=&#039;57/571397/Hsa_with_ibp/1&#039;&amp;gt;ibuprofen&amp;lt;/scene&amp;gt;, an anti-inflammatory drug).  &lt;br /&gt;
&lt;br /&gt;
Because HSA is very abundant in blood serum, most biomarker studies involving serum requires preliminary removal of HSA so that other non-abundant but otherwise important disease-indicating proteins can be detected.  In our group, we exploit several properties of HSA in order to efficiently remove it from serum prior to biomarker analysis. These properties include its low isoelectric point (pI of about 4.7) due to a number of &amp;lt;scene name=&#039;57/571397/Overall_structure_of_hsa/5&#039;&amp;gt;acidic residues&amp;lt;/scene&amp;gt;, and its tendency to bind hydrophobic molecules through its hydrophobic pockets.&lt;/div&gt;</summary>
		<author><name>Mahalia Serrano</name></author>
	</entry>
	<entry>
		<id>https://proteopedia.org/index.php?title=Mahalia_Serrano/Sandbox1&amp;diff=2075846</id>
		<title>Mahalia Serrano/Sandbox1</title>
		<link rel="alternate" type="text/html" href="https://proteopedia.org/index.php?title=Mahalia_Serrano/Sandbox1&amp;diff=2075846"/>
		<updated>2014-12-04T04:20:24Z</updated>

		<summary type="html">&lt;p&gt;Mahalia Serrano: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;== &#039;&#039;&#039;HUMAN SERUM ALBUMIN (HSA)&#039;&#039;&#039; ==&lt;br /&gt;
&lt;br /&gt;
&amp;lt;Structure load=&#039;4K2C_all_domains_v2.pdb&#039; size=&#039;500&#039; frame=&#039;true&#039; align=&#039;right&#039; caption=&#039;Human serum albumin (PDB code [[4iw1]])&#039; scene=&#039;Insert optional scene name here&#039; /&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Human serum albumin&#039;&#039;&#039; (HSA) is the most abundant protein in the blood plasma, amounting to about 35 to 50 grams per liter of serum.  With a molecular weight of about 66.5 kDa, it functions mainly to maintain the pH and osmotic pressure of the blood and to transport a wide variety of endogenous and exogenous substances.&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== Structure ==&lt;br /&gt;
&lt;br /&gt;
HSA exists as a monomer that is comprised mostly of alpha helices that form several hydrophobic binding pockets throughout the molecule. Each of the three homologous helical domains are further divided into subdomains A and B (A=darker shade, B=lighter shade)&lt;br /&gt;
&lt;br /&gt;
&amp;lt;scene name=&#039;57/571397/Different_domains/1&#039;&amp;gt;subdomains: IA, IB, IIA, IIB, IIIA, IIIB&amp;lt;/scene&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== Function ==&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Being the major protein in blood, it functions to maintain the osmotic pressure and the pH of the blood. But most importantly, it functions to transport various substances through the bloodstream.  HSA does not carry a specific cargo, although it does have preference for fat-soluble substances as it can bury the water-insoluble molecules into its hydrophobic core.  Here, we can see &amp;lt;scene name=&#039;57/571397/Hsa_with_myr_and_aspirin/5&#039;&amp;gt;HSA with both myristate (a fatty acid, shown in grey spheres) and aspirin (a common analgesic, shown in pink) bound&amp;lt;/scene&amp;gt; to its hydrophobic pockets.  HSA transports a wide variety of substances through the bloodstream including carbohydrates (e.g &amp;lt;scene name=&#039;57/571397/Hsa_with_glucose/6&#039;&amp;gt;glucose&amp;lt;/scene&amp;gt;), fatty acids (e.g. &amp;lt;scene name=&#039;57/571397/Hsa_with_arachidonic_acid/3&#039;&amp;gt;arachidonic acid&amp;lt;/scene&amp;gt;), hormones (e.g. &amp;lt;scene name=&#039;57/571397/Hsa_with_thyroxine/6&#039;&amp;gt;thyroxine&amp;lt;/scene&amp;gt;, a thyroid hormone), and drugs (e.g. &amp;lt;scene name=&#039;57/571397/Hsa_with_ibp/1&#039;&amp;gt;ibuprofen&amp;lt;/scene&amp;gt;, an anti-inflammatory drug).  &lt;br /&gt;
&lt;br /&gt;
Because HSA is very abundant in blood serum, most biomarker studies involving serum requires preliminary removal of HSA so that other non-abundant but otherwise important disease-indicating proteins can be detected.  In our group, we exploit several properties of HSA in order to efficiently remove it from serum prior to biomarker analysis. These properties include its low isoelectric point (pI of about 4.7) due to a number of &amp;lt;scene name=&#039;57/571397/Overall_structure_of_hsa/5&#039;&amp;gt;acidic residues&amp;lt;/scene&amp;gt;, and its tendency to bind hydrophobic molecules through its hydrophobic pockets.&lt;/div&gt;</summary>
		<author><name>Mahalia Serrano</name></author>
	</entry>
	<entry>
		<id>https://proteopedia.org/index.php?title=Mahalia_Serrano/Sandbox1&amp;diff=2075839</id>
		<title>Mahalia Serrano/Sandbox1</title>
		<link rel="alternate" type="text/html" href="https://proteopedia.org/index.php?title=Mahalia_Serrano/Sandbox1&amp;diff=2075839"/>
		<updated>2014-12-03T23:34:36Z</updated>

		<summary type="html">&lt;p&gt;Mahalia Serrano: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;== &#039;&#039;&#039;HUMAN SERUM ALBUMIN (HSA)&#039;&#039;&#039; ==&lt;br /&gt;
&lt;br /&gt;
&amp;lt;Structure load=&#039;4K2C_all_domains_v2.pdb&#039; size=&#039;500&#039; frame=&#039;true&#039; align=&#039;right&#039; caption=&#039;Human serum albumin (PDB code [[4iw1]])&#039; scene=&#039;Insert optional scene name here&#039; /&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Human serum albumin&#039;&#039;&#039; (HSA) is the most abundant protein in the blood plasma, amounting to about 35 to 50 grams per liter of serum.  With a molecular weight of about 66.5 kDa, it functions mainly to maintain the pH and osmotic pressure of the blood and to transport a wide variety of endogenous and exogenous substances.&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== Structure ==&lt;br /&gt;
&lt;br /&gt;
HSA exists as a monomer that is comprised mostly of &amp;lt;scene name=&#039;57/571397/Alpha_helices/1&#039;&amp;gt;alpha helices&amp;lt;/scene&amp;gt; that form several hydrophobic binding pockets throughout the molecule. Each of the three homologous helical domains are further divided into subdomains A and B (A=darker shade, B=lighter shade)&lt;br /&gt;
&lt;br /&gt;
&amp;lt;scene name=&#039;57/571397/Different_domains/1&#039;&amp;gt;subdomains: IA, IB, IIA, IIB, IIIA, IIIB&amp;lt;/scene&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Being the major protein in blood, it functions to maintain the osmotic pressure and the pH of the blood. But most importantly, it functions to transport various substances through the bloodstream.  HSA does not carry a specific cargo, although it does have preference for fat-soluble substances as it can bury the water-insoluble molecules into its hydrophobic core.  Here, we can see &amp;lt;scene name=&#039;57/571397/Hsa_with_myr_and_aspirin/5&#039;&amp;gt;HSA with both myristate (a fatty acid, shown in grey spheres) and aspirin (a common analgesic, shown in pink) bound&amp;lt;/scene&amp;gt; to its hydrophobic pockets.  HSA transports a wide variety of substances through the bloodstream including carbohydrates (e.g &amp;lt;scene name=&#039;57/571397/Hsa_with_glucose/6&#039;&amp;gt;glucose&amp;lt;/scene&amp;gt;), fatty acids (e.g. &amp;lt;scene name=&#039;57/571397/Hsa_with_arachidonic_acid/3&#039;&amp;gt;arachidonic acid&amp;lt;/scene&amp;gt;), hormones (e.g. &amp;lt;scene name=&#039;57/571397/Hsa_with_thyroxine/6&#039;&amp;gt;thyroxine&amp;lt;/scene&amp;gt;, a thyroid hormone), and drugs (e.g. &amp;lt;scene name=&#039;57/571397/Hsa_with_ibp/1&#039;&amp;gt;ibuprofen&amp;lt;/scene&amp;gt;, an anti-inflammatory drug).  &lt;br /&gt;
&lt;br /&gt;
Because HSA is very abundant in blood serum, most biomarker studies involving serum requires preliminary removal of HSA so that other non-abundant but otherwise important disease-indicating proteins can be detected.  In our group, we exploit several properties of HSA in order to efficiently remove it from serum prior to biomarker analysis. These properties include its low isoelectric point (pI of about 4.7) due to a number of &amp;lt;scene name=&#039;57/571397/Overall_structure_of_hsa/5&#039;&amp;gt;acidic residues&amp;lt;/scene&amp;gt;, and its tendency to bind hydrophobic molecules through its hydrophobic pockets.&lt;/div&gt;</summary>
		<author><name>Mahalia Serrano</name></author>
	</entry>
	<entry>
		<id>https://proteopedia.org/index.php?title=Mahalia_Serrano/Sandbox1&amp;diff=2075836</id>
		<title>Mahalia Serrano/Sandbox1</title>
		<link rel="alternate" type="text/html" href="https://proteopedia.org/index.php?title=Mahalia_Serrano/Sandbox1&amp;diff=2075836"/>
		<updated>2014-12-03T23:24:58Z</updated>

		<summary type="html">&lt;p&gt;Mahalia Serrano: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;== &#039;&#039;&#039;HUMAN SERUM ALBUMIN (HSA)&#039;&#039;&#039; ==&lt;br /&gt;
&lt;br /&gt;
&amp;lt;Structure load=&#039;4K2C_all_domains_v2.pdb&#039; size=&#039;500&#039; frame=&#039;true&#039; align=&#039;right&#039; caption=&#039;Human serum albumin (PDB code [[4iw1]])&#039; scene=&#039;Insert optional scene name here&#039; /&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Human serum albumin&#039;&#039;&#039; (HSA) is the most abundant protein in the blood plasma, amounting to about 35 to 50 grams per liter of serum.  With a molecular weight of about 66.5 kDa, it functions mainly to maintain the pH and osmotic pressure of the blood and to transport a wide variety of endogenous and exogenous substances.&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== Structure ==&lt;br /&gt;
&lt;br /&gt;
HSA exists as a monomer that is comprised mostly of homologous &amp;lt;scene name=&#039;57/571397/Alpha_helices/1&#039;&amp;gt;alpha helices&amp;lt;/scene&amp;gt; that form several hydrophobic binding pockets throughout the molecule. &lt;br /&gt;
&lt;br /&gt;
&amp;lt;scene name=&#039;57/571397/Different_domains/1&#039;&amp;gt;subdomains: IA, IB, IIA, IIB, IIIA, IIIB&amp;lt;/scene&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Being the major protein in blood, it functions to maintain the osmotic pressure and the pH of the blood. But most importantly, it functions to transport various substances through the bloodstream.  HSA does not carry a specific cargo, although it does have preference for fat-soluble substances as it can bury the water-insoluble molecules into its hydrophobic core.  Here, we can see &amp;lt;scene name=&#039;57/571397/Hsa_with_myr_and_aspirin/5&#039;&amp;gt;HSA with both myristate (a fatty acid, shown in grey spheres) and aspirin (a common analgesic, shown in pink) bound&amp;lt;/scene&amp;gt; to its hydrophobic pockets.  HSA transports a wide variety of substances through the bloodstream including carbohydrates (e.g &amp;lt;scene name=&#039;57/571397/Hsa_with_glucose/6&#039;&amp;gt;glucose&amp;lt;/scene&amp;gt;), fatty acids (e.g. &amp;lt;scene name=&#039;57/571397/Hsa_with_arachidonic_acid/3&#039;&amp;gt;arachidonic acid&amp;lt;/scene&amp;gt;), hormones (e.g. &amp;lt;scene name=&#039;57/571397/Hsa_with_thyroxine/6&#039;&amp;gt;thyroxine&amp;lt;/scene&amp;gt;, a thyroid hormone), and drugs (e.g. &amp;lt;scene name=&#039;57/571397/Hsa_with_ibp/1&#039;&amp;gt;ibuprofen&amp;lt;/scene&amp;gt;, an anti-inflammatory drug).  &lt;br /&gt;
&lt;br /&gt;
Because HSA is very abundant in blood serum, most biomarker studies involving serum requires preliminary removal of HSA so that other non-abundant but otherwise important disease-indicating proteins can be detected.  In our group, we exploit several properties of HSA in order to efficiently remove it from serum prior to biomarker analysis. These properties include its low isoelectric point (pI of about 4.7) due to a number of &amp;lt;scene name=&#039;57/571397/Overall_structure_of_hsa/5&#039;&amp;gt;acidic residues&amp;lt;/scene&amp;gt;, and its tendency to bind hydrophobic molecules through its hydrophobic pockets.&lt;/div&gt;</summary>
		<author><name>Mahalia Serrano</name></author>
	</entry>
	<entry>
		<id>https://proteopedia.org/index.php?title=Molecular_Playground/Human_Serum_Albumin&amp;diff=2075835</id>
		<title>Molecular Playground/Human Serum Albumin</title>
		<link rel="alternate" type="text/html" href="https://proteopedia.org/index.php?title=Molecular_Playground/Human_Serum_Albumin&amp;diff=2075835"/>
		<updated>2014-12-03T23:24:24Z</updated>

		<summary type="html">&lt;p&gt;Mahalia Serrano: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;== &#039;&#039;&#039;HUMAN SERUM ALBUMIN (HSA)&#039;&#039;&#039; ==&lt;br /&gt;
&lt;br /&gt;
&amp;lt;Structure load=&#039;4K2C_all_domains_v2.pdb&#039; size=&#039;500&#039; frame=&#039;true&#039; align=&#039;right&#039; caption=&#039;Human serum albumin (PDB code [[4iw1]])&#039; scene=&#039;Insert optional scene name here&#039; /&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Human serum albumin&#039;&#039;&#039; (HSA) is the most abundant protein in the blood plasma, amounting to about 35 to 50 grams per liter of serum.  With a molecular weight of about 66.5 kDa, it functions mainly to maintain the pH and osmotic pressure of the blood and to transport a wide variety of endogenous and exogenous substances.&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== Structure ==&lt;br /&gt;
&lt;br /&gt;
HSA exists as a monomer that is comprised mostly of homologous &amp;lt;scene name=&#039;57/571397/Alpha_helices/1&#039;&amp;gt;alpha helices&amp;lt;/scene&amp;gt; that form several hydrophobic binding pockets throughout the molecule. &lt;br /&gt;
&lt;br /&gt;
&amp;lt;scene name=&#039;57/571397/Different_domains/1&#039;&amp;gt;subdomains: IA, IB, IIA, IIB, IIIA, IIIB&amp;lt;/scene&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Being the major protein in blood, it functions to maintain the osmotic pressure and the pH of the blood. But most importantly, it functions to transport various substances through the bloodstream.  HSA does not carry a specific cargo, although it does have preference for fat-soluble substances as it can bury the water-insoluble molecules into its hydrophobic core.  Here, we can see &amp;lt;scene name=&#039;57/571397/Hsa_with_myr_and_aspirin/5&#039;&amp;gt;HSA with both myristate (a fatty acid, shown in grey spheres) and aspirin (a common analgesic, shown in pink) bound&amp;lt;/scene&amp;gt; to its hydrophobic pockets.  HSA transports a wide variety of substances through the bloodstream including carbohydrates (e.g &amp;lt;scene name=&#039;57/571397/Hsa_with_glucose/6&#039;&amp;gt;glucose&amp;lt;/scene&amp;gt;), fatty acids (e.g. &amp;lt;scene name=&#039;57/571397/Hsa_with_arachidonic_acid/3&#039;&amp;gt;arachidonic acid&amp;lt;/scene&amp;gt;), hormones (e.g. &amp;lt;scene name=&#039;57/571397/Hsa_with_thyroxine/6&#039;&amp;gt;thyroxine&amp;lt;/scene&amp;gt;, a thyroid hormone), and drugs (e.g. &amp;lt;scene name=&#039;57/571397/Hsa_with_ibp/1&#039;&amp;gt;ibuprofen&amp;lt;/scene&amp;gt;, an anti-inflammatory drug).  &lt;br /&gt;
&lt;br /&gt;
Because HSA is very abundant in blood serum, most biomarker studies involving serum requires preliminary removal of HSA so that other non-abundant but otherwise important disease-indicating proteins can be detected.  In our group, we exploit several properties of HSA in order to efficiently remove it from serum prior to biomarker analysis. These properties include its low isoelectric point (pI of about 4.7) due to a number of &amp;lt;scene name=&#039;57/571397/Overall_structure_of_hsa/5&#039;&amp;gt;acidic residues&amp;lt;/scene&amp;gt;, and its tendency to bind hydrophobic molecules through its hydrophobic pockets.&lt;/div&gt;</summary>
		<author><name>Mahalia Serrano</name></author>
	</entry>
	<entry>
		<id>https://proteopedia.org/index.php?title=Molecular_Playground/Human_Serum_Albumin&amp;diff=2075833</id>
		<title>Molecular Playground/Human Serum Albumin</title>
		<link rel="alternate" type="text/html" href="https://proteopedia.org/index.php?title=Molecular_Playground/Human_Serum_Albumin&amp;diff=2075833"/>
		<updated>2014-12-03T23:16:08Z</updated>

		<summary type="html">&lt;p&gt;Mahalia Serrano: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;== &#039;&#039;&#039;HUMAN SERUM ALBUMIN (HSA)&#039;&#039;&#039; ==&lt;br /&gt;
&lt;br /&gt;
&amp;lt;Structure load=&#039;4K2C_all_domains_v2.pdb&#039; size=&#039;500&#039; frame=&#039;true&#039; align=&#039;right&#039; caption=&#039;Human serum albumin (PDB code [[4iw1]])&#039; scene=&#039;Insert optional scene name here&#039; /&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Human serum albumin&#039;&#039;&#039; (HSA) is the most abundant protein in the blood plasma, amounting to about 35 to 50 grams per liter of serum.  With a molecular weight of about 66.5 kDa, it consists mostly of &amp;lt;scene name=&#039;57/571397/Alpha_helices/1&#039;&amp;gt;alpha helices&amp;lt;/scene&amp;gt; that form several hydrophobic binding pockets throughout the molecule. &lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== Structure ==&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&amp;lt;scene name=&#039;57/571397/Different_domains/1&#039;&amp;gt;subdomains: IA, IB, IIA, IIB, IIIA, IIIB&amp;lt;/scene&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Being the major protein in blood, it functions to maintain the osmotic pressure and the pH of the blood. But most importantly, it functions to transport various substances through the bloodstream.  HSA does not carry a specific cargo, although it does have preference for fat-soluble substances as it can bury the water-insoluble molecules into its hydrophobic core.  Here, we can see &amp;lt;scene name=&#039;57/571397/Hsa_with_myr_and_aspirin/5&#039;&amp;gt;HSA with both myristate (a fatty acid, shown in grey spheres) and aspirin (a common analgesic, shown in pink) bound&amp;lt;/scene&amp;gt; to its hydrophobic pockets.  HSA transports a wide variety of substances through the bloodstream including carbohydrates (e.g &amp;lt;scene name=&#039;57/571397/Hsa_with_glucose/6&#039;&amp;gt;glucose&amp;lt;/scene&amp;gt;), fatty acids (e.g. &amp;lt;scene name=&#039;57/571397/Hsa_with_arachidonic_acid/3&#039;&amp;gt;arachidonic acid&amp;lt;/scene&amp;gt;), hormones (e.g. &amp;lt;scene name=&#039;57/571397/Hsa_with_thyroxine/6&#039;&amp;gt;thyroxine&amp;lt;/scene&amp;gt;, a thyroid hormone), and drugs (e.g. &amp;lt;scene name=&#039;57/571397/Hsa_with_ibp/1&#039;&amp;gt;ibuprofen&amp;lt;/scene&amp;gt;, an anti-inflammatory drug).  &lt;br /&gt;
&lt;br /&gt;
Because HSA is very abundant in blood serum, most biomarker studies involving serum requires preliminary removal of HSA so that other non-abundant but otherwise important disease-indicating proteins can be detected.  In our group, we exploit several properties of HSA in order to efficiently remove it from serum prior to biomarker analysis. These properties include its low isoelectric point (pI of about 4.7) due to a number of &amp;lt;scene name=&#039;57/571397/Overall_structure_of_hsa/5&#039;&amp;gt;acidic residues&amp;lt;/scene&amp;gt;, and its tendency to bind hydrophobic molecules through its hydrophobic pockets.&lt;/div&gt;</summary>
		<author><name>Mahalia Serrano</name></author>
	</entry>
	<entry>
		<id>https://proteopedia.org/index.php?title=Molecular_Playground/Human_Serum_Albumin&amp;diff=2075830</id>
		<title>Molecular Playground/Human Serum Albumin</title>
		<link rel="alternate" type="text/html" href="https://proteopedia.org/index.php?title=Molecular_Playground/Human_Serum_Albumin&amp;diff=2075830"/>
		<updated>2014-12-03T23:13:47Z</updated>

		<summary type="html">&lt;p&gt;Mahalia Serrano: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;== &#039;&#039;&#039;HUMAN SERUM ALBUMIN (HSA)&#039;&#039;&#039; ==&lt;br /&gt;
&lt;br /&gt;
&amp;lt;Structure load=&#039;4iw1&#039; size=&#039;500&#039; frame=&#039;true&#039; align=&#039;right&#039; caption=&#039;Human serum albumin (PDB code [[4iw1]])&#039; scene=&#039;Insert optional scene name here&#039; /&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Human serum albumin&#039;&#039;&#039; (HSA) is the most abundant protein in the blood plasma, amounting to about 35 to 50 grams per liter of serum.  With a molecular weight of about 66.5 kDa, it consists mostly of &amp;lt;scene name=&#039;57/571397/Alpha_helices/1&#039;&amp;gt;alpha helices&amp;lt;/scene&amp;gt; that form several hydrophobic binding pockets throughout the molecule. &lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== Structure ==&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&amp;lt;scene name=&#039;57/571397/Different_domains/1&#039;&amp;gt;subdomains: IA, IB, IIA, IIB, IIIA, IIIB&amp;lt;/scene&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Being the major protein in blood, it functions to maintain the osmotic pressure and the pH of the blood. But most importantly, it functions to transport various substances through the bloodstream.  HSA does not carry a specific cargo, although it does have preference for fat-soluble substances as it can bury the water-insoluble molecules into its hydrophobic core.  Here, we can see &amp;lt;scene name=&#039;57/571397/Hsa_with_myr_and_aspirin/5&#039;&amp;gt;HSA with both myristate (a fatty acid, shown in grey spheres) and aspirin (a common analgesic, shown in pink) bound&amp;lt;/scene&amp;gt; to its hydrophobic pockets.  HSA transports a wide variety of substances through the bloodstream including carbohydrates (e.g &amp;lt;scene name=&#039;57/571397/Hsa_with_glucose/6&#039;&amp;gt;glucose&amp;lt;/scene&amp;gt;), fatty acids (e.g. &amp;lt;scene name=&#039;57/571397/Hsa_with_arachidonic_acid/3&#039;&amp;gt;arachidonic acid&amp;lt;/scene&amp;gt;), hormones (e.g. &amp;lt;scene name=&#039;57/571397/Hsa_with_thyroxine/6&#039;&amp;gt;thyroxine&amp;lt;/scene&amp;gt;, a thyroid hormone), and drugs (e.g. &amp;lt;scene name=&#039;57/571397/Hsa_with_ibp/1&#039;&amp;gt;ibuprofen&amp;lt;/scene&amp;gt;, an anti-inflammatory drug).  &lt;br /&gt;
&lt;br /&gt;
Because HSA is very abundant in blood serum, most biomarker studies involving serum requires preliminary removal of HSA so that other non-abundant but otherwise important disease-indicating proteins can be detected.  In our group, we exploit several properties of HSA in order to efficiently remove it from serum prior to biomarker analysis. These properties include its low isoelectric point (pI of about 4.7) due to a number of &amp;lt;scene name=&#039;57/571397/Overall_structure_of_hsa/5&#039;&amp;gt;acidic residues&amp;lt;/scene&amp;gt;, and its tendency to bind hydrophobic molecules through its hydrophobic pockets.&lt;/div&gt;</summary>
		<author><name>Mahalia Serrano</name></author>
	</entry>
	<entry>
		<id>https://proteopedia.org/index.php?title=Molecular_Playground/Human_Serum_Albumin&amp;diff=2075819</id>
		<title>Molecular Playground/Human Serum Albumin</title>
		<link rel="alternate" type="text/html" href="https://proteopedia.org/index.php?title=Molecular_Playground/Human_Serum_Albumin&amp;diff=2075819"/>
		<updated>2014-12-03T22:53:25Z</updated>

		<summary type="html">&lt;p&gt;Mahalia Serrano: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;== &#039;&#039;&#039;HUMAN SERUM ALBUMIN (HSA)&#039;&#039;&#039; ==&lt;br /&gt;
&lt;br /&gt;
&amp;lt;Structure load=&#039;4iw1&#039; size=&#039;500&#039; frame=&#039;true&#039; align=&#039;right&#039; caption=&#039;Human serum albumin (PDB code [[4iw1]])&#039; scene=&#039;Insert optional scene name here&#039; /&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Human serum albumin&#039;&#039;&#039; (HSA) is the most abundant protein in the blood plasma, amounting to about 35 to 50 grams per liter of serum.  It consists mostly of &amp;lt;scene name=&#039;57/571397/Alpha_helices/1&#039;&amp;gt;alpha helices&amp;lt;/scene&amp;gt; that form several hydrophobic binding pockets throughout the molecule. &lt;br /&gt;
&lt;br /&gt;
&amp;lt;scene name=&#039;57/571397/Different_domains/1&#039;&amp;gt;subdomains: IA, IB, IIA, IIB, IIIA, IIIB&amp;lt;/scene&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Being the major protein in blood, it functions to maintain the osmotic pressure and the pH of the blood. But most importantly, it functions to transport various substances through the bloodstream.  HSA does not carry a specific cargo, although it does have preference for fat-soluble substances as it can bury the water-insoluble molecules into its hydrophobic core.  Here, we can see &amp;lt;scene name=&#039;57/571397/Hsa_with_myr_and_aspirin/5&#039;&amp;gt;HSA with both myristate (a fatty acid, shown in grey spheres) and aspirin (a common analgesic, shown in pink) bound&amp;lt;/scene&amp;gt; to its hydrophobic pockets.  HSA transports a wide variety of substances through the bloodstream including carbohydrates (e.g &amp;lt;scene name=&#039;57/571397/Hsa_with_glucose/6&#039;&amp;gt;glucose&amp;lt;/scene&amp;gt;), fatty acids (e.g. &amp;lt;scene name=&#039;57/571397/Hsa_with_arachidonic_acid/3&#039;&amp;gt;arachidonic acid&amp;lt;/scene&amp;gt;), hormones (e.g. &amp;lt;scene name=&#039;57/571397/Hsa_with_thyroxine/6&#039;&amp;gt;thyroxine&amp;lt;/scene&amp;gt;, a thyroid hormone), and drugs (e.g. &amp;lt;scene name=&#039;57/571397/Hsa_with_ibp/1&#039;&amp;gt;ibuprofen&amp;lt;/scene&amp;gt;, an anti-inflammatory drug).  &lt;br /&gt;
&lt;br /&gt;
Because HSA is very abundant in blood serum, most biomarker studies involving serum requires preliminary removal of HSA so that other non-abundant but otherwise important disease-indicating proteins can be detected.  In our group, we exploit several properties of HSA in order to efficiently remove it from serum prior to biomarker analysis. These properties include its low isoelectric point (pI of about 4.7) due to a number of &amp;lt;scene name=&#039;57/571397/Overall_structure_of_hsa/5&#039;&amp;gt;acidic residues&amp;lt;/scene&amp;gt;, and its tendency to bind hydrophobic molecules through its hydrophobic pockets.&lt;/div&gt;</summary>
		<author><name>Mahalia Serrano</name></author>
	</entry>
	<entry>
		<id>https://proteopedia.org/index.php?title=File:4K2C_all_domains_v2.pdb&amp;diff=2075808</id>
		<title>File:4K2C all domains v2.pdb</title>
		<link rel="alternate" type="text/html" href="https://proteopedia.org/index.php?title=File:4K2C_all_domains_v2.pdb&amp;diff=2075808"/>
		<updated>2014-12-03T22:29:59Z</updated>

		<summary type="html">&lt;p&gt;Mahalia Serrano: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;&lt;/div&gt;</summary>
		<author><name>Mahalia Serrano</name></author>
	</entry>
	<entry>
		<id>https://proteopedia.org/index.php?title=File:4K2C_all_domains.pdb&amp;diff=2075807</id>
		<title>File:4K2C all domains.pdb</title>
		<link rel="alternate" type="text/html" href="https://proteopedia.org/index.php?title=File:4K2C_all_domains.pdb&amp;diff=2075807"/>
		<updated>2014-12-03T22:27:29Z</updated>

		<summary type="html">&lt;p&gt;Mahalia Serrano: uploaded a new version of &amp;quot;Image:4K2C all domains.pdb&amp;quot;&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;&lt;/div&gt;</summary>
		<author><name>Mahalia Serrano</name></author>
	</entry>
	<entry>
		<id>https://proteopedia.org/index.php?title=File:4K2C_all_domains.pdb&amp;diff=2075806</id>
		<title>File:4K2C all domains.pdb</title>
		<link rel="alternate" type="text/html" href="https://proteopedia.org/index.php?title=File:4K2C_all_domains.pdb&amp;diff=2075806"/>
		<updated>2014-12-03T22:25:54Z</updated>

		<summary type="html">&lt;p&gt;Mahalia Serrano: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;&lt;/div&gt;</summary>
		<author><name>Mahalia Serrano</name></author>
	</entry>
	<entry>
		<id>https://proteopedia.org/index.php?title=File:4K2C_domains_v2.pdb&amp;diff=2075805</id>
		<title>File:4K2C domains v2.pdb</title>
		<link rel="alternate" type="text/html" href="https://proteopedia.org/index.php?title=File:4K2C_domains_v2.pdb&amp;diff=2075805"/>
		<updated>2014-12-03T22:22:47Z</updated>

		<summary type="html">&lt;p&gt;Mahalia Serrano: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;&lt;/div&gt;</summary>
		<author><name>Mahalia Serrano</name></author>
	</entry>
	<entry>
		<id>https://proteopedia.org/index.php?title=File:4K2C_domains.pdb&amp;diff=2075804</id>
		<title>File:4K2C domains.pdb</title>
		<link rel="alternate" type="text/html" href="https://proteopedia.org/index.php?title=File:4K2C_domains.pdb&amp;diff=2075804"/>
		<updated>2014-12-03T22:20:58Z</updated>

		<summary type="html">&lt;p&gt;Mahalia Serrano: uploaded a new version of &amp;quot;Image:4K2C domains.pdb&amp;quot;&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;&lt;/div&gt;</summary>
		<author><name>Mahalia Serrano</name></author>
	</entry>
	<entry>
		<id>https://proteopedia.org/index.php?title=File:4K2C_domains_v2_state01.pdb&amp;diff=2075803</id>
		<title>File:4K2C domains v2 state01.pdb</title>
		<link rel="alternate" type="text/html" href="https://proteopedia.org/index.php?title=File:4K2C_domains_v2_state01.pdb&amp;diff=2075803"/>
		<updated>2014-12-03T22:12:53Z</updated>

		<summary type="html">&lt;p&gt;Mahalia Serrano: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;&lt;/div&gt;</summary>
		<author><name>Mahalia Serrano</name></author>
	</entry>
	<entry>
		<id>https://proteopedia.org/index.php?title=File:4K2C_domains.pdb&amp;diff=2075802</id>
		<title>File:4K2C domains.pdb</title>
		<link rel="alternate" type="text/html" href="https://proteopedia.org/index.php?title=File:4K2C_domains.pdb&amp;diff=2075802"/>
		<updated>2014-12-03T22:09:18Z</updated>

		<summary type="html">&lt;p&gt;Mahalia Serrano: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;&lt;/div&gt;</summary>
		<author><name>Mahalia Serrano</name></author>
	</entry>
	<entry>
		<id>https://proteopedia.org/index.php?title=Molecular_Playground/Human_Serum_Albumin&amp;diff=2075683</id>
		<title>Molecular Playground/Human Serum Albumin</title>
		<link rel="alternate" type="text/html" href="https://proteopedia.org/index.php?title=Molecular_Playground/Human_Serum_Albumin&amp;diff=2075683"/>
		<updated>2014-12-03T19:09:37Z</updated>

		<summary type="html">&lt;p&gt;Mahalia Serrano: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;== &#039;&#039;&#039;HUMAN SERUM ALBUMIN (HSA)&#039;&#039;&#039; ==&lt;br /&gt;
&lt;br /&gt;
&amp;lt;Structure load=&#039;4iw1&#039; size=&#039;500&#039; frame=&#039;true&#039; align=&#039;right&#039; caption=&#039;Human serum albumin (PDB code [[4iw1]])&#039; scene=&#039;Insert optional scene name here&#039; /&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Human serum albumin&#039;&#039;&#039; (HSA) is the most abundant protein in the blood plasma, amounting to about 35 to 50 grams per liter of serum.  It consists mostly of &amp;lt;scene name=&#039;57/571397/Alpha_helices/1&#039;&amp;gt;alpha helices&amp;lt;/scene&amp;gt; that form several hydrophobic binding pockets throughout the molecule. &lt;br /&gt;
&lt;br /&gt;
Being the major protein in blood, it functions to maintain the osmotic pressure and the pH of the blood. But most importantly, it functions to transport various substances through the bloodstream.  HSA does not carry a specific cargo, although it does have preference for fat-soluble substances as it can bury the water-insoluble molecules into its hydrophobic core.  Here, we can see &amp;lt;scene name=&#039;57/571397/Hsa_with_myr_and_aspirin/5&#039;&amp;gt;HSA with both myristate (a fatty acid, shown in grey spheres) and aspirin (a common analgesic, shown in pink) bound&amp;lt;/scene&amp;gt; to its hydrophobic pockets.  HSA transports a wide variety of substances through the bloodstream including carbohydrates (e.g &amp;lt;scene name=&#039;57/571397/Hsa_with_glucose/6&#039;&amp;gt;glucose&amp;lt;/scene&amp;gt;), fatty acids (e.g. &amp;lt;scene name=&#039;57/571397/Hsa_with_arachidonic_acid/3&#039;&amp;gt;arachidonic acid&amp;lt;/scene&amp;gt;), hormones (e.g. &amp;lt;scene name=&#039;57/571397/Hsa_with_thyroxine/6&#039;&amp;gt;thyroxine&amp;lt;/scene&amp;gt;, a thyroid hormone), and drugs (e.g. &amp;lt;scene name=&#039;57/571397/Hsa_with_ibp/1&#039;&amp;gt;ibuprofen&amp;lt;/scene&amp;gt;, an anti-inflammatory drug).  &lt;br /&gt;
&lt;br /&gt;
Because HSA is very abundant in blood serum, most biomarker studies involving serum requires preliminary removal of HSA so that other non-abundant but otherwise important disease-indicating proteins can be detected.  In our group, we exploit several properties of HSA in order to efficiently remove it from serum prior to biomarker analysis. These properties include its low isoelectric point (pI of about 4.7) due to a number of &amp;lt;scene name=&#039;57/571397/Overall_structure_of_hsa/5&#039;&amp;gt;acidic residues&amp;lt;/scene&amp;gt;, and its tendency to bind hydrophobic molecules through its hydrophobic pockets.&lt;/div&gt;</summary>
		<author><name>Mahalia Serrano</name></author>
	</entry>
	<entry>
		<id>https://proteopedia.org/index.php?title=Molecular_Playground/Human_Serum_Albumin&amp;diff=2075679</id>
		<title>Molecular Playground/Human Serum Albumin</title>
		<link rel="alternate" type="text/html" href="https://proteopedia.org/index.php?title=Molecular_Playground/Human_Serum_Albumin&amp;diff=2075679"/>
		<updated>2014-12-03T19:01:21Z</updated>

		<summary type="html">&lt;p&gt;Mahalia Serrano: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;== &#039;&#039;&#039;HUMAN SERUM ALBUMIN (HSA)&#039;&#039;&#039; ==&lt;br /&gt;
&lt;br /&gt;
&amp;lt;Structure load=&#039;4iw1&#039; size=&#039;500&#039; frame=&#039;true&#039; align=&#039;right&#039; caption=&#039;Human serum albumin (PDB code [[4iw1]])&#039; scene=&#039;Insert optional scene name here&#039; /&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Human serum albumin&#039;&#039;&#039; (HSA) is the most abundant protein in the blood plasma, amounting to about 35 to 50 grams per liter of serum.  It consists mostly of &amp;lt;scene name=&#039;57/571397/Start/5&#039;&amp;gt;alpha helices&amp;lt;/scene&amp;gt; that form several hydrophobic binding pockets throughout the molecule. &lt;br /&gt;
&lt;br /&gt;
Being the major protein in blood, it functions to maintain the osmotic pressure and the pH of the blood. But most importantly, it functions to transport various substances through the bloodstream.  HSA does not carry a specific cargo, although it does have preference for fat-soluble substances as it can bury the water-insoluble molecules into its hydrophobic core.  Here, we can see &amp;lt;scene name=&#039;57/571397/Hsa_with_myr_and_aspirin/5&#039;&amp;gt;HSA with both myristate (a fatty acid, shown in grey spheres) and aspirin (a common analgesic, shown in pink) bound&amp;lt;/scene&amp;gt; to its hydrophobic pockets.  HSA transports a wide variety of substances through the bloodstream including carbohydrates (e.g &amp;lt;scene name=&#039;57/571397/Hsa_with_glucose/6&#039;&amp;gt;glucose&amp;lt;/scene&amp;gt;), fatty acids (e.g. &amp;lt;scene name=&#039;57/571397/Hsa_with_arachidonic_acid/3&#039;&amp;gt;arachidonic acid&amp;lt;/scene&amp;gt;), hormones (e.g. &amp;lt;scene name=&#039;57/571397/Hsa_with_thyroxine/6&#039;&amp;gt;thyroxine&amp;lt;/scene&amp;gt;, a thyroid hormone), and drugs (e.g. &amp;lt;scene name=&#039;57/571397/Hsa_with_ibp/1&#039;&amp;gt;ibuprofen&amp;lt;/scene&amp;gt;, an anti-inflammatory drug).  &lt;br /&gt;
&lt;br /&gt;
Because HSA is very abundant in blood serum, most biomarker studies involving serum requires preliminary removal of HSA so that other non-abundant but otherwise important disease-indicating proteins can be detected.  In our group, we exploit several properties of HSA in order to efficiently remove it from serum prior to biomarker analysis. These properties include its low isoelectric point (pI of about 4.7) due to a number of &amp;lt;scene name=&#039;57/571397/Overall_structure_of_hsa/5&#039;&amp;gt;acidic residues&amp;lt;/scene&amp;gt;, and its tendency to bind hydrophobic molecules through its hydrophobic pockets.&lt;/div&gt;</summary>
		<author><name>Mahalia Serrano</name></author>
	</entry>
	<entry>
		<id>https://proteopedia.org/index.php?title=Molecular_Playground/Human_Serum_Albumin&amp;diff=2075678</id>
		<title>Molecular Playground/Human Serum Albumin</title>
		<link rel="alternate" type="text/html" href="https://proteopedia.org/index.php?title=Molecular_Playground/Human_Serum_Albumin&amp;diff=2075678"/>
		<updated>2014-12-03T18:57:21Z</updated>

		<summary type="html">&lt;p&gt;Mahalia Serrano: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;== &#039;&#039;&#039;HUMAN SERUM ALBUMIN (HSA)&#039;&#039;&#039; ==&lt;br /&gt;
&lt;br /&gt;
&amp;lt;Structure load=&#039;4k2c&#039; size=&#039;500&#039; frame=&#039;true&#039; align=&#039;right&#039; caption=&#039;Human serum albumin dimer (PDB code [[4k2c]])&#039; scene=&#039;Insert optional scene name here&#039; /&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Human serum albumin&#039;&#039;&#039; (HSA) is the most abundant protein in the blood plasma, amounting to about 35 to 50 grams per liter of serum.  It consists mostly of &amp;lt;scene name=&#039;57/571397/Start/5&#039;&amp;gt;alpha helices&amp;lt;/scene&amp;gt; that form several hydrophobic binding pockets throughout the molecule. &lt;br /&gt;
&lt;br /&gt;
Being the major protein in blood, it functions to maintain the osmotic pressure and the pH of the blood. But most importantly, it functions to transport various substances through the bloodstream.  HSA does not carry a specific cargo, although it does have preference for fat-soluble substances as it can bury the water-insoluble molecules into its hydrophobic core.  Here, we can see &amp;lt;scene name=&#039;57/571397/Hsa_with_myr_and_aspirin/5&#039;&amp;gt;HSA with both myristate (a fatty acid, shown in grey spheres) and aspirin (a common analgesic, shown in pink) bound&amp;lt;/scene&amp;gt; to its hydrophobic pockets.  HSA transports a wide variety of substances through the bloodstream including carbohydrates (e.g &amp;lt;scene name=&#039;57/571397/Hsa_with_glucose/6&#039;&amp;gt;glucose&amp;lt;/scene&amp;gt;), fatty acids (e.g. &amp;lt;scene name=&#039;57/571397/Hsa_with_arachidonic_acid/3&#039;&amp;gt;arachidonic acid&amp;lt;/scene&amp;gt;), hormones (e.g. &amp;lt;scene name=&#039;57/571397/Hsa_with_thyroxine/6&#039;&amp;gt;thyroxine&amp;lt;/scene&amp;gt;, a thyroid hormone), and drugs (e.g. &amp;lt;scene name=&#039;57/571397/Hsa_with_ibp/1&#039;&amp;gt;ibuprofen&amp;lt;/scene&amp;gt;, an anti-inflammatory drug).  &lt;br /&gt;
&lt;br /&gt;
Because HSA is very abundant in blood serum, most biomarker studies involving serum requires preliminary removal of HSA so that other non-abundant but otherwise important disease-indicating proteins can be detected.  In our group, we exploit several properties of HSA in order to efficiently remove it from serum prior to biomarker analysis. These properties include its low isoelectric point (pI of about 4.7) due to a number of &amp;lt;scene name=&#039;57/571397/Overall_structure_of_hsa/5&#039;&amp;gt;acidic residues&amp;lt;/scene&amp;gt;, and its tendency to bind hydrophobic molecules through its hydrophobic pockets.&lt;/div&gt;</summary>
		<author><name>Mahalia Serrano</name></author>
	</entry>
	<entry>
		<id>https://proteopedia.org/index.php?title=Molecular_Playground/Human_Serum_Albumin&amp;diff=2075677</id>
		<title>Molecular Playground/Human Serum Albumin</title>
		<link rel="alternate" type="text/html" href="https://proteopedia.org/index.php?title=Molecular_Playground/Human_Serum_Albumin&amp;diff=2075677"/>
		<updated>2014-12-03T18:50:04Z</updated>

		<summary type="html">&lt;p&gt;Mahalia Serrano: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;== &#039;&#039;&#039;HUMAN SERUM ALBUMIN (HSA)&#039;&#039;&#039; ==&lt;br /&gt;
&lt;br /&gt;
&amp;lt;Structure load=&#039;4k2c&#039; size=&#039;500&#039; frame=&#039;true&#039; align=&#039;right&#039; caption=&#039;Human serum albumin dimer (PDB code [[4k2c]])&#039; scene=&#039;Insert optional scene name here&#039; /&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Human serum albumin&#039;&#039;&#039; (HSA) is the most abundant protein in the blood plasma, amounting to about 35 to 50 grams per liter of serum.  It consists mostly of &amp;lt;scene name=&#039;57/571397/Overall_structure_of_hsa/3&#039;&amp;gt;alpha helices&amp;lt;/scene&amp;gt; that form several hydrophobic binding pockets throughout the molecule. &lt;br /&gt;
&lt;br /&gt;
Being the major protein in blood, it functions to maintain the osmotic pressure and the pH of the blood. But most importantly, it functions to transport various substances through the bloodstream.  HSA does not carry a specific cargo, although it does have preference for fat-soluble substances as it can bury the water-insoluble molecules into its hydrophobic core.  Here, we can see &amp;lt;scene name=&#039;57/571397/Hsa_with_myr_and_aspirin/5&#039;&amp;gt;HSA with both myristate (a fatty acid, shown in grey spheres) and aspirin (a common analgesic, shown in pink) bound&amp;lt;/scene&amp;gt; to its hydrophobic pockets.  HSA transports a wide variety of substances through the bloodstream including carbohydrates (e.g &amp;lt;scene name=&#039;57/571397/Hsa_with_glucose/6&#039;&amp;gt;glucose&amp;lt;/scene&amp;gt;), fatty acids (e.g. &amp;lt;scene name=&#039;57/571397/Hsa_with_arachidonic_acid/3&#039;&amp;gt;arachidonic acid&amp;lt;/scene&amp;gt;), hormones (e.g. &amp;lt;scene name=&#039;57/571397/Hsa_with_thyroxine/6&#039;&amp;gt;thyroxine&amp;lt;/scene&amp;gt;, a thyroid hormone), and drugs (e.g. &amp;lt;scene name=&#039;57/571397/Hsa_with_ibp/1&#039;&amp;gt;ibuprofen&amp;lt;/scene&amp;gt;, an anti-inflammatory drug).  &lt;br /&gt;
&lt;br /&gt;
Because HSA is very abundant in blood serum, most biomarker studies involving serum requires preliminary removal of HSA so that other non-abundant but otherwise important disease-indicating proteins can be detected.  In our group, we exploit several properties of HSA in order to efficiently remove it from serum prior to biomarker analysis. These properties include its low isoelectric point (pI of about 4.7) due to a number of &amp;lt;scene name=&#039;57/571397/Overall_structure_of_hsa/5&#039;&amp;gt;acidic residues&amp;lt;/scene&amp;gt;, and its tendency to bind hydrophobic molecules through its hydrophobic pockets.&lt;/div&gt;</summary>
		<author><name>Mahalia Serrano</name></author>
	</entry>
	<entry>
		<id>https://proteopedia.org/index.php?title=Molecular_Playground/Human_Serum_Albumin&amp;diff=2075676</id>
		<title>Molecular Playground/Human Serum Albumin</title>
		<link rel="alternate" type="text/html" href="https://proteopedia.org/index.php?title=Molecular_Playground/Human_Serum_Albumin&amp;diff=2075676"/>
		<updated>2014-12-03T18:49:01Z</updated>

		<summary type="html">&lt;p&gt;Mahalia Serrano: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;== &#039;&#039;&#039;HUMAN SERUM ALBUMIN (HSA)&#039;&#039;&#039; ==&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Human serum albumin&#039;&#039;&#039; (HSA) is the most abundant protein in the blood plasma, amounting to about 35 to 50 grams per liter of serum.  It consists mostly of &amp;lt;scene name=&#039;57/571397/Overall_structure_of_hsa/3&#039;&amp;gt;alpha helices&amp;lt;/scene&amp;gt; that form several hydrophobic binding pockets throughout the molecule. &lt;br /&gt;
&lt;br /&gt;
Being the major protein in blood, it functions to maintain the osmotic pressure and the pH of the blood. But most importantly, it functions to transport various substances through the bloodstream.  HSA does not carry a specific cargo, although it does have preference for fat-soluble substances as it can bury the water-insoluble molecules into its hydrophobic core.  Here, we can see &amp;lt;scene name=&#039;57/571397/Hsa_with_myr_and_aspirin/5&#039;&amp;gt;HSA with both myristate (a fatty acid, shown in grey spheres) and aspirin (a common analgesic, shown in pink) bound&amp;lt;/scene&amp;gt; to its hydrophobic pockets.  HSA transports a wide variety of substances through the bloodstream including carbohydrates (e.g &amp;lt;scene name=&#039;57/571397/Hsa_with_glucose/6&#039;&amp;gt;glucose&amp;lt;/scene&amp;gt;), fatty acids (e.g. &amp;lt;scene name=&#039;57/571397/Hsa_with_arachidonic_acid/3&#039;&amp;gt;arachidonic acid&amp;lt;/scene&amp;gt;), hormones (e.g. &amp;lt;scene name=&#039;57/571397/Hsa_with_thyroxine/6&#039;&amp;gt;thyroxine&amp;lt;/scene&amp;gt;, a thyroid hormone), and drugs (e.g. &amp;lt;scene name=&#039;57/571397/Hsa_with_ibp/1&#039;&amp;gt;ibuprofen&amp;lt;/scene&amp;gt;, an anti-inflammatory drug).  &lt;br /&gt;
&lt;br /&gt;
Because HSA is very abundant in blood serum, most biomarker studies involving serum requires preliminary removal of HSA so that other non-abundant but otherwise important disease-indicating proteins can be detected.  In our group, we exploit several properties of HSA in order to efficiently remove it from serum prior to biomarker analysis. These properties include its low isoelectric point (pI of about 4.7) due to a number of &amp;lt;scene name=&#039;57/571397/Overall_structure_of_hsa/5&#039;&amp;gt;acidic residues&amp;lt;/scene&amp;gt;, and its tendency to bind hydrophobic molecules through its hydrophobic pockets.&lt;/div&gt;</summary>
		<author><name>Mahalia Serrano</name></author>
	</entry>
	<entry>
		<id>https://proteopedia.org/index.php?title=Molecular_Playground/Human_Serum_Albumin&amp;diff=2075633</id>
		<title>Molecular Playground/Human Serum Albumin</title>
		<link rel="alternate" type="text/html" href="https://proteopedia.org/index.php?title=Molecular_Playground/Human_Serum_Albumin&amp;diff=2075633"/>
		<updated>2014-12-03T17:30:46Z</updated>

		<summary type="html">&lt;p&gt;Mahalia Serrano: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;== &#039;&#039;&#039;HUMAN SERUM ALBUMIN (HSA)&#039;&#039;&#039; ==&lt;br /&gt;
&amp;lt;Structure load=&#039;4k2c&#039; size=&#039;500&#039; frame=&#039;true&#039; align=&#039;right&#039; caption=&#039;Human serum albumin dimer (PDB code [[4k2c]])&#039; scene=&#039;Insert optional scene name here&#039; /&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Human serum albumin&#039;&#039;&#039; (HSA) is the most abundant protein in the blood plasma, amounting to about 35 to 50 grams per liter of serum.  It consists mostly of &amp;lt;scene name=&#039;57/571397/Overall_structure_of_hsa/3&#039;&amp;gt;alpha helices&amp;lt;/scene&amp;gt; that form several hydrophobic binding pockets throughout the molecule. &lt;br /&gt;
&lt;br /&gt;
Being the major protein in blood, it functions to maintain the osmotic pressure and the pH of the blood. But most importantly, it functions to transport various substances through the bloodstream.  HSA does not carry a specific cargo, although it does have preference for fat-soluble substances as it can bury the water-insoluble molecules into its hydrophobic core.  Here, we can see &amp;lt;scene name=&#039;57/571397/Hsa_with_myr_and_aspirin/5&#039;&amp;gt;HSA with both myristate (a fatty acid, shown in grey spheres) and aspirin (a common analgesic, shown in pink) bound&amp;lt;/scene&amp;gt; to its hydrophobic pockets.  HSA transports a wide variety of substances through the bloodstream including carbohydrates (e.g &amp;lt;scene name=&#039;57/571397/Hsa_with_glucose/6&#039;&amp;gt;glucose&amp;lt;/scene&amp;gt;), fatty acids (e.g. &amp;lt;scene name=&#039;57/571397/Hsa_with_arachidonic_acid/3&#039;&amp;gt;arachidonic acid&amp;lt;/scene&amp;gt;), hormones (e.g. &amp;lt;scene name=&#039;57/571397/Hsa_with_thyroxine/6&#039;&amp;gt;thyroxine&amp;lt;/scene&amp;gt;, a thyroid hormone), and drugs (e.g. &amp;lt;scene name=&#039;57/571397/Hsa_with_ibp/1&#039;&amp;gt;ibuprofen&amp;lt;/scene&amp;gt;, an anti-inflammatory drug).  &lt;br /&gt;
&lt;br /&gt;
Because HSA is very abundant in blood serum, most biomarker studies involving serum requires preliminary removal of HSA so that other non-abundant but otherwise important disease-indicating proteins can be detected.  In our group, we exploit several properties of HSA in order to efficiently remove it from serum prior to biomarker analysis. These properties include its low isoelectric point (pI of about 4.7) due to a number of &amp;lt;scene name=&#039;57/571397/Overall_structure_of_hsa/5&#039;&amp;gt;acidic residues&amp;lt;/scene&amp;gt;, and its tendency to bind hydrophobic molecules through its hydrophobic pockets.&lt;/div&gt;</summary>
		<author><name>Mahalia Serrano</name></author>
	</entry>
	<entry>
		<id>https://proteopedia.org/index.php?title=Molecular_Playground/Human_Serum_Albumin&amp;diff=2075631</id>
		<title>Molecular Playground/Human Serum Albumin</title>
		<link rel="alternate" type="text/html" href="https://proteopedia.org/index.php?title=Molecular_Playground/Human_Serum_Albumin&amp;diff=2075631"/>
		<updated>2014-12-03T17:29:38Z</updated>

		<summary type="html">&lt;p&gt;Mahalia Serrano: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;== &#039;&#039;&#039;HUMAN SERUM ALBUMIN (HSA)&#039;&#039;&#039; ==&lt;br /&gt;
&lt;br /&gt;
&amp;lt;scene name=&#039;57/571397/Start/3&#039;&amp;gt;&#039;&#039;&#039;Human serum albumin&#039;&#039;&#039; (HSA)&amp;lt;/scene&amp;gt; &lt;br /&gt;
 is the most abundant protein in the blood plasma, amounting to about 35 to 50 grams per liter of serum.  It consists mostly of &amp;lt;scene name=&#039;57/571397/Overall_structure_of_hsa/3&#039;&amp;gt;alpha helices&amp;lt;/scene&amp;gt; that form several hydrophobic binding pockets throughout the molecule. &lt;br /&gt;
&lt;br /&gt;
Being the major protein in blood, it functions to maintain the osmotic pressure and the pH of the blood. But most importantly, it functions to transport various substances through the bloodstream.  HSA does not carry a specific cargo, although it does have preference for fat-soluble substances as it can bury the water-insoluble molecules into its hydrophobic core.  Here, we can see &amp;lt;scene name=&#039;57/571397/Hsa_with_myr_and_aspirin/5&#039;&amp;gt;HSA with both myristate (a fatty acid, shown in grey spheres) and aspirin (a common analgesic, shown in pink) bound&amp;lt;/scene&amp;gt; to its hydrophobic pockets.  HSA transports a wide variety of substances through the bloodstream including carbohydrates (e.g &amp;lt;scene name=&#039;57/571397/Hsa_with_glucose/6&#039;&amp;gt;glucose&amp;lt;/scene&amp;gt;), fatty acids (e.g. &amp;lt;scene name=&#039;57/571397/Hsa_with_arachidonic_acid/3&#039;&amp;gt;arachidonic acid&amp;lt;/scene&amp;gt;), hormones (e.g. &amp;lt;scene name=&#039;57/571397/Hsa_with_thyroxine/6&#039;&amp;gt;thyroxine&amp;lt;/scene&amp;gt;, a thyroid hormone), and drugs (e.g. &amp;lt;scene name=&#039;57/571397/Hsa_with_ibp/1&#039;&amp;gt;ibuprofen&amp;lt;/scene&amp;gt;, an anti-inflammatory drug).  &lt;br /&gt;
&lt;br /&gt;
Because HSA is very abundant in blood serum, most biomarker studies involving serum requires preliminary removal of HSA so that other non-abundant but otherwise important disease-indicating proteins can be detected.  In our group, we exploit several properties of HSA in order to efficiently remove it from serum prior to biomarker analysis. These properties include its low isoelectric point (pI of about 4.7) due to a number of &amp;lt;scene name=&#039;57/571397/Overall_structure_of_hsa/5&#039;&amp;gt;acidic residues&amp;lt;/scene&amp;gt;, and its tendency to bind hydrophobic molecules through its hydrophobic pockets.&lt;/div&gt;</summary>
		<author><name>Mahalia Serrano</name></author>
	</entry>
	<entry>
		<id>https://proteopedia.org/index.php?title=Molecular_Playground/Human_Serum_Albumin&amp;diff=2075628</id>
		<title>Molecular Playground/Human Serum Albumin</title>
		<link rel="alternate" type="text/html" href="https://proteopedia.org/index.php?title=Molecular_Playground/Human_Serum_Albumin&amp;diff=2075628"/>
		<updated>2014-12-03T17:28:52Z</updated>

		<summary type="html">&lt;p&gt;Mahalia Serrano: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;== &#039;&#039;&#039;HUMAN SERUM ALBUMIN (HSA)&#039;&#039;&#039; ==&lt;br /&gt;
&lt;br /&gt;
&amp;lt;scene name=&#039;57/571397/Start/3&#039;&amp;gt;&#039;&#039;&#039;Human serum albumin&#039;&#039;&#039; (HSA)&amp;lt;/scene&amp;gt;&lt;br /&gt;
 is the most abundant protein in the blood plasma, amounting to about 35 to 50 grams per liter of serum.  It consists mostly of &amp;lt;scene name=&#039;57/571397/Overall_structure_of_hsa/3&#039;&amp;gt;alpha helices&amp;lt;/scene&amp;gt; that form several hydrophobic binding pockets throughout the molecule. &lt;br /&gt;
&lt;br /&gt;
Being the major protein in blood, it functions to maintain the osmotic pressure and the pH of the blood. But most importantly, it functions to transport various substances through the bloodstream.  HSA does not carry a specific cargo, although it does have preference for fat-soluble substances as it can bury the water-insoluble molecules into its hydrophobic core.  Here, we can see &amp;lt;scene name=&#039;57/571397/Hsa_with_myr_and_aspirin/5&#039;&amp;gt;HSA with both myristate (a fatty acid, shown in grey spheres) and aspirin (a common analgesic, shown in pink) bound&amp;lt;/scene&amp;gt; to its hydrophobic pockets.  HSA transports a wide variety of substances through the bloodstream including carbohydrates (e.g &amp;lt;scene name=&#039;57/571397/Hsa_with_glucose/6&#039;&amp;gt;glucose&amp;lt;/scene&amp;gt;), fatty acids (e.g. &amp;lt;scene name=&#039;57/571397/Hsa_with_arachidonic_acid/3&#039;&amp;gt;arachidonic acid&amp;lt;/scene&amp;gt;), hormones (e.g. &amp;lt;scene name=&#039;57/571397/Hsa_with_thyroxine/6&#039;&amp;gt;thyroxine&amp;lt;/scene&amp;gt;, a thyroid hormone), and drugs (e.g. &amp;lt;scene name=&#039;57/571397/Hsa_with_ibp/1&#039;&amp;gt;ibuprofen&amp;lt;/scene&amp;gt;, an anti-inflammatory drug).  &lt;br /&gt;
&lt;br /&gt;
Because HSA is very abundant in blood serum, most biomarker studies involving serum requires preliminary removal of HSA so that other non-abundant but otherwise important disease-indicating proteins can be detected.  In our group, we exploit several properties of HSA in order to efficiently remove it from serum prior to biomarker analysis. These properties include its low isoelectric point (pI of about 4.7) due to a number of &amp;lt;scene name=&#039;57/571397/Overall_structure_of_hsa/5&#039;&amp;gt;acidic residues&amp;lt;/scene&amp;gt;, and its tendency to bind hydrophobic molecules through its hydrophobic pockets.&lt;/div&gt;</summary>
		<author><name>Mahalia Serrano</name></author>
	</entry>
	<entry>
		<id>https://proteopedia.org/index.php?title=Molecular_Playground/Human_Serum_Albumin&amp;diff=2075627</id>
		<title>Molecular Playground/Human Serum Albumin</title>
		<link rel="alternate" type="text/html" href="https://proteopedia.org/index.php?title=Molecular_Playground/Human_Serum_Albumin&amp;diff=2075627"/>
		<updated>2014-12-03T17:27:59Z</updated>

		<summary type="html">&lt;p&gt;Mahalia Serrano: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;== &#039;&#039;&#039;HUMAN SERUM ALBUMIN (HSA)&#039;&#039;&#039; ==&lt;br /&gt;
&amp;lt;Structure load=&#039;4k2c&#039; size=&#039;500&#039; frame=&#039;true&#039; align=&#039;right&#039; caption=&#039;Human serum albumin dimer (PDB code [[4k2c]])&#039; scene=&#039;Insert optional scene name here&#039; /&amp;gt;&lt;br /&gt;
&amp;lt;scene name=&#039;57/571397/Start/3&#039;&amp;gt;TextToBeDisplayed&amp;lt;/scene&amp;gt;&lt;br /&gt;
&#039;&#039;&#039;Human serum albumin&#039;&#039;&#039; (HSA) is the most abundant protein in the blood plasma, amounting to about 35 to 50 grams per liter of serum.  It consists mostly of &amp;lt;scene name=&#039;57/571397/Overall_structure_of_hsa/3&#039;&amp;gt;alpha helices&amp;lt;/scene&amp;gt; that form several hydrophobic binding pockets throughout the molecule. &lt;br /&gt;
&lt;br /&gt;
Being the major protein in blood, it functions to maintain the osmotic pressure and the pH of the blood. But most importantly, it functions to transport various substances through the bloodstream.  HSA does not carry a specific cargo, although it does have preference for fat-soluble substances as it can bury the water-insoluble molecules into its hydrophobic core.  Here, we can see &amp;lt;scene name=&#039;57/571397/Hsa_with_myr_and_aspirin/5&#039;&amp;gt;HSA with both myristate (a fatty acid, shown in grey spheres) and aspirin (a common analgesic, shown in pink) bound&amp;lt;/scene&amp;gt; to its hydrophobic pockets.  HSA transports a wide variety of substances through the bloodstream including carbohydrates (e.g &amp;lt;scene name=&#039;57/571397/Hsa_with_glucose/6&#039;&amp;gt;glucose&amp;lt;/scene&amp;gt;), fatty acids (e.g. &amp;lt;scene name=&#039;57/571397/Hsa_with_arachidonic_acid/3&#039;&amp;gt;arachidonic acid&amp;lt;/scene&amp;gt;), hormones (e.g. &amp;lt;scene name=&#039;57/571397/Hsa_with_thyroxine/6&#039;&amp;gt;thyroxine&amp;lt;/scene&amp;gt;, a thyroid hormone), and drugs (e.g. &amp;lt;scene name=&#039;57/571397/Hsa_with_ibp/1&#039;&amp;gt;ibuprofen&amp;lt;/scene&amp;gt;, an anti-inflammatory drug).  &lt;br /&gt;
&lt;br /&gt;
Because HSA is very abundant in blood serum, most biomarker studies involving serum requires preliminary removal of HSA so that other non-abundant but otherwise important disease-indicating proteins can be detected.  In our group, we exploit several properties of HSA in order to efficiently remove it from serum prior to biomarker analysis. These properties include its low isoelectric point (pI of about 4.7) due to a number of &amp;lt;scene name=&#039;57/571397/Overall_structure_of_hsa/5&#039;&amp;gt;acidic residues&amp;lt;/scene&amp;gt;, and its tendency to bind hydrophobic molecules through its hydrophobic pockets.&lt;/div&gt;</summary>
		<author><name>Mahalia Serrano</name></author>
	</entry>
</feed>